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 Zusammenfassung 
Cadherine stellen eine große Familie von transmembranen Adhäsionsrezeptoren auf Zelloberflächen 
dar, deren erlesene Bindungsspezifitäten für die Formation und Instandhaltung der Gewebearchitektur 
von Vertebraten und Invertebraten verantwortlich sind. Circa 100 nicht klassische und 19 klassische 
Cadherine sind in Wirbeltiergenomen kodiert. Klassische Cadherine gliedern sich in zwei 
Unterfamilien: Typ I und II, von denen beide Kalzium abhängige Zelladhäsion vermitteln, die 
morphologischen Prozessen in Wirbeltieren zu Grunde liegen. Typ I Cadherine sind zumeist 
großflächig in Keimblättern und Epithelien exprimiert, wohingegen Typ II Cadherine im sich 
entwickelnden und erwachsenen zentralen Nervensystem (ZNS) weitaus feingliedriger und auch 
überlappend exprimiert sind. Vaskulär-endotheliales (VE) Cadherin, ein divergentes Mitglied der Typ 
II Familie, vermittelt homophile Zelladhäsion ausschließlich im Endothel, das die Blutgefäße 
auskleidet und ist unabkömmlich für vaskuläre Angiogenese und Instandhaltung der Vaskulatur. Für 
bakteriell produzierte VE-cadherin Ektodomän Fragmente wurde ein Adhäsionsmodel vorgeschlagen, 
bei dem sich das Protein auf derselben Zelloberfläche lateral zu Trimeren organisiert, die mit Trimeren 
nebeneinander liegender Zellen trans adhäsive Hexamere bilden. Dieses Model weicht stark vom 
allgemein akzeptierten Bindungsmechanismus anderer Cadherine ab, der als ‚strand swap’ 
Mechanismus bezeichnet wird, da er auf dem Austausch N-terminaler Regionen der extrazellulären 
cadherin (EC) ähnlichen Domänen zwischen zwei Protomeren besteht, aber keine Bildung von 
Trimeren involviert. Die vorliegende Dissertation befasst sich mit der detaillierten Charakterisierung 
des adhäsiven Bindungsmechanismus von VE-cadherin Ektodomänen, die in Säugetierzellen 
produziert wurden. Biophysikalische Studien, wie analytische Ultrazentrifugation, Größenausschluß-
chromatographie, Lichtstreudetektion und Aggregation von Liposomen sowie spektroskopische 
Rasterkraftmikroskopie von Proteinen in Lösung und Elektronen-mikroskopie künstlicher 
Zellverbindungen, zeigen, dass VE-cadherin den ‚strand swap’ Mechanismus klassischer Cadherine 
adoptiert, indem ausschließlich trans adhäsive Dimere gebildet werden. Zusätzlich wurde gefunden, 
dass die beschriebenen Trimere Artefakte repräsentieren, deren Bildung durch die Abwesenheit von 
Glykosylierung bei bakteriell produzierten Proteinen hervorgerufen wurde. Die Kristallstruktur der 
adhäsiven Domänen EC1-2 von VE-cadherin mit einer Auflösung von 2.1Å enthüllte Homodimere, 
deren Formation der ‚strand swap’ Mechanismus zu Grunde liegt. Die adhäsive Interaktionsseite ist 
einzigartig, da sie Charakteristika von Typ I und II Cadherinen vereint, was zu einer unüblichen 
Konfiguration des Dimers führt. VE-cadherin stellt daher einen strukturellen Außenseiter der Typ II 
Cadherine dar. Eine Studie, die homo- und heterophile Interaktionen von Typ II Cadherinen 
untersuchte, schlägt zum ersten Mal einen Bindungscode für diese Zelladhäsionsproteine vor, der die 
Spezifität ihres heterophilen Bindungsmusters entschlüsselt. Interessanter Weise wurde auch eine 
Interaktion zwischen Typ I N- und Typ II VE-cadherin, identifiziert, die unabhängig vom ‚strand 
swap’ Mechanismus ist, und eine neuartige Form einer cis-Interaction verspricht.  
Schlüsselwörter: Zell-Zell-Adhäsion / Cadherine / Kristallstruktur.   
 
 
Abstract 
Cadherins constitute a large family of cell surface transmembrane adhesion receptors whose binding 
specificity is important in generation and maintenance of tissue architecture in vertebrates and 
invertebrates. About 100 nonclassical cadherins and approximately 18 classical cadherins are encoded 
in vertebrate genomes. Classical cadherins, comprised of two subfamilies the type I and type II 
cadherins, mediate calcium dependent cell-cell adhesion that is essential for morphogenesis in 
vertebrates. Type I cadherins are typically expressed broadly in germ layers or epithelia, whereas type 
II cadherins have a finely grained expression pattern, which is overlapping and primarily restricted to 
the developing and adult nervous system. A divergent member of the type II cadherin family, vascular 
endothelial (VE) cadherin, mediates homophilic adhesion in the vascular endothelium and is crucial 
for vascular angiogenesis, maintenance and restoration of vascular integrity after injury. In the past a 
binding model for VE-cadherin has been proposed based on data from bacterially produced 
ectodomain fragments in which the protein forms trimers laterally on the same cell surface, which bind 
to trimers presented by juxtaposed cells to form adherent hexamers. This model is substantially 
different from the well characterized binding mechanism of other classical cadherins, which is 
mediated by N-terminal extracellular cadherin (EC) domains in a three dimensional domain swapping 
mechanism, termed the ‘strand swap mechanism’, and involves no trimer interactions. Here I report 
extensive studies of purified mammalian produced VE-cadherin ectodomains to elucidate the adhesive 
binding mechanism of this crucial protein. Biophysical studies such as analytical ultracentrifugation, 
size exclusion chromatography and multi angle light scattering in addition to liposome aggregation 
and atomic force microscopy imaging studies and cryo electron microscopy of artificial junctions 
reveal that VE-cadherin forms adhesive trans dimers between monomers emanating from opposing 
cell surfaces and not hexamers. Trimerization of bacterially produced protein is found to be artifactual 
due to lack of glycosylation. I present the 2.1Å resolution crystal structure of VE-cadherin adhesive 
domains EC1-2 which reveals that the strand swap mechanism common to classical cadherins 
underlies homodimerization. The adhesive interface of VE-cadherin is unique as it features 
characteristics of both cadherin subfamilies. Two tryptophan residues are exchanged which is 
reminiscent of type II cadherins, but an extended non polar interface region specific to type II 
subfamily members is absent as observed for type I cadherins, resulting in an unusual overall dimer 
organization. VE-cadherin can therefore be described as a structural outlier among classical cadherins. 
A systematic binding study of homophilic and heterophilic interactions of type II cadherins, including 
VE-cadherin, was performed and reveals evidence for a new binding code which appears to govern the 
specificity of these important CNS cell adhesion proteins. In addition, for the first time, a strong 
heterophilic interaction between type I N-cadherin and type II VE-cadherin could be identified, which 
appears to be strand swap independent and may represent a novel cis interaction between these 
cadherins.  
Key words: Cell-cell adhesion / cadherins / crystal structure. 
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List of commonly used abbreviations 
 
Abbreviation Description 
  
A pool Adductor motor pool 
Å Angström 
AFM Atomic force microscopy 
AUC Analytical ultracentrifugation 
A*-strand N-terminal section of the A-strand used for strand swapping 
Avi-tag C-terminal tag (GGGLNDIFEAGKIEWE) 
Avi*bio-tag Biotinylated C-terminal tag (GGGLNDIFEAGKIEWE, Lys biotinylated) 
BSA Buried solvent accessible area 
Cα Carbon alpha atom of amino acid 
CAM Cell adhesion molecule 
C-cadherin Compact embryonal stage cadherin 
Cis Lateral association between proteins on the same cell or liposome surface 
CM-dextran Carboxymethyl-dextran 
CYS-tag C-terminal tag (GGGC)  
C9-tag C-terminal tag (GGGTETSQVAPA) 
Da Dalton 
DGS-NTA (Ni) 1,2-dioleoyl-sn-glycero-3-[(N-(5-amino-1-carboxypentyl)iminodiacetic acid)-succinyl] 
nickel salt 
DOPC 1,2-dioleyl-sn-glycero-3-phsphocholine 
E9.5 Embryonic stage day 9.5 
E-cadherin Epithelial cadherin 
EC-domain Extracellular cadherin domain 
EDC 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide 
eF motor pool External Femorotibialis motor pool 
EM Electron microscopy 
FLAG-tag C-terminal tag (DYKDDDDK), FLAG owned by Sigma 
GPI-anchor Glycosylphosphatidylinositole anchor 
HEK 293 F cells Human embryonal kidney cells line 293 fast growth 
HEK 293 GNTI- HEK-cells 293 lacking enzyme N-acetylglucosamine transferase I 
KD Dissociation constant as measure for binding affinity 
KD(i) Isodesmic dissociation constant 
MALDI Matrix-assisted laser desorption/ ionisation 
MALS Multi angle light scatterin 
MN-cadherin Motor neuron cadherin 
N-cadherin Neural cadherin 
NHS N-hydroxysuccinimide 
NTA Nitrilotriacetic acid (chelating agent) 
Ni-NTA Nitrilotriacetic acid chelating Nickel (II)  
P Crystallographic point group 
PAGE Poly acrylamid gel electrophoresis 
P-cadherin Placental cadherin 
Pdb Protein data bank 
PDEA 2-(2-pyrdinyldithio) ethaneamine 
PISA Protein interactions, surfaces and assemblies 
r. m. s. d.  Root mean square deviation 
RU Response Unit 
SDS Sodium Dodecyl Sulfate 
SPR Surface Plasmon Resonance 
T-cadherin Truncated cadherin 
TCEP Tris(2-carboxyethyl)phosphine 
TOF Time of flight 
Trans Association between two opposing cells or liposomes 
VE-cadherin Vascular endothelial cadherin 
1d4 Antibody recognizing C9 antigen 
3D Three dimensional 
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1.1 Cell adhesion in multicellular organisms 
Every multicellular organism is constituted of heterotypic cells arranged into specific tissues, 
which form the basis for the formation of organs and complex tissue architectures (Gumbiner, 
1996; Takeichi, 1991). Selective organization of cells within and between these tissues is 
governed by the process of cell adhesion through which cells bind to adjacent cells or to 
extracellular structures (Gumbiner, 1996; Takeichi, 1991). Cell surface associated 
glycoproteins, termed cell-adhesion molecules (CAMs), are responsible for these processes. 
CAMs adhere either to other CAMs on surfaces of adjacent cells to mediate cell-cell adhesion 
or instead to components of the extracellular matrix to mediate cell-matrix adhesion 
(Takeichi, 1991). Interactions of CAMs are highly specific and can be either homophilic, in 
which identical CAMs bind to each other, or heterophilic, in which binding occurs between 
distinct proteins. Specific interactions at the molecular level are thought to underlie tissue 
morphogenesis and architecture on the cellular level.  
 
Since the first observations of selective cell adhesion (Steinberg and Gilbert, 2004) several 
major families of CAMs have been identified. Integrins and integrin ligands are primarily 
responsible for cell-matrix adhesion (Tuckwell and Humphries, 1993). Calcium independent 
cell-cell adhesion is mediated by members of the immunoglobin-like superfamily, including 
nectins and NCAMs (Goridis and Brunet, 1992; Takai et al., 2008) in addition to smaller 
families of adhesion molecules such as claudins and connexins (Cruciani and Mikalsen, 2006; 
Koval, 2006). The major family of adhesion proteins responsible for calcium dependent cell-
cell adhesion in vertebrates and invertebrates are the cadherins. Cadherins are essential during 
all stages of development for intercellular adhesion and cell sorting and are expressed in 
virtually all solid tissues in the adult where they are responsible for maintenance of tissue 
architecture (Patel et al., 2003; Suzuki, 1997; Takeichi, 1990, 1991). This important family of 
cell adhesion proteins will be the focus of this thesis. 
 
1.1 The cadherin superfamily of calcium dependent cell adhesion molecules 
Cadherins, which mediate cell-cell adhesion dependent on calcium ions, constitute a large 
superfamily of more than 350 proteins (Hulpiau and van Roy, 2009). Members of this 
superfamily are expressed in all vertebrates and invertebrates and are found even in 
choanoflagellates, the closest known unicellular relative of animals (Abedin and King, 2008). 
Most are thought to function in cell adhesion or recognition processes. Cadherins are all 
membrane associated glycoproteins, most being single-pass transmembrane proteins, which 
12 
 
have at least two tandem repeats of a characteristic structural element, the extracellular 
cadherin-like (EC) domain in their extracellular region (Nollet et al., 2000). The overall 
protein domain organization, number of EC domains present in the molecule and other 
sequence characteristics vary widely between different cadherins, allowing division of this 
family into several subfamilies (Figure 1 and (Nollet et al., 2000)). The classical type I and II 
cadherins constitute the best characterized of these. Classical cadherins are single-pass 
transmembrane proteins with an extracellular region comprised of five EC domains and are 
linked to the actin cytoskeleton by a highly conserved cytoplasmic domain that interacts with 
adaptor proteins called catenins. Classical cadherins are expressed exclusively in vertebrates 
throughout all stages of development including in the adult and are essential for tissue 
morphogenesis. Type I and type II classical cadherins are the focus of this thesis work and 
will be described in detail in subsequent sections. Other subfamilies have been less studied, 
but have similarly important roles. Protocadherins represents the largest subfamily of 
cadherins in mammals with more than 60 different proteins, which are primarily expressed in 
the central nervous system where their diversity may be important for neural patterning 
(Hulpiau and van Roy, 2009; Sano et al., 1993). Desmocollin and desmoglein subfamily 
members are localized together in the same cellular structure in vertebrate animals, referred to 
as the desmosome, which is a specialized cell-cell junction found mostly in tissues subject to 
mechanical stress, that is anchored to intermediate filaments intracellularly (Huber, 2003). 
Flamingo cadherins are unusual in the superfamily in that they are seven-pass transmembrane 
receptors. These are involved in planar cell polarity processes in both vertebrates and 
invertebrates (Usui et al., 1999). In addition, there are a few solitary atypical cadherin 
superfamily members which, too, mediate cell-cell adhesion, but cannot be grouped into the 
aforementioned subfamilies. These include the invertebrate ‘classical’ cadherins such as 
drosophila melanogaster DN- and DE-cadherins (Hynes and Zhao, 2000), as well as FAT and 
dachsous proteins (Sopko and McNeill, 2009). They are comprised of large numbers (>5) of 
EC domain repeats intermixed with other structural motifs. Another solitary member of the 
cadherin family is truncated (T-) cadherin (Figure 1), which shows an overall extracellular 
domain organization closely similar to that of classical cadherins with the caveat that T-
cadherin lacks the cytoplasmic domain, which is replaced by a glycosylphophatidyl inositole 
(GPI)-anchor (Ranscht and Dours-Zimmermann, 1991). 
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1.2 General features of classical cadherins  
Classical cadherins are divided into two groups, type I and type II, on the basis of differences 
at the level of sequence and genomic organization (Nollet et al., 2000). Both type I and type II 
classical cadherins mediate calcium-dependent cell-cell adhesion and show some degree of 
homophilic specificity in that adhesion between identical cadherin subtypes is favored, at 
least to some extent, over that between different cadherins (see Section 8.4 for discussion). 
Type I and II cadherins are expressed in solid tissues of all vertebrates, but they exhibit 
different types of distribution regarding their expression pattern. Type I cadherins have rather 
broad expression patterns, which are separated by germ layers and tissue types (Nakagawa 
and Takeichi, 1998), whereas type II cadherins are predominantly expressed in finely grained, 
often overlapping patterns in the central nervous system (Price et al., 2002; Suzuki et al., 
1991), in which they occur often in combinations of two or more subsets per single cell (Price 
et al., 2002). A notable exception is the type II cadherin-5 (VE-cadherin) that is found to be 
expressed exclusively in the vascular endothelium (See Introduction 1.8, (Breier et al., 1996; 
Lampugnani et al., 1992). 18 classical cadherins have been identified so far in mouse and 
human, five of which are type I cadherins: Epithelial (E-), Neural (N-), Placental (P-), Retinal 
(R-) and Muscle (M-) cadherin and 14 are type II cadherins vascular endothelial (VE-) 
cadherin (sometimes referred to as cadherin-5), cadherin-6, -7, -8, -9, -10, -11, -12,  -18, -19, 
-20, -22 and -24 (Hulpiau and van Roy, 2009; Posy et al., 2008). The phenotypes of knockout 
mice for individual classical cadherin subtypes tend to reflect the different types of expression 
patterns observed for type I and type II cadherins. Effects of type I cadherin inactivation are 
severe, at least in the cases of E- and N-cadherin. E-cadherin null embryos die at the 
preimplantation stage due to failure of adhesion and compaction in the blastocyst, while N-
cadherin null embryos die during gestation due to severe cell adhesion defects in the heart and 
also show malformation of the neural tube (Charlton et al., 1997). Both knockouts underscore 
the essential role for classical cadherin-mediated calcium dependent adhesion throughout 
development. In contrast, type II cadherin knockout phenotypes tend to be more subtle. For 
example, cadherin-6 and cadherin-8 knockout mice are viable but show defects in 
compartmentalization in the CNS and kidney development or in cold sensation, respectively 
(Inoue et al., 2001; Suzuki et al., 2007). The VE-cadherin knockout phenotype will be 
discussed in a later Section 1.8.2. 
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Table 1: Classical type I and II cadherins identified in mouse and human. 
 
Classical type I cadherins Classical type II cadherins 
  
E-cadherin VE-cadherin /cadherin-5a 
N-cadherin cadherin-6 
P-cadherin cadherin-7 
R-cadherin cadherin-8 
M-cadherin cadherin-9 
 cadherin-10 
 cadherin-11 
 cadherin-12 
 cadherin-18b 
 cadherin-19 
 MN-cadherin / cadherin-20 a 
 cadherin-22 
 cadherin-24 
  
 
a These cadherins are more commonly known under the first listed name. 
b Human Cadherin-18 is sometimes referred to as cadherin-14. 
 
All classical cadherins share the same overall protein organization (Figure 1 and 2) and are 
expressed as inactive pro-proteins, with an N-terminal pro-domain resembling a cadherin EC-
like domain fold, which is removed by furine proteases on the cell surface yielding mature 
protein that is active in adhesion (Koch et al., 2004). The mature protein is comprised of a 
large extracellular domain, commonly referred to as the ectodomain, a single pass class I 
transmembrane domain and a short cytoplasmic tail of approximately 150 amino acids in 
length, which is highly conserved on the sequence level (Figure 2)(Nollet et al., 2000). 
Mature ectodomains are composed of five successive EC domains with approximately 110 
amino acids each connected by interdomain linkers, reminiscent of beads on a string. A wide 
array of structural data revealed that these EC domains are each composed of a seven stranded 
β-barrel (Boggon et al., 2002; Ciatto et al., 2010; Harrison et al., 2010a; Harrison et al., 
2010b; Haussinger et al., 2004; Nagar et al., 1996; Patel et al., 2003; Patel et al., 2006; 
Shapiro et al., 1995), in which the strands are by convention named A to G from the most N-
terminal to the most C-terminal strand (Figure 2b and c).  
16 
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The A strand is further divided into an N-terminal portion (the A* strand) and a C-terminal 
portion (the A strand), which hydrogen bond to the B and G strands, respectively (Figure 2b). 
Three atomic resolution structures of full length classical cadherins (Boggon et al., 2002; 
Harrison et al., 2010b) gave detailed information about the arrangement and conformation of 
the cadherin ectodomain, which was found in each to adopt a highly similar crescent shaped, 
curved form (Figure 2a). Successive EC-domains bind three divalent calcium ions in their 
interdomain linker regions (Figure 2), principally via carboxylate side chains of acidic 
residues in three motifs, conserved on sequence level for all classical cadherins: DRE, in the 
EC domain preceding the interdomain linker, DXND directly in the linker region and DXD 
localized in the EC domain posterior to the linker (Figure 2 and 3) (Boggon et al., 2002; 
Nagar et al., 1996). Electron microscopy studies of cadherin ectodomains in presence and 
absence of calcium (II) revealed, that it is crucial for locking the orientation of successive EC 
domains to each other into a rigid curved overall shape; in the absence of calcium 
ectodomains are folded into globular shapes (Pokutta et al., 1994). In addition, cell-cell 
aggregation experiments of cadherin expressing cells showed that removal of calcium (II) 
resulted in abrogation of adhesion (Takeichi et al., 1988), which confirms its role for the 
biological importance of these proteins. Notably, the binding to calcium also protects the 
ectodomains of cadherins, especially the interdomain linker regions, from proteolytic 
digestion (Takeichi, 1991). These rigid cadherins ectodomains engage in binding interactions 
across intercellular contacts to mediate adhesion and are linked to the cytoplasm through 
interactions of the cadherin cytoplasmic tail with armadillo proteins β- or γ- and p120-catenin 
(Figure 2a and (Gentil-Dit-Maurin et al., 2010; Huber and Weis, 2001; Ishiyama et al., 2010; 
Lampugnani et al., 1995; Ozawa et al., 1989)). These adaptor proteins enable the indirect 
attachment of cadherins to the cytoskeleton via further intracellular protein interactions with 
proteins such as α-catenin (Figure 2a) (Kobielak and Fuchs, 2004). p120 catenin also has a 
well defined role in regulation of cadherin trafficking (Liu et al., 2007; Reynolds and 
Carnahan, 2004).  
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1.3 Molecular basis of cadherin-cadherin binding 
Early in vitro studies showed that a variety of cell lines that do not normally form aggregates 
in suspension could be induced to aggregate in a calcium dependent manner by transfection 
with cDNA encoding cell surface type I or type II classical cadherins (Breviario et al., 1995; 
Hatta et al., 1988; Nagafuchi et al., 1987; Takeichi et al., 1988). Blocking studies also 
demonstrated that calcium dependent adhesion between cells in culture or in embryonic 
tissues could be disrupted by addition of antibodies against the cadherin ectodomain (May et 
al., 2005; Vestweber and Kemler, 1985; Volk et al., 1984).Together with subsequent 
experiments, including mutational analyses and gene deletion studies, these assays established 
the role of molecular interactions between cadherins in driving calcium dependent cell-cell 
adhesion. These interactions occur between cadherin ectodomains presented on opposing 
cells. Purified ectodomain fragments were found to associate homophilically in a variety of 
assays (Harrison 2010b, 2010a, Katsamba 2009, Ahrens 2003, Boggon 2002, Nagar 1996). 
Additionally, while interactions between the cadherin cytoplasmic domain and the 
cytoskeleton were found to be essential for proper cellular cohesion (Gentil-dit-Maurin 2010, 
Kintner 1992, Nagafuchi 1989), recently it has been found that in cryo EM and transfection 
studies (Harrison et al., 2010b; Hong et al., 2010; Ozaki et al., 2010), cadherin ectodomains 
attached to the plasma membrane are sufficient for initial cell-cell adhesion. 
 
The binding interface between cadherin ectodomains that underlies homophilic classical 
cadherin adhesion has been extensively characterized by atomic resolution structures of 
adhesive ectodomain fragments from classical type I (Boggon et al., 2002; Harrison et al., 
2010a; Harrison et al., 2010b; Haussinger et al., 2004; Nagar et al., 1996; Shapiro et al., 1995) 
and type II (Patel et al., 2006) cadherins. In crystal structures of each type, dimers are 
observed between molecules oriented as if interacting across the intercellular space, in which 
two cadherin protomers bind to each other via their membrane distal EC1 domains (Figure 
3a). The dimers are two fold symmetrical and EC1 domains are arranged approximately 
parallel producing, due to the curvature of the protomers, an overall trans dimer orientation. 
In all native classical cadherin dimers, the amino terminal residues of the A-strand, designated 
the A*-strand, are exchanged between both protomers (Figure 3b) and are held in place by 
intermolecular hydrophobic and ionic interactions as well as hydrogen bonds. This 
arrangement is referred to as the strand swapped cadherin dimer. The exchange of β-strands is 
stabilized by docking of one tryptophan residue (Trp2) in type I cadherins or two tryptophan 
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residues, Trp2 and Trp4, in type II cadherins into a hydrophobic acceptor pocket of the 
partnering molecule (Figure 3b).  
 
Type I and type II cadherins share the mechanism of strand swapping, but there are a few 
major differences in the detail which may underlie adhesive specificity between the two 
subfamilies (see Section 1.6). Type II cadherins have in contrast to type I cadherins an 
extended hydrophobic region along the entire face of the EC1 domain whereas type I 
cadherins form contacts only close to the site of A*-strand swapping near the apex of the 
domain (Patel et al., 2006). Also, the size of the acceptor pocket of type I cadherins is rather 
small accommodating a single Trp2 side chain, whereas the acceptor pocket of type II 
cadherins has to accommodate Trp2 and Trp4 and thus is significantly larger (Patel et al., 
2006). These differences suggest potential steric incompatibility of type I and type II 
cadherins with regard to adhesive dimer formation. 
 
Biological importance of the strand swapped dimer observed in crystal structures of classical 
cadherins has been confirmed by a number of methods. Sequence analyses show that Trp2 in 
type I cadherins and Trp2 and Trp4 in type II cadherins as well as the respective residues 
lining the acceptor pocket are found to be highly conserved within classical cadherins (Figure 
3c). Mutation of Trp2 in type I cadherins (Kitagawa et al., 2000; Tamura et al., 1998) or either 
Trp2 or Trp4 in type II cadherins (Harrison et al., 2010b; May et al., 2005) to alanine is 
sufficient to abrogate strand swap mediated adhesion. In agreement with these results, 
alteration of one of the alanine residues lining the acceptor pocket to a large methionine in 
order to ‘occupy’ the pocket (Tamura et al., 1998) or addition of indole-3-acetic acid, which is 
the soluble analogue of the tryptophan side chain, resulted in loss of adhesive function in both 
cell based experiments (Tamura et al., 1998) and studies with purified cadherin proteins 
(Perret et al., 2002). Additionally, the N-terminal amino group of the cadherin engages in an 
intermolecular salt bridge in the dimer configuration, which is conserved for type I and II 
classical cadherins. Extension of the mature N-terminus by one or two residues prevents 
formation of the salt bridge and was shown to result in loss of adhesive binding (Bibert et al., 
2002; Boggon et al., 2002; Harrison et al., 2010a; Ozawa et al., 1990). Cross-linking studies 
with E- and N-cadherin also detected the strand swap dimer (Harrison et al., 2005; 
Troyanovsky et al., 2003). 
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More generally, the critical role for the EC1 domain suggested by structures of the adhesive 
dimer is also supported by several lines of evidence. The involvement of N-termini regions 
alone for trans adhesion was also observed in rotary shadowing electron microscopy 
experiments of full length type I E- and N-cadherin and type II VE-cadherin ectodomains 
conducted by Engel and collaborators (Ahrens et al., 2003; Pertz et al., 1999; Tomschy et al., 
1996). In addition, fluorescence resonance energy transfer (FRET) experiments with purified 
E-cadherin supported overlap of EC1 domains only (Sivasankar et al., 2009). In a more 
physiologically relevant context, He et al. (2003) and Al-Amoudi et al (2008) visualized the 
organization of desmosomal cadherins, which show the same overall domain organization as 
classical cadherins, in desmosomes of mouse and human skin, respectively (Figure 4a). 
Fitting of strand swapped C-cadherin trans dimer structures into electron tomography 
reconstructions of sections of mouse neo-natal and human skin, confirmed that N-terminal 
domains are employed also in situ (Figure 4b). In the tomograms, cadherins adopted the dimer 
arrangement observed in crystal structures and these therefore are very likely to be the 
biological relevant adhesive binding unit for classical and desmosomal cadherins.  
 
1.4 Cadherins utilize a 3D domain swapping mechanism for adhesion 
The strand swap mechanism described here for cadherin adhesive binding is an example of 
3D domain swapping (Bennett et al., 1995; Shapiro et al., 1995), because the swapped A* β-
strand, is replaced by the exact same domain from the partnering protomer and vice versa. 
The swapped domain has in monomer and homodimer configuration an identical residue 
environment, provided by intramolecular or intermolecular interactions, respectively. Domain 
swapping resulting in dimer formation is accompanied by an entropy loss, which can be 
compensated by a less energetically favorable monomeric conformation. In the case of 
cadherins this is likely to be caused by a strained conformation of the A-strand in the 
monomer configuration, which is eased in the dimer (Vendome et al., 2010). 3D domain 
swapping in cadherins is likely to be responsible for the relatively low binding affinities 
observed for type I E-, N- and C-cadherin and type II cadherin-6, which are found to be in the 
micromolar range (Chappuis-Flament et al., 2001; Ciatto et al., 2010; Harrison et al., 2010a; 
Harrison et al., 2010b; Katsamba et al., 2009). This is because the closed monomer form can 
act as a form of ‘competitive inhibitor’ by sequestering the A-strand. The low affinity of 
cadherin homophilic binding is thought to be important for specificity in adhesion, since 
higher affinity dimerization mechanisms would be less sensitive to small differences in 
interfacial residues between mismatched molecules (Chen et al., 2005). 
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1.5 T-cadherin structures reveal a novel adhesive binding mechanism 
Recently, the crystal structure of the adhesive interface of a divergent vertebrate cadherin, T-
cadherin, has been determined (Ciatto et al., 2010). The structure, comprising domains EC1-2, 
revealed a novel interface adopting an overall X shaped configuration (Figure 5a), which is 
characterized by a symmetrical contact region centered around the calcium linker region 
(Figure 5a). Domains EC1-2 are oriented almost parallel to each other with hydrophobic, 
ionic and hydrogen bonding interactions involving residues of the EC1 domain, the 
interdomain linker and domain EC2 (Figure 5b). The area of the EC1 domain involved in this 
interface is almost the same as found in the strand swapped dimer of classical cadherins, 
which was described above. However, the analogous region to the A* strand in classical 
cadherins is found not to be swapped between protomers. Instead, Ile2, at the same position as 
key residue Trp2 in type I cadherins (Figure 3c), is docked into a small hydrophobic pocket in 
its own protomer and no strand exchange occurs. Extensive mutagenesis studies targeting this 
novel interface revealed in biophysical assays, cell aggregation assays and axon guidance 
experiments (Ciatto et al., 2010) that the X interface is crucial to T-cadherin adhesion, 
suggesting this interface to be the biological adhesive interface. 
 
Interestingly, this interface was also observed in E-cadherin and cadherin-6 mutants, in which 
strand swap adhesion was impaired (Harrison et al., 2010a). Mutations specifically disrupting 
the X interface in type I E-cadherin and type II cadherin-6 whilst leaving the strand swap 
interface intact, lead to loss of adhesive binding in short time scale SPR and cell aggregation 
experiments without lowering the binding affinity in long time scale sedimentation 
equilibrium AUC analysis. Further biophysical experiments suggested that exchange between 
monomer and dimer was slowed in these mutants. This leads to a model, in which the X-
dimer interface acts as a binding intermediate, which positions the A-strands in close 
apposition for strand swapping (Figure 5c). 
 
Interestingly, despite the fact that EC1-domains alone are responsible for trans adhesive 
strand swapped binding and are able to form dimers at high concentration in protein crystals 
(Patel et al., 2006; Shapiro et al., 1995), deletion mutagenesis studies revealed, that EC1 
domains alone are not sufficient to mediate trans dimerization of cells and require, in 
addition, presence of domain EC2 in order to mediate adhesion (Shan et al., 2004). The 
requirement for EC2 may reflect its involvement in the X dimer interface, though other 
effects of EC2 removal such as changes in EC1 folding or orientation can not be ruled out. 
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1.6 Specificity and promiscuity of adhesive interactions between cadherins 
Numerous studies suggest that within and between each subfamily of vertebrate classical 
cadherins proteins bind homophilically to each other, preferring binding to the same or similar 
subtype (Boggon et al., 2002; Ciatto et al., 2010; Harrison et al., 2010a; Harrison et al., 
2010b; Katsamba et al., 2009; Nagar et al., 1996; Patel et al., 2006; Price et al., 2002; Shan et 
al., 2004; Shan et al., 2000; Shapiro et al., 1995; Shimoyama et al., 1999; Shimoyama et al., 
2000; Takeichi et al., 1988). This provides a potential simple and efficient mechanism, to 
segregate identical cells into homogenous tissues (Patel et al., 2003).  
 
In multiple cell aggregation studies it was found that cells transfected with type I cadherins 
fail to intermix with cells expressing type II cadherins and in all cases form separate cell 
aggregates (Duguay et al., 2003; Foty and Steinberg, 2005; Katsamba et al., 2009; Patel et al., 
2006; Shimoyama et al., 2000). These results suggest that type I and type II cadherin binding 
is orthogonal, because there were no cross reactions found between subfamilies, and may be 
explained by the substantial differences in the adhesive interface between these subfamilies 
(Section 1.3). 
 
Within type I cadherins, an example for homophilic binding was described by Nose et al 
(1989). Lungs of mouse embryos consist of epithelial cells expressing E- and P-cadherin and 
mesenchymal cells expressing N-cadherin. After dissociation of the lung tissues with trypsin, 
it was observed that these cells were able to re-assemble into a lung like tissue within which 
epithelial and mesenchymal cells were segregated. Further, this group found that L-cells 
expressing recombinant E-cadherin added after homogenisation colocalized with epithelial, 
but not with mesenchymal cells in the reconstituted structures showing that cadherin subtype 
expression could determine sorting in a tissue-like environment. Similar sorting of cells based 
on type I cadherin sub-type was observed in aggregation assays of mixtures of transfected 
cells singly expressing either E- or P cadherin, or E and N-cadherin (Nose et al., 1990; Shan 
et al., 2000). However, other experiments, mostly involving cell aggregation or co-culture 
assays revealed heterophilic binding between chicken and mouse N- and R-cadherin 
(Matsunami et al., 1993), chicken N- and E-cadherin (Volk et al., 1984), chicken and human 
E- and P-cadherin (Murphy-Erdosh et al., 1995) and chicken R- and P-cadherin and N- and P-
cadherin (Duguay et al., 2003), suggesting, that type I cadherin binding is considerably more 
promiscuous. Recent studies from Katsamba and Carroll et al (2009) reproduced in 
biophysical surface plasmon resonance (SPR) using purified E- and N-cadherin the 
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heterophilic binding behavior of type I E- and N-cadherin in vitro, which appears to be 
delicately regulated by homodimerization and heterodimerization affinities.  
 
The type II subfamily has an even more elaborate heterophilic binding pattern than found for 
type I cadherins. A well characterized example of homophilic selectivity for type II cadherins 
was reported by Price et al (2002). Type II cadherins are expressed throughout the cns during 
development and adult stages and are found to be expressed in motor pools in the spinal cord, 
which are functional subsets of motor neurons clustered in the lateral motor column (Price et 
al., 2002). Neurons within a motor pool are electrically coupled to each other (Price et al., 
2002) and control a single muscle target in the limbs. Cadherins are found to be expressed 
either alone or in subsets of different combinations of two or more subfamily members in 
motor pools. For example, motor neuron (MN-) cadherin (chicken homolog to human and 
mouse cadherin-20) expression becomes restricted to the Adductor (A) pool during 
segregation of motor pools (Price et al., 2002). In ovo electroporation studies, which re-
introduced MN-cadherin expression into the neurons of other segregated motor pools in the 
lateral motor column, found that MN-cadherin mis-expression resulted in intermixing of the 
A and external Femorotibialis (eF) pool exclusively, whereas other pools remained separated 
from each other. Reintroduction of MN-expression into the eF neurons removed any 
differences in cadherin expression between these pools in vivo. The A and eF neurons were 
then expressing the exact same set of type II cadherins whereas for the other motor pools cell 
surface differences where maintained, which suggests a complex fine tuned degree of 
adhesive specificity introduced by type II cadherins (Price et al., 2002). 
 
Shimoyama et al (2000) conducted a systematic cell aggregation study that revealed not only 
homophilic, but also heterophilic binding behavior of type II cadherins. The study was 
conducted with eight transfected L-cell lines of which each expressed one of the human type 
II cadherins 6, 7, 8, 9, 10, 11, 12 and 14. All of the type II cadherins tested exhibited equal 
homophilic binding behavior, in that they all formed approximately the same aggregate size, 
except cadherin-9 and -10 which had lower initial expression levels. Heterophilic cell 
aggregation assays conducted on all possible cadherin pairs of the eight proteins resulted in 
one of three outcomes: Some cadherin pairs aggregated homogenously, from which similar 
adhesive specificity was concluded; others were found in heterogeneous partially mixed 
aggregates, from which was assumed that these cadherins share part of their binding 
specificities; or complete segregation was observed, where no binding specificity is in 
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common between the two cadherins tested. For example, cells expressing cadherin-6 were 
found in homogeneous aggregates with those expressing cadherin-9, in heterogeneous 
aggregates with those expressing cadherin-10 and showed no intermixing with cadherin-11 
expressing cells. These assays indicated a complex pattern of type II specificity although they 
were conducted only on cadherin pairs. In vivo type II cadherins are found to be expressed in 
a complex pattern, sometimes with multiple cadherins on the same cell, which makes a highly 
complex homo- and heterophilic interaction pattern likely.  This may be important since type 
II cadherins are expressed in the developing brain and spinal cord, with notable regional 
expression patterns in the cerebral cortex, cerebellum and thalamus as well as in motor pools 
as described above (Price et al., 2002; Redies et al., 2003; Suzuki, 1997). 
 
Domain shuffling experiments using either type I or type II cadherins revealed that inherent 
cadherin specificity is governed by adhesive domain EC1 (Nose et al., 1990; Patel et al., 
2006; Shan et al., 2000). Type I and II chimera proteins were produced for these experiments, 
which were composed of domain EC1 (‘head’) of one cadherin and the ‘body’ (EC2-4) of 
another. Their binding behavior was assessed by cell aggregation assays and it was found that 
cells expressing cadherins with matched EC1-domains, e.g. E-cadherin wild type and E-
cadherin EC1 chimera or cadherin-6b wild type and its EC1 chimera, formed homogenous 
aggregates of wild type and chimera proteins and in contrast, proteins which had mis-matched 
EC1 domains (‘heads’), but matched domains EC2-4 (‘bodies’) formed separate aggregates 
(Patel et al., 2006). Based on these experiments and other studies (Chen et al., 2005; 
Klingelhofer et al., 2000; Posy et al., 2008) it was proposed that adhesive specificity is 
governed exclusively by amino terminal EC1 domains. This is in agreement with the 
localization of the strand swapped adhesive interface in the EC1 domain and suggests that 
differences between cadherin subtypes in the interface region may underlie specificity. 
 
 
1.7 Classical cadherins are the core molecules of adherens junctions 
Adherens junctions are intercellular structures which play a pivotal role in cell-cell adhesion 
and their major transmembrane components are classical cadherins (Farquhar and Palade 
1963; McNutt and Weinstein 1973; Takeichi 1991). In particular, cell-cell junctions found in 
the intestinal epithelium are well studied and electron microscopy of these shows an 
interesting arrangement of adherens junctions with other cell-cell junctions in what is referred 
to as the junctional complex (Figure 6a). Most apical positioned are tight junctions (O) which 
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are formed by claudins and occludins and seal the underlying tissues from the intestine lumen 
(Koval, 2006). Sub-apical to those are located the zonula adherens (ZA), which represent a 
specialized form of cadherin mediated adherens junction. In addition, smaller adherens 
junction clusters of cadherins are also found distributed along the entire lateral part of the cell 
(Ozaki et al., 2010).  
 
Further toward the basal side of the lateral membrane are desmosomes, in which as mentioned 
above the cadherin superfamily members desmogleins and desmocollins mediate adhesion 
between cells and are connected via intracellular proteins to intermediate filaments, visible as 
electron-dense plaques in the micrographs (Al-Amoudi and Frangakis, 2008; He et al., 2003). 
Zonula adherens a type of adherens junctions that are observed in intestinal epithelium link 
cells together in a belt extending around the sub apical zone, which assembles cells into 
sheets, allowing coordinated tissue movements across entire epithelial layers (Harris and 
Nelson, 2010). In addition, other examples for specialization of cadherin mediated adherens 
junctions are intercalated discs, which are found in the cardiac muscle, puncta adherentia 
which are adherens junctions found bordering synapses and adherens junctions in the vascular 
endothelium, which will be described in greater detail in Section 1.8. In all adherens 
junctions, opposing cell membranes are positioned parallel to each other with an 
intermembrane spacing of approximately 150-300Å (Farquhar and Palade, 1963; Harrison et 
al., 2010b; McNutt and Weinstein, 1973) and a high extracellular concentration of protein, 
representing cadherin ectodomains, is observed between the membranes. This assembly is 
accompanied by cytoplasmic plaques, representing the intracellular assembly of proteins and 
F-actin (Farquhar and Palade, 1963; McNutt and Weinstein, 1973).  
 
Extracellular domains of cadherins mediate trans adhesion in adherens junctions via the well 
understood strand swap binding mechanism as described above. However, the understanding 
of the molecular mechanism underlying lateral, cis, assembly of cadherins has been less clear. 
A potential cis interaction was described for the first time by Boggon et. al. (2002) for C-
cadherin and has been very recently extensively studied additionally for E- and N- type I 
classical cadherins (Harrison et al., 2010b). Together, these studies suggest that the assembly 
of ectodomains in a molecular layer formed by a single cis interface in addition to the 
swapped trans interface that was observed in the crystal structures of type I E-, N- and C-
cadherin represent the arrangement of cadherins in adherens junctions (Figure 6b) (Boggon et 
al., 2002; Harrison et al., 2010a). The cis interface was identified to be an interaction between 
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EC1, comprising a region opposite the strand swap interface involving strands C, F and G and 
residues of the quasi β-helix of one protomer, and strands B, D and E of EC2 of the following 
protomer (Figure 6c). The biological relevance of this interface for junction formation was 
tested by mutagenesis studies of E-cadherin mutants, in which hydrophobic core residues 
found in this interface, Val81 (EC1) and Leu175 (EC2), were substituted with negatively 
charged Asp residues to introduce repulsion and specifically inhibit cis interactions while 
leaving trans interactions functional. Crystal structures of two domain fragments of E-
cadherin cis mutant protein lacked the assembly of the molecular layer which was observed 
for all previous two domain and five domain type I cadherin structures, and, notably, even for 
strand swap mutants adopting X shaped dimer confirmations (Harrison et al., 2010a). In a 
cellular context, wild type E-cadherin formed stable, non fluctuating adherens junctions, 
whereas the mutant protein was found to produce highly mobile and unstable junctions, which 
the mutant protein diffused in and out of quickly (Harrison et al., 2010b). In addition, cryo 
EM studies of wild type and cis mutant proteins showed clearly, that despite the fact that both 
molecules were able to aggregate liposomes similarly well, only wild type E-cadherin 
arranged into an ordered array at intermembrane contact sites, closely resembling the 
molecular layer seen in the crystal structures (Figure 6d, left panel). The mutant protein was 
concentrated at junctions, but was shown to be unordered (Figure 6d, right panel). Together, 
the cell and liposome studies suggest that passive diffusion or cytoplasmic interactions alone 
are not sufficient to induce clustering of cadherins into ordered junctions, which is most likely 
driven by suggested cis interface.  
 
This cis interface observed for type I cadherins, or similar potential cis interface, could not be 
identified in type II cadherin crystal structures (Patel et al., 2006) or in electron tomography 
studies of desmosomal cadherins. Nonetheless, a comparable ectodomain-mediated clustering 
mechanism may operate, because both of these cadherin subfamilies are known to form 
adherens junctions or desmosomal junctions, respectively (Al-Amoudi and Frangakis, 2008; 
He et al., 2003; Kiener et al., 2006; Uehara, 2006). 
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1.8 Vascular endothelial cadherin, a divergent classical cadherin  
1.8.1 Special features of the vascular endothelium 
Under physiological conditions, fluids, cells and nutrients are exchanged between the blood 
compartment and surrounding tissues. Endothelial cells line the vasculature and represent a 
selective barrier separating blood from the underlying tissues as they control the passage of 
blood proteins, cells such as leukocytes, and fluids (Harris and Nelson, 2010). Passage of 
these is achieved by specialized transport vesicles and by coordinated disassembly, ‘opening’, 
and assembly, ‘closure’, of adherens junctions (Dejana et al., 2009). The endothelium is also 
the site for angiogenesis, which involves remodelling and extension of the vasculature (Harris 
and Nelson, 2010) and junctions found in this monolayer do function not only as barrier, but 
also as signalling structures which limit growth and apoptosis and regulate vascular 
homeostasis (Dejana, 2004). Thus, many pathological diseases such as atherosclerosis, 
diabetes, brain stroke and disease states like inflammation, allergy and hypertension and also 
tumor metastasis (Dejana et al., 2009; Harris and Nelson, 2010) are found to involve 
abnormal permeability of the endothelium layer.  
 
Cell-cell junctions in endothelial cells are less rigidly organized than those found in epithelial 
cells despite the mechanical stress and shear forces they endure (Sato and Ohashi, 2005), 
likely so they can accommodate the high degree of change these cells undergo during blood 
vessel formation, maintenance and remodelling (Dejana, 2004; Gavard, 2009). Endothelial 
cells contain tight junctions and adherens junctions, which are, in contrast to those in 
epithelial cells, intermingled in that tight junctions are not exclusively found at the apical side 
of the intercellular cleft (Dejana et al., 2009; Harris and Nelson, 2010). Tight junctions play a 
role especially in endothelial cells in stringent barriers, i.e. those of the blood-brain barrier, 
and in addition regulate the permeability of the monolayer. Adherens junctions are more 
important during initial cell-cell contact, establishment and maintenance of adhesion and also 
for remodelling processes (Harris and Nelson, 2010). Interestingly, it is suggested that 
adherens junctions are formed first and tight junctions occur once the junction is 
stabilized(Harris and Nelson, 2010), which is supported by the fact that in some cell systems 
blocking of adherens junctions ablates correct formation of tight junctions (Dejana et al., 
2009). Vascular endothelial (VE) cadherin, a divergent type II cadherin, is the endothelial-
specific protein in adherens junctions (Breier et al., 1996; Dejana et al., 1996; Lampugnani et 
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al., 1992; Vittet et al., 1997) and claudin-5 is the major component of tight junctions in the 
endothelium. 
 
1.8.2 VE-cadherin plays a pivotal role in the vascular endothelium 
VE-cadherin is found in vertebrate species including birds, fish, amphibia and mammals and 
plays a pivotal role in the vascular endothelium. Endothelial cells express, in addition to VE-
cadherin, type I N-cadherin and low levels of P-cadherin, but exclusively VE-cadherin is 
found to be concentrated in adherens junctions (Figure 7a and b)(Kapadia, 1984; Uehara, 
2006), whereas N-cadherin is found to be dispersed over the cell surface and absent from cell-
cell contacts (Gentil-Dit-Maurin et al., 2010; Jaggi et al., 2002; Liaw et al., 1990; Navarro et 
al., 1998; Salomon et al., 1992). VE-cadherin knockout mice die during gestation at E9.5 due 
to disintegration of primitive vasculature (Carmeliet et al., 1999) and, furthermore, VE-
cadherin gene null mutations in murine embryonic stem cells lead to a dispersed endothelium 
lacking organized vasculature in embryonic bodies (Vittet et al., 1997). Similarly, depletion of 
VE-cadherin in zebrafish embryos resulted in collapse of initial vascular networks as vessels 
could not form cell-cell junctions critical for lumen formation (Dejana, 2004).  
 
In another set of experiments, in which antibodies directed against VE-cadherin were injected 
into adult mice, permeability of the vasculature increased, leukocyte trafficking was enhanced 
and the vasculature disassembled, which resulted in death within 24 hours post injection 
(Corada et al., 1999; May et al., 2005). In contrast, knockout mice for claudin-5, which is the 
major component of tight junctions in the vascular endothelium, had a normal overall 
morphology of the vasculature, but died within 10 hours after birth due to dysfunction of the 
blood brain barrier. Overall, these experiments suggest a crucial, specific, non-redundant role 
for cell-cell adhesion mediated by VE-cadherin. This important protein is also involved in 
regulation of cellular processes like cell contact inhibition, leukocyte trafficking (Navarro et 
al., 1995), signaling processes (Harris and Nelson, 2010) and control of vascular permeability 
(Corada et al., 2001). 
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Interestingly, N-cadherin, which is co-expressed with VE-cadherin on endothelial cells, was 
not able to rescue the severe defects caused by VE-cadherin removal, although it is a potent 
cell-cell adhesion protein in other important tissues. Gentil-dit-Maurin et al (2010) conducted 
a study with embryonic bodies, in which VE-cadherin expression was silenced and N-
cadherin adhesive behavior observed. Embryoid bodies expressing VE-cadherin showed 
angiogenesis sprouting whereas bodies lacking VE-cadherin did not. N-cadherin also failed in 
these experiments to mediate sprouting in place of VE-cadherin once silenced, which supports 
VE-cadherins non-redundant role for adhesion in the vasculature. N-cadherin is found to be 
dispersed evenly over the cell surface in presence of VE-cadherin (Jaggi et al., 2002; Salomon 
et al., 1992), but localized to junctions when VE-cadherin was not expressed (Gentil-Dit-
Maurin et al., 2010; Navarro et al., 1998). In in vitro transfection experiments, 
immunofluorescence staining of endothelium cells and different transfected cell lines co-
expressing N-cadherin and VE-cadherin (Jaggi et al., 2002; Navarro et al., 1998) revealed that 
VE-cadherin excludes N-cadherin actively from junctional localization, which is the reason 
for its even distribution on the cell surface. A study by Jaggi et al (2002) provided additional 
insight, showing that the effect VE-cadherin has on type I N-cadherin is specific; it has no 
effect on other type I cadherins like E- and P-cadherin, because in immunofluorescence 
staining of cells co-expressing E- and VE-cadherin or P- and VE-cadherin, these proteins 
were found to co-localize at cell-cell contacts (Jaggi et al., 2002). This is the first time that 
competition between cadherins for clustering at junctions was observed. Nonetheless, N-
cadherin can in presence of VE-cadherin still homophilically adhere to cells expressing N-
cadherin only, which suggests that N-cadherin homophilic adhesion might be responsible for 
connection of the endothelial-monolayer to the surrounding cell types such as smooth muscle 
cells or pericytes (Navarro et al., 1998).  
 
1.8.3 Hexamer model for VE-cadherin binding 
VE-cadherin shares several features with classical type II cadherins including exon and intron 
arrangement on the DNA level and the overall domain organization of the protein (Nollet et 
al., 2000). It also has a small prodomain, an ectodomain composed of domains EC1-5, a 
single transmembrane domain and a short cytoplasmic tail similar to type II cadherins. In 
addition VE-cadherin is associated in endothelial cells with β-, γ- and p120 catenins (Gentil-
Dit-Maurin et al., 2010; Lampugnani et al., 1995; Lim et al., 2001; Potter et al., 2005) which 
promote interactions via α-catenin to F-actin for classical cadherins (see above).  
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Surprisingly, despite these similarities, bacterially produced VE-cadherin ectodomain 
fragments spanning domains EC1-4, purified from inclusion bodies, were not found to form 
adhesive dimers like other classical type II cadherins (Harrison et al., 2010b; Patel et al., 
2006). Instead, several experimental approaches including cryo electron microscopy (Hewat 
et al., 2007; Lambert et al., 2005; Legrand et al., 2001) and solution biophysics experiments 
such as chemical cross linking, analytical size exclusion chromatography and equilibrium 
analytical ultracentrifugation (Bibert et al., 2002) revealed a novel hexameric binding model 
for these VE-cadherin fragments in which six molecules associated in an approximately 
cylindrical arrangement. Single particle 3D reconstruction of EM-micrographs (Figure 7c) 
yielded 24Ǻ resolution electron density map, into which a homology model of VE-cadherin 
was fitted (Figure 7d). This shed light on the VE-cadherin hexamer binding configuration 
(Figure 7e), which was found to adopt a compact elongated cigar like shape with a length of 
233Ǻ corresponding to the length of two EC1-4 domain proteins in tandem (Hewat et al., 
2007). Protomers were oriented as if emanating from juxtaposed cells, with three molecules 
on each side (Figure 7e). Two different contact sites were identified in the hexamer: one 
involves a trans EC1 domain contact which was suggested to be mediated by strand swapping 
similar to that of classical cadherins forming anti parallel dimers; and the other was a novel 
trimeric interaction involving domain EC4 (Figure 7e). It appears that the EC4 contact is 
lateral, so that VE-cadherin ectodomains on the same cell surface would assemble into cis 
trimers, which form a dimer together with a cis trimer from the opposing cell to produce a 
final hexameric assembly. So far, however, the hexameric arrangement has been observed 
only for purified, bacterially expressed ectodomain fragments and the biological relevance of 
this novel VE-cadherin binding model remains to be determined. 
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1.9 Aims of this work 
The work described in this thesis will focus primarily on the investigation of the adhesive 
binding mechanism of VE-cadherin, a divergent type II cadherin crucial to the formation and 
maintenance of the vascular endothelium. No atomic level structure of the VE-cadherin 
binding interface is available and a novel binding mechanism has been proposed for which 
biological importance needs to be investigated. The binding affinities and specificities of 
other type II classical cadherins will also be investigated, as will the binding mechanism of 
the atypical classical cadherin T-cadherin. 
 
Specific experimental aims are: 
(1) VE-cadherin full ectodomains and a fragment containing the putative trimerization site 
will be expressed in a mammalian expression system to provide natively glycosylated soluble 
protein, which will be used in an extensive biophysical approach such as sedimentation 
equilibrium analytical ultracentrifugation (AUC), analytical size exclusion and multi angle 
light scattering (MALS) to characterize the adhesive binding mechanism and to test the 
hexamer binding model. 
 
(2) Fragments of the VE-cadherin ectodomain will be expressed in bacteria to identify the 
minimal adhesive binding unit of VE-cadherin and structural studies will be performed to 
determine the structure of the trans adhesive interface. 
 
(3) The homodimerization binding affinities of a set of five additional type II cadherins in 
addition to VE-cadherin, all produced in bacteria, will be assessed by equilibrium AUC 
experiments to determine general binding trends in the classical cadherin family. 
 
(4) To determine the relative binding specificities inherent to type II cadherins and assess the 
degree of promiscuous binding, surface plasmon resonance experiments will conducted. In 
addition, the ability of VE-cadherin to heterophilically interact with other type II subfamily 
members and with  type I cadherins, with which it is coexpressed in vivo, will be tested. 
 
(5) To test the dependency of T-cadherin mediated adhesion on the strand swap mechanism 
common to classical cadherins, in order to test models from structural studies suggesting that 
T-cadherin uses a non-swapped dimerization mechanism. I will introduce strand swap 
targeted mutations into T-cadherin and simultaneously into mouse type I E-cadherin and type 
II cadherin-6 so that the impact of these mutations on adhesive binding can be assessed by 
equilibrium AUC. 
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Chapter 2:  
Materials and Methods 
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2.1 Protein Production 
Plasmid construction, protein expression and purification for all proteins produced in 
mammalian and bacterial systems that were used in the biophysical and biochemical studies 
in this work are described in this section. 
 
 
2.1.1 Mammalian protein production 
2.1.1.1 Plasmid construction 
Coding sequences for human VE-cadherin EC1-5 (Asp1-Asp542, all numbering according to 
the mature proteins), EC3-5 (Ile204-Asp542) and chicken VE-cadherin EC1-5 (Asp1-Glu545) 
were amplified by polymerase chain reaction (95°C for 2’ activation polymerase; 40 cycles of 
95°C 30’’ dissociation, 63°C 1’ annealing, 68°C 2’ extension; final extension at 68°C for 
10min, stored at 4°C) from cDNA libraries (human VE-cadherin from human heart library, 
Invitrogen and chicken cDNA library clone pgp 1n.pk007.i4, Delaware Biotechnology 
Institute) using KOD Hot start DNA polymerase (Novagen) according to manufacturer’s 
instructions with primers at a concentration of 10pM. A Kozak sequence (gtt gtt) was 
included before the start methionine; signal sequence and prodomain encoding regions found 
in naive cadherin sequences were replaced by the signal sequence of CD33 
(MPLLLLWAGALA) and the transmembrane and cytoplasmic domains were replaced by a 
hexa histidine tag. All proteins were cloned into the KpnI/NotI  restriction sites (enzymes 
from New England Biolabs)of the episomal expresion vector pCEP4 (Invitrogen). An 
expression construct encoding wild-type mouse E-cadherin (Asp1-Ala544), cloned in the 
same manner, was produced as described in Harrison et al (2010b). Point mutations W2A 
W4A in VE- and W2A K14E in E-cadherin were introduced by site directed mutagenesis 
using the Quickchange method (Stratagene). DNA sequences of produced plasmids were 
validated by Sanger DNA sequencing (Genewiz, Inc.).  
 
 
2.1.1.3 Tissue culture 
All proteins referred to as ‘mammalian produced’ were expressed either in adherent human 
embryonic kidney (HEK) 293 Fast Growth (F) cell lines or in 293 N-acetylglucosamine 
transferase I deficient (GNTI-) cell lines. HEK 293 F produce proteins with native N-linked 
glycosylation, whereas HEK 293 GNTI- cells produce proteins with limited N-linked 
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glycosylation (Man5GlcNac2) (Reeves, J. 2002). Both cell lines, which will be referred to 
together as HEK 293 cells, were cultured in advanced glutamine free DMEM/F12 medium 
(Gibco, Invitrogen) freshly supplemented with 100µg/ml Penicillin/Streptomycin (Gibco, 
Invitrogen), 4mM L-Glutamine (Gibco, invitrogen) and 10% Newborn calf serum (<10 days 
old, Fisher Scientific) in a Thermo Scientific Hepa class 100 incubator at 37°C in presence of 
5% CO2 and 90% humidity. This medium composition will be referred to as DMEM/F12, 
when composition is altered, supplements added will be specified. Cells were maintained by 
splitting 1:10 every seven days by removing medium, dissociating with pre-warmed trypsin 
0.05% (1X) with EDTA (Gibco, invitrogen) for 5 minutes, pelleting the cells by spinning at 
1000g at 25°C for 6 minutes and resuspension in 10mL of DMEM/F12. For replating, 1mL of 
cell suspension was transferred to 75cm² flask with vented caps (Corning) containing 20mL 
DMEM/F12 pre-warmed medium. 
 
 
2.1.1.4 Transfection of HEK 293 cells 
For transfection cells were lifted and pelleted as described in the previous section, 
resuspended in 20mL of DMEM/F12 without Penicillin and Streptomycin supplements and 
seeded into a 6 well plate of 2cm2 per well surface area to grow until they reached 
approximately 80% confluency. On the day of transfection cells were transfected with 6µg 
cadherin-pCEP4 expression construct plasmid DNA prepared with the HiSpeed Maxi prep kit 
according to the manufacturer’s instructions (Qiagen) using Lipofectamine 2000 following 
the instructions provided by the company (Invitrogen). On the following day, transfectant 
medium was removed from cells and cells were resuspended in 2mL of DMEM/F12 and 
transferred into a 75cm² flask containing 25mL of DMEM/F12. Selection for successfully 
transfected cells was begun 48 hours after transfection by supplementing the medium with 
200µM Hygromycin B (MediaGrowth, Fisher Scientific) as pCEP4 carries the resistance gene 
for this aminoglycoside. Transfected stable cell lines were cultured in the presence of 200µM 
Hygromycin at all times.  
 
 
2.1.1.5 Protein Expression 
Cells transfected as described above secrete the respective soluble cadherin proteins into the 
conditioned medium, so once cells reached confluence in 75cm² flasks, medium was tested 
for presence of hexa-histidine tagged cadherins by Western Blotting and immunological 
40 
 
detection by horseradish peroxidase (HRP) labeled monoclonal antibody against the His tag 
(Qiagen, see Section 2.3.3.2 below). Once protein expression was validated, the relevant cell 
culture was expanded to a 10 layer cell Stack flask with tissue culture surface totaling in 
6360cm² surface area (Corning). Cells were cultured in 1 liter DMEM/F12 + 200µM 
Hygromycin B per cell stack farm and every 14 days the culture split in half as described 
before, 200mL of trypsin solution are needed per split. Dissociated cells were spun down in 
50mL Corning graduated plastic tubes at 1000g for 6min at 25°C and were resuspended in 
DMEM/F12 for replating in cell stack farms. Each time, conditioned media were collected 
before trypsinization. and cell debris was removed by 20 minute spins at 13000g at 4°C.  
Conditioned media were then stored at -80°C until 4 liters of were collected for purification. 
 
 
2.1.1.6 Protein purification 
Supernatants were thawed on ice and filtered using a 1L 0.22µm PES funnel filter (Corning) 
and vacuum prior purification. Supernatants were supplemented with 500mM sodium 
chloride (Sigma), 20mM Tris-Cl pH8.0 (Fisher Scientific), 3mM calcium chloride (J.T. baker, 
Fisher Scientific) and 10mM imidazole pH8.0 (Fisher Scientific), then were transferred to 4L 
plastic beaker (Nalgene) covered by Styrofoam lid, in which a Wheaton BiStir stirrer ( Model 
356887, ‘floating stir bar’) was inserted. Hexa-histidine tagged cadherins were collected by 
nickel batch affinity purification through addition of 20mL nickel (II) charged IMAC 
Sepharose 6 fast flow resin (GE Healthcare), which was equilibrated in 500mM sodium 
chloride, 20mM Tris-Cl pH8.0, 3mM calcium chloride, 10mM imidazole pH8.0. After 
incubation for 3 hours at 4°C under gentle stirring, resin was extracted by passing through a 
7cm diameter Kontes column (Kimble Chase, ~250mL) using gravity and washed with 20 
column volumes total of 500mM sodium chloride, 20mM Tris-Cl pH8.0, 3mM calcium 
chloride and 12.5mM imidazole to remove non specifically bound contaminant serum 
proteins. Resin was transferred to a XK 16 column (GE Healthcare) and connected to an 
AKTA FPLC 900 (GE healthcare) operated by Unicorn software. After an additional 20 
column volumes of washing, proteins were eluted by increasing the imidazole concentration 
to 75mM (GE Healthcare) in ~5 column volumes. Protein elution was monitored by 
absorbance at a wavelength of 280nm. Eluted proteins were dialyzed in 10 MWCO snake skin 
dialysis tubing (Thermo Scientific) for 18 hours at 4°C in 5L of 100mM sodium chloride, 
20mM Tris-Cl pH8.0, 3mM calcium chloride. For further purification the protein was flown 
over a Mono S ion exchange column HR10/10 (GE Healthcare) to remove high molecular 
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weight contaminants, which were found to bind tightly the column. Cadherins uniformly were 
found in the flow through and were collected and then passed over an anion exchange column 
MonoQ MQ HR10/10 (GE Healthcare) to remove residual contaminants. The protein was 
concentrated to a volume of approximately 3mL using Amivon 50K MWCO Spin 
concentrators (Millipore). Proteins were spun at 4000g in 3min intervals at 4°C until desired 
volume of 3mL was reached. The last step of purification was size exclusion chromatography 
by a HiLoad 26/60 Superdex S200 prepgrade column. The peak containing the protein of 
interest was collected and purified protein was concentrated using same method as described 
above, tested for purity by SDS-PAGE (see below) and flash frozen in liquid nitrogen in 
aliquot sizes of 15-30µL. All proteins were in a final buffer of 150mM sodium chloride, 
10mM Tris-Cl pH8.0 and 3mM calcium chloride. 
 
 
2.1.2 Bacterial protein production 
2.1.2.1 Plasmid construction 
Coding sequences of two and three domain wild type cadherin proteins were amplified by 
PCR (95°C for 2’ activation polymerase; 40 repetitions of 95°C 30’’ dissociation, 63°C 1’ 
annealing, 68°C 1’ extension; final extension at 68°C for 10min, stored at 4°C) from cDNA 
libraries (human VE-cadherin from human heart library, Invitrogen and chicken cDNA library 
clone pgp 1n.pk007.i4, Delaware Biotechnology Institute, mouse proteins from mouse 
multiple tissue cDNA (MTC) panel I libraries, clontech) using KOD Hot start DNA 
polymerase (Novagen) according to manufacturer’s instructions with primers at concentration 
of 10pM. Mouse cadherin-6, -8, -9, -10, -11 and VE-cadherin EC1-2 and chicken VE-
cadherin and cadherin-6b as well as human VE-cadherin EC1-2 and mouse cadherin-8 EC1-3 
fragments were cloned in frame with an N-terminal hexa His tagged SUMO protein into the 
BamHI/NotI sites of the bacterial pSMT3 T7 polymerase expression vector (Invitrogen). 
Quickchange site-directed mutagenesis (Stratagene) was used to introduce all point mutations, 
extensions or to delete parts of the N-terminus. The same method was applied to remove extra 
bases between the encoded protease site (Gly-Gly) and the amino terminus of the encoded 
protein to ensure correct mature cadherin N-termini. Constructs encoding Avi-tagged proteins 
(Avidity) were prepared by inclusion of a sequence encoding the Avitag at the cadherin 
fragment C-terminus immediately prior to the stop codon. All plasmids were transformed into 
XL10-gold E. coli (Stratagene), positive colonies selected with Kanamycin and plasmid DNA 
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generated by Mini prep (Qiagen) according to the companies instruction. Correct DNA 
sequences were validated as for mammalian plasmids. 
 
 
2.1.2.2 Protein Expression 
Verified pSMT3plasmids encoding cadherin fragments were transformed into E. coli 
Rosetta2DE3 pLysS strains (Novagen) for expression following the manufacturer’s manual. 
Small cultures of 3mL LB medium (Miller, granulated LB-broth, EMD) were prepared with 
50µg/mL Kanamycin and 34µg/mL Chloramphenicol, inoculated with one colony of bacteria 
and incubated for 18h at 37°C shaking at 200rpm to grow. 100µL of this culture were used to 
inoculate a starter culture of 300mL LB with the same antibiotic composition, which was also 
incubated for 18h at 37°C. A glycerol stock of each culture was prepared where 1.2mL of 
culture were supplemented with 30% glycerol to be stored at -80°C. For protein expression, 
25mL of the starter culture were used per Liter of expression culture for a batch of 12Liters 
total. Once OD600 of 0.6 was reached by the bacterial culture, protein expression was induced 
by adding 100µM ITPG and temperature lowered to 18°C for a total of 18h of expression, 
shaking at 200rpm for all proteins but cadherin-6 (wild type, tagged protein and mutants), for 
which the temperature was kept at 37°C for an additional 5hours instead (Harrison 2010a).  
 
To obtain biotinylated Avi-tagged cadherins, pSMT3-cadherin with sequence encoding the 
Avi-tag at the C-terminus was co-transformed with BirA plasmid (Chloramphenicol 
resistance) which encodes for the biotin ligase and into E. coli strain BL21 (Invitrogen). 
Expression was as described above, with the addition that medium was supplemented with 
IPTG and 50µM Biotin. 
 
Bacteria were harvested in 1L buckets at 4,000g for 20min at 4°C, supernatants discarded and 
pellets retained for lysis and purification as described below.. 
 
 
2.1.2.3 Bacterial Protein Purification 
Bacterial pellets were resuspended in 250mL of 500mM sodium chloride, 20mM Tris-Cl 
pH8.0, 3mM calcium chloride and 20mM imidazole pH8.0. Cells were lyzed by sonication on 
ice for a total of 6 minutes in intervals of 15sec of pulse with 45sec rest with Branson Digital 
Sonifier. Cell debris was pelleted and lysates cleared by centrifugation for 30min at 20,000g 
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at 4°C. His-tagged SUMO-cadherin fusion proteins were collected from lysates by flowing 
over 5mL of nickel charged IMAC sepharose 6 Fast Flow resin (GE Healthcare). Resin with 
captured protein was washed with 40 column volumes of the same buffer and His-tagged 
SUMO-cadherin fusion proteins were eluted by increasing the imidazole pH8.0 concentration 
in the buffer to 250mM for a total volume of ~50mL (10 column volumes). His-SUMO tags 
were removed during dialysis in 50mM sodium chloride for E-, N-, T-cadherins and cadherin-
6 and 100mM sodium chloride for cadherins 8, 9, 10, 11 and VE-cadherin and 20mM Tris-Cl 
pH8.0 and 3mM calcium chloride by specific proteolytic cleavage after the Gly-Gly motif by 
2µg/mL ubiquitin ligase protein I (Invitrogen), leaving all proteins in this study with native N-
termini unless specifically altered. 
 
Hexa His-SUMO tags and uncut fusion proteins were removed from the dialyzates by batch 
binding for 30min at 25°C with rotation to 5mL of nickel charged resin (as above) 
preequilibrated in respective dialysis buffer. Cadherins were further purified by flowing over 
an anion exchange column MQ HR10/10 followed by size exclusion chromatography with a 
hiLoad 26/60 Superdex S75 (GE Healthcare). All proteins were in a final buffer of 150mM 
sodium chloride, 10mM Tris-Cl pH8.0, 3mM calcium chloride and for cadherins carrying the 
C-terminal CYS-tag 1mM TCEP was included in the buffer. Proteins were concentrated in 
10K MWCO Amicon spin concentrators (Millipore) and 10µg of each protein analyzed by 
SDS-PAGE. Biotinylation of proteins was verified after transfer to nitrocellulose membranes 
by binding NeutrAvidin-HRP followed by chemiluminescent detection. All proteins were 
flash frozen in 15-100µL aliquots according to need to avoid multiple freeze-thaw cycles. 
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2.2 Biophysical Methods 
2.2.1 Analytical ultracentrifugation 
All equilibrium analytical ultracentrifugation experiments were performed together with 
Goran Ahlsen (Columbia University) using a Beckman XLA/I ultracentrifuge, with a Ti50An 
or Ti60An rotor. All proteins were diluted with buffer (150mM sodium chloride, 10mM Tris-
Cl pH8.0, 3mM calcium chloride) and dialyzed for 16h at 4°C in 1L of the same buffer prior 
to each experiment. 120μL of proteins at three different concentrations 0.7mg/mL, 
0.46mg/mL and 0.24mg/mL were loaded into six-channel equilibrium cells with parallel sides 
and sapphire windows. All experiments were performed at 25°C and data was collected at 
wavelengths of 280 nm (UV) and 660 nm (interference). Five-domain proteins (VE-cadherin 
EC1-5 and E-cadherin EC1-5) were spun for 20h at 8,800g and four scans (1 per hour) were 
collected, then speed was increased to 12,300g for 10h and four scans (1 per hour) were 
collected and speed was increased to highest speed of 16,400g for another 10h and four scans 
(1 per hour) were taken, which yielded 72 scans per sample. Three-domain proteins (VE-
cadherin EC3-5, cadherin-8 EC1-3) were analyzed using the same protocol, except using 
speeds of initial 14,200g, followed by 23,500g and 35,200g as highest speed. For two-domain 
proteins (VE-cadherin EC1-2, EC3-4; type I cadherins E, N, P, T; type II cadherin-6, -8, -9, -
10, -11; wild type, tagged and mutant proteins), speeds of 23,500g, 35,200g and 49,100g were 
used. Relative centrifugal forces are given at the measuring cell center at a radius of 65mm. 
Buffer density and protein v-bars were calculated using the software SednTerp (Alliance 
Protein Laboratories), and retrieved data was analyzed using HeteroAnalysis 1.1.0.28 
(http://www.biotech.uconn.edu/auf). We fitted data from all concentrations and speeds 
globally by nonlinear regression to either a monomer-dimer equilibrium model or an ideal 
monomer model. All experiments were performed at least in duplicate, except for C-
terminally tagged bacterial cadherins, which were only measured once.  
 
2.2.2 Analytical size exclusion chromatography 
A volume of 150µL of purified proteins at a concentration of 6µM were flown over analytical 
superose 12 10/30 column (GE Healthcare) which was pre-equilibrated with 150mM sodium 
chloride, 100mM HEPES pH7.0, 3mM calcium chloride for at least two column volumes. 
Experiments were performed at 4°C using the AKTA FPLC-900 system operated by Unicorn 
and a steady low of 300µL/min. Fractions of 500µL each were collected and UV-signal at 
280nm recorded. Fractions of sufficient UV signal peaks were analyzed by SDS-PAGE and 
immunological detection with tetra His antibody (Qiagen), so every monitored peak was 
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validated to be the expected cadherin. Void volume of the column was determined to be 8mL 
using Blue Dextran (GE Healthcare). 
 
 
2.2.3 Multi angle light scattering 
Human VE-cadherin EC1-5 and EC3-5 and mouse E-cadherin mutant W2A K14E expressed 
in HEK 293 GNTI- cells and purified as described above were used at a concentration of 
1mg/mL for MALS experiments. Proteins were passed over a TSKgel Super SW3000 
operated by an HPLC to separate different protein species from each other and then measured 
for absolute molecular weight and dispersity by the triple-angle MALS light scattering 
detector miniDAWN Treos (Wyatt Technology, Europe GmbH) at New York Structural 
Biology Center (New York, USA) using continuous flow detection. Data were analyzed and 
absolute molecular weights calculated with Astra V Software. 
 
 
2.2.4 Liposome aggregation assays 
2.2.4.1 Preparation of liposomes 
1,2-dioleyl-sn-glycero-3-phosphocholine (DOPC) and 1,2-dioleoyl-sn-glycero-3-[(N-(5-
amino-1-carboxypentyl)iminodiacetic acid)-succinyl] nickel salt (DGS-NTA-(Ni)) were 
obtained from Avanti lipids and prepared according to the manufacturer’s manual. Liposomes 
used for aggregation and cryo-EM studies were composed of a 9:1 ratio of DOPC and DGS-
NTA(Ni), respectively, and were prepared using the hydration and extrusion method, in 
which liposomes were suspended in 25mM HEPES pH7.4, 0.1M potassium chloride, 10% 
(v/v) glycerol, 3mM calcium chloride (liposome aggregation buffer). To equalize size within 
liposomes they were extruded through a 100nm filter membrane following Avanti’s 
instructions for the extruder. Liposomes were stored for 3 month at 4°C. 
 
 
2.2.4.2 Liposome aggregation assays 
Aggregation assays were conducted according to the method described by He et al (2009) and 
Harrison et al (2010b). Liposomes were first diluted in liposome buffer to a final 
concentration of ~5mg/mL and at the starting point of the experiment, hexa-His-tagged 
cadherin fragments were added to yield the final concentration of 6µM. Aggregation was 
monitored at OD of 650nm in 20sec intervals for a total of 2,500sec. For the reference 
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sample, protein was substituted with liposome aggregation buffer (negative control). 
Experiments were performed in triplicate for all human and chicken ectodomains and the 
negative control, and in duplicates for mouse E-cadherin ectodomains and human VE-
cadherin EC3-5 fragments. 
 
 
2.2.4.3 Cryo Electron microscopy studies 
Liposome aggregation was performed with full ectodomains of human VE-cadherin and 
mouse E-cadherin, both expressed in HEK 293 F cells as described in the previous section. 
Liposomes were allowed to aggregate for 10min and were then transferred to 300 mesh 
copper TEM grids with R2/1 Quantifoil. Samples were vitrified by blotting and plunge-frozen 
into liquid nitrogen cooled ethane using the automated Vitrobot (FEI company, Hillsboro, 
Oregon; as described by Harrison et al 2010b). Grids were stored in liquid nitrogen until 
imaging was performed using a Tecnai Polara F30 TEM (FEI company, Hillsboro, Oregon) at 
the New York Structural Biology center (New York, New York) by Ruben Diaz (New York 
Structural Biology Consortium). Frozen grids were imaged at 300kV using a Tietz 4Kx4K 
CCD camera (Tietz video and Image Processing Systems GmbH, Gauting, Germany). Images 
were recorded under low-dose conditions at ~10µm under focus using the serialEM software 
(Mastronarde, 2005) and processed with IMOD software (Kremer et al 1996) Microscope 
magnification was 39,000-59,000fold. 
 
 
2.2.5 Atomic force microscopy imaging 
AFM sample pucks were prepared as follows: 10mm diameter disks of Muscovite mica (Agar 
Scientific) were stamped out from the as-received sheets. Each sample puck was fixed to a 
13mm steel puck (agar Scientific) with cyanoacrylate super-glue and allowed to dry for 16h. 
Poly-L-lysine (Sigma Aldrich) was diluted 1/100 into BPC-grade water (Sigma Aldrich) and 
45μL of this solution pipetted onto freshly-cleaved mica, given 30min incubation at 25°C, 
washed 10 times with 1mL BCP-grade water and dried under a gentle, steady stream of 
nitrogen.  
 
Cadherin ectodomains used in AFM imaging studies were produced in HEK 293 F cells. VE-
cadherin samples were diluted in 150mM sodium chloride, 20mM Tris-Cl pH8.0, 3mM 
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calcium chloride to a final concentration of ~2nM and stored at 4°C which yielded workable 
and consistent surface concentrations of protein. E-cadherin samples were diluted using the 
same buffer, but to a higher concentration of E-cadherin, ~8μM, was needed to allow dimer 
formation to be observed. 45μL of sample was pipetted onto poly-L-lysine coated mica and 
incubated at room temperature for 10min, then washed 10x with 1mL of BPC-grade water 
and dried under a gentle and steady stream of dry nitrogen. 
 
Imaging was performed at the Department of Pharmacology (Henderson Laboratory, 
Cambridge University, UK) with a Multimode atomic force microscope with attached 
Nanoscope IIIa controller (both Veeco) under ambient conditions in tapping mode, using 
OMCL0AC160TS single-crystal silicon probes (Olympus, Japan) with a resonant frequency 
of ~300kHz, a nominal spring constant of ~42Nm and a radius of curvature <10nm. We 
collected images at 3Hz with an integral gain of 0.2, a proportional gain of 0.35, a look-ahead 
gain of 0 and a set point of ~0.85 (to minimize vertical probe-induced sample deformation). 
Length determination of molecules was performed using SPIP (Scanning Probe Image 
Processor) version 3.3 from 3-dimensional AFM data using the full-width at half-maximal 
approach. 
 
 
2.2.6 Protein crystallography 
2.2.6.1 Screening trials 
Sparse matrix screening and precipitant screening was performed in sitting drop assays at 
20°C and 4°C using 100nL protein solution at concentrations of 6.8-8.6mg/mL and 100nL 
well solution in 96 well screening plates (Axygen). Crystal suites used for screening were 
Index (Hampton), Wizard I+II (Emerald), Classics, Classics II, PEGs, PEGs II, pH clear, pH 
clear II, JCSG+,Anions and Cations (Qiagen). 75µL of crystallization condition was 
transferred to each well of the 96 well plate using a twelve channel electronic pipette and the 
crystallization experiments were set up using the mosquito nanodrop crystallization robot. 
Plates were stored after set up either at 20°C or 4°C and checked after 12h, 24h and then daily 
for 14 days and again after 30 and 60 days with a microscope. 
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2.2.6.2 Crystal optimization 
Crystal optimizations were performed using the hanging drop vapor diffusion method. 500µL 
of crystallization solution was prepared in reservoirs of 24 well screening plates (Hampton), 
of which the rims were greased prior to set up. For each crystallization condition three 
different protein: well solution ratios were used: 1 protein: 1 well solution, 1 protein: 2 well 
solution and 2 protein:1 well solution to increase the variation of crystallization conditions by 
varying initial and final precipitant and protein concentrations. Initial volumes of the mixed 
drops were 1.2 to 1.8µl. Protein and solution were pipetted on dust and lint free siliconized 
cover slips (Hampton) and placed above the well with the rim gently pushed onto the grease 
to seal the vapor diffusion chamber. Chicken VE-cadherin EC1-2 crystals grew within 18h at 
20°C in 18% (w/v) PEG 8,000, 200mM calcium acetate and 100mM sodium cacodylate 
pH6.5. Crystals were harvested for crystallization by mounting with 200µm nylon loops 
mounted on metal bases (Hampton), then transferred and immersed in cryo protectant (well 
solution + 30% (w/v) glycerol) for 5-10sec and immediately flash frozen in liquid nitrogen. 
Crystals were stored in Hampton vials under liquid nitrogen, which were transported in canes. 
 
 
2.2.6.3 Data collection 
Diffraction data was collected on beam line X4C at the National Synchrotron Light Source, 
Brookhaven National Laboratory, USA. A data set of 180 frames with 1° oscillation per frame 
was collected on a single frozen crystal of chicken VE-cadherin EC1-2 at a wavelength of 
0.979Å using an ADSC ccd Quantum 4 detector (Area Detector Systems Corporation) with 
20sec exposure time.  
 
 
2.2.6.4 Data processing 
The collected images of the chicken VE-cadherin EC1-2 diffraction pattern were processed 
using the HKL suite (Owtwinowski and Minor 1997). The structure was solved by molecular 
replacement with the phaser program as part of the ccp4i suite using the crystal structure of 
mouse cadherin-11 EC1-2 (pdb ID code 2A4E) as template. Refinement of the obtained 
structure was carried out by alternating cycles of manual building in coot (Emsley, Cowlan 
2004), followed by automated refinement in Refmac 5 (ccp4 suite, Bailey 1994). Data 
collection and refinement statistics are summarized in Table 11. Ramachandran plot statistics 
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for the final model of chicken VE-cadherin EC1-2 are 97.1% of residues in favored positions, 
100% in allowed regions and no residues found in disallowed regions. The structure factors 
and pdb file have been submitted to the protein data bank and can be found under pdb 
accession ID 3PPE. 
 
 
2.2.7 Surface plasmon resonance  
All Surface plasmon resonance (SPR) binding experiments were conducted with a Biacore 
T100 biosensor (Biacore, Uppsala, Sweden) using a low charge series S CM4 sensor chip 
(Biacore). Reagents used for amine and thiol coupling were also purchased from Biacore.  
 
2.2.7.1 Amine Coupling for affinity capture 
Sensor chip surface carboxymethyl (CM) groups were activated by injection of 50mM N-
hydroxysuccinimide (NHS) in presence of 200mM N-ethyl-N’-(3-dimethylaminopropyl) 
carbodiimide (EDC) over all four flow cells at 20µL per min for a total of 7min. Either 
Immunopure Neutravidin (Thermofisher), one of four different anti-FLAG antibodies, or a 
Rho1d4 (anti C9) antibody were dissolved in sodium acetate pH4.5 and flown over the 
activated surfaces for 7min with 20µL per min for coupling. Unoccupied activated 
carboxymethyl groups were quenched with a 7min injection of 1M ethanolamine-HCl pH8.5 
at 20µL per min. Immobilization levels and summary of antibodies and Neutravidin 
immobilized by amine coupling is shown in Table 2. Running buffer was HEPES-buffered 
saline (HBS, 10mM HEPES pH7.4, 150mM sodium chloride) and immobilization was 
performed at 32°C.  
Table 2: Immobilization levels of antibodies and NeutrAvidin used in SPR studies. 
 
Name Company Immobilization level [RU] 
   
Mouse mAB anti-FLAG M2 clone Sigma cat# F3165 7,069 
Mouse mAB anti-FLAG M2 clonea  Sigma cat# F1804 5,600 
Rat mAB anti-DYKDDDDDK Stratagene cat# 200473 5,684 
Rat mAB anti-FLAG M2 6F7 Sigma cat# SAB4200071 4,203 
Mouse Rho1d4 AB anti-C9 Flintbox 7,360 
Immunopure Neutravidin Thermo Fisher 9,000-13,000 
aAntibody was affinity purified. 
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C-terminally tagged cadherin captures and binding experiments were performed at 25°C in a 
running buffer composed of 150mM sodium chloride, 20mM Tris-Cl pH8.0, 3mM calcium 
chloride, 0.25mg/mL bovine serum albumin (Sigma) and 0.005% (v/v) Tween-20. In one 
experiment, cadherin-6-bio was captured over one flow cell and another was left with only 
immobilized NeutrAvidin which served as reference cell. In 10sec pulses cadherin-6-bio at a 
concentration of ~15µM was injected in 10sec pulses at a flow rate of 20µL/min until 
approximately 500RU were captured (Harrison et al., 2010a; Katsamba et al., 2009). The 
same approach was taken for cadherin-FLAG and -C9 captures and cadherin levels [RU] 
captured by antigen-antibody binding are shown in SPR traces in Figure 32a (FLAG) and 32b 
(C9) (Chapter 6).  
 
 
2.2.7.2 Ligand thiol coupling 
CYS-tagged proteins underwent a buffer change prior experiments as the proteins were kept 
in presence of 1mM TCEP. Zeba spin desalting columns (thermo fisher) were used by loading 
30µL of protein-CYS onto a 10mM sodium acetate pH4.0 pre-equilibrated column. Spinning 
was performed according to the manufacturer’s manual. Eluates were diluted ~10fold yielding 
final concentrations of 50µg/mL for N-cadherin-CYS and 300µg/mL for VE-cadherin-CYS 
and were tested in subsequent experiments for pre-concentration by ionic charge to the sensor 
chip surface (see Figure 33a, Chapter 6). For both proteins the highest binding response was 
achieved in sodium acetate pH4.0 buffer.  
 
For covalent coupling of the thiol tagged proteins to the SPR sensor chip, carboxymethyl 
groups of the CM4 sensor chip were activated only in flow cells needed by injecting for 2min 
a mixture of 50mM NHS and 200mM EDC. In the next step reactive sulfur groups were 
introduced during a 4min pulse of 80mM PDEA pH8.5, which was freshly prepared 
immediately before the experiment by mixing 100µL of 120mM PDEA with 50µL 100mM 
sodium borate pH8.5. Desalted N- or VE-cadherin-CYS were injected to produce a binding 
response of 1570RU (60sec pulse) for N- and 4660 (12sec pulse, high concentration surface) 
and 1575 RU (20sec, 6sec, 7sec pulse with 50µg/mL diluted VE-cadherin-CYS, low 
concentration surface) for VE-cadherin. Remaining reactive disulfides were quenched by a 
4min injection of 50mM L-cysteine (Sigma) in 1M sodium chloride, 100mM sodium acetate 
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pH4.0. Final immobilization levels were for N-cadherin-CYS 1542RU and for VE-cadherin-
CYS 4643 and 1575RU. Immobilization profiles are shown in Figure 33b and 34b for N- and 
VE-cadherin, respectively. All immobilizations were performed at 25°C in HBS buffer and a 
flow rate of 20µL/min. To obtain a reference flow cell, the surface was treated exactly the 
same as described above, but CYS-tagged cadherin injection was omitted. 
 
 
2.2.7.3 SPR binding experiments 
For all binding experiments the same running buffer composed of 150mM sodium chloride, 
20mM Tris-Cl pH8.0, 3mM calcium chloride, 0.25mg/mL bovine serum albumin (Sigma) and 
0.005% (v/v) Tween-20 was used. Cadherins were immobilized on the sensor chip surface 
either by thiol coupling or affinity capture as described above. All analyte proteins were used 
at a concentration range of 40µM-78.1nM in a 2fold dilution series unless otherwise noted in 
the results section. Injections were performed in duplicates for 60sec at a flow rate of 
50µL/min, which was followed by a 60sec dissociation phase and a buffer injection of 1min 
to minimize the contamination of the next sample by carryover. All binding experiments were 
conducted at 25°C except for a single experiment at 37°C with VE-cadherin. 
 
A slight modification of the above method was used for the VE-cadherin kinetic experiment 
at 37°C and 25°C and the experiment with strand swap mutant W2A of N-cadherin at 25°C. 
These were performed at only one concentration of 40µM using a flow rate of 30µL/min. 
Running buffer composition, 60sec dissociation phase and buffer injections to minimize 
sample carryover remain the same. 
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2.3 Biochemical Methods 
2.3.1 N-terminal sequencing 
Purified mammalian proteins at a concentration of 1-2mg/mL were sent in solution to the 
Protein Core Facility (Columbia University, NY, USA) for N-terminal sequencing of the first 
five amino terminal residues using the Edman Sequencing technique. 
 
 
2.3.2 Mass Spectrometry 
For determination of absolute mass from proteins expressed and purified from mammalian 
cells including all posttranslational modifications, cadherins were brought in solution to the 
Protein Core Facility (Columbia University, NY, USA) at a concentration of 1-2mg/mL for 
mass spectrometry using MALDI-TOF (matrix-assisted laser desorption ionization time-of-
flight). For determination of N-linked glycosylation sites, human VE-cadherin ectodomains 
produced in HEK 293 F cells and Endoglycosidase H treated ectodomains expressed in HEK 
293 GNTI- cells were digested with trypsin in presence of EDTA and peptide masses 
determined using MALDI-TOF. N-linked glycosylation sites were determined by deviations 
in peptide mass between the two differently glycosylated proteins. 
 
 
2.3.3 SDS-PAGE 
10µg of protein were supplemented with 4x SDS loading buffer (Invitrogen) run on precast 
NuPAGE 4-12% BisTris Gel 1.00mmx15well (Invitrogen) in 1xMES buffer  at 200V current 
using 4µL SDS SeeBlue(R) Plus prestained standard (Invitrogen).  
 
 
2.3.3.1 Coomassie staining of proteins separated by SDS-PAGE 
Protein bands were visualized by staining with Coomassie Brilliant Blue G-250 (0.2% (w/v) 
Coomassie, 7.5% (v/v) glacial acetic acid, 50% (v/v) ethanol) for 10minutes at 25°C and 
destained (0.75% (v/v) acetic acid, 10% ethanol) until gels were transparent and protein bands 
were clearly distinguishable from background. Gel images were taken by LAS 4000 Imaging 
system (Fujifilm). 
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2.3.3.2 Immunological detection of proteins separated by SDS-PAGE 
Protein visualization using immunological methods was performed as follows. 13µl of 
conditioned media from transfected cells or 5µL of purified protein solution of 1mg/mL were 
separated using SDS-PAGE and proteins were transferred to nitrocellulose membranes 
activated for 20sec in 100% methanol (Fisher Scientific), by using a semi-dry blotting 
technique in Biorad transblot semi-dry transfer chambers according to the manufacturers 
manual. Whatman paper was equilibrated in Towbin buffer (25mM Tris-base, 192mM 
glycine, 10% (v/v) methanol) and a transfer-sandwich assembled as follows from bottom to 
top electrode: 2 whatman papers, activated nitrocellulose membrane, SDS-polyacrylamide 
gel, 2 whatman papers. Trapped air bubbles were gently removed by rolling over a 5mL glass 
pipette. Proteins were transferred from the gel to the membrane in 60minutes with current of 
200mAmp. Following transfer,membranes were blocked either with TBS-Tween-20 0.025% 
and 5% milk when using 1:5,000 dilution of Tetra His Antibody (Qiagen) and secondary anti 
mouse-HRP coupled antibody (Peroxidase AffiniPure F(ab')2 fragment donkey anti-mouse 
IgG (H+L) from Jackson Immunoresearch) for detection of His tagged proteins or with 5% 
Bovine serum albumin, fraction V (Sigma, ~ 99% pure) for 1:2,000 dilution of Horse radish 
peroxidase conjugated NeutrAvidin (Thermo Scientific) for detection of biotinylated proteins. 
Blots were developed using Thermofisher thing and developed by the LAS 4000 Imaging 
system (Fujifilm). 
 
 
2.3.4 Removal of N-linked glycan with Endoglycosidase H 
Mammalian proteins expressed in HEK 293 GNTI- cells carry simplified N-linked glycans, 
which can be removed enzymatically by Endoglycosidase H to leave only a single mannose 
on Asn residues behind. N-linked glycosylation was removed from human and chicken VE-
cadherin EC1-5 and EC3-5 expressed in these cells by using Endoglycosidase H (New 
England Biolabs) according to the company’s instruction, with the exception, that the 
recommended reaction buffer was substituted with 150mM sodium chloride, 100mM HEPES 
pH7.0, 3mM calcium chloride and digest was carried out at 37°C. Subsequently, enzyme was 
removed by flowing proteins over size exclusion column Superdex S200 as described before. 
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2.3.5 Complex immunoprecipitation assays 
For Co-immunoprecipitation (ip) experiments of homophilic and heterophilic cadherin 
complexes, experiments were conducted at 25°C using mixtures of purified, differently 
tagged cadherin EC1-2 fragments. For homophilic complex formation assays using N-
cadherin-C9/N-cadherin-bio or VE-cadherin-C9/VE-cadherom-FLAG, 15µM of each protein 
were mixed, resulting in a total cadherin concentration of 30µM, which is well above the 
binding affinity of both proteins. The same concentration level of 15µM per tagged protein 
was also used for heterophilic Co-ip assays using mixtures of different cadherin subtypes. In 
negative controls the C9-tagged protein was replaced by immunoprecipitation buffer (150mM 
sodium chloride, 20mM Tris-Cl p8.0, 3mM calcium chloride, 1% Bovine serum albumin, 
0.1% Tween-20) and in preliminary tests none of the proteins were found to nonspecifically 
bind to dynabeads protein G coated with antibody that were used in the full experiments for 
precipitation of the complex. In all cases, the mixtures of purified proteins were incubated 
with slow rotation at 25°C for 3h to allow equilibration between differently tagged cadherins. 
In the meantime, 40µL of dynabeads protein G (Invitrogen) were coated with Rho1d4 
antibody prior each experiments at levels sufficient to provide equimolar binding sites for the 
total purified C9-tagged protein in the assay. Beads were washed with 3fold bead volume of 
ip buffer using a two sample dynabead magnet (Promega). Buffer was discarded and replaced 
with the Rho1d4 antibody solution. Beads were incubated rotating at 25°C for 15min to allow 
antibody immobilization and unbound antibody was then removed by three wash cycles with 
ip-buffer. The antibody coated beads were then added to the mixed protein solutions for 
precipitation of the C9-tagged cadherin along with any associated differently tagged cadherin. 
After 10min of incubation at 25°C on rotator, protein was removed, beads washed three times 
as described before, but this time with ice cold ip buffer. Finally, beads were resuspended in 
1x SDS gel loading buffer (Invitrogen) and boiled at 98°C for 5min and immediately the 
precipitated proteins were separated by SDS PAGE. Proteins were detected either 
immunologically with anti FLAG antibody (affinity purified M2mAB α-FLAG F1804, Sigma, 
see Table 2) and secondary anti mouse antibody or directly by Neutravidin-HRP, as described 
in Section 2.3.3.2 above.  
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Chapter 3: 
Protein Production 
 
  
56 
 
3.1 Mammalian protein production in human embryonic kidney cells 293F 
and 293 GNTI- 
Previously published work showed that human VE-cadherin EC1-4 fragments formed 
hexamers to mediate adhesive binding(Hewat et al., 2007). Cryo EM data revealed that the 
hexamers are composed of two cell surface trimers which are formed by a cis interface 
located in EC4 (Section 1.8.3) and trans adhesion is mediated by EC1 domains between 
trimers on apposing cells. However, proteins used in these previously published studies did 
not include the membrane proximal domain EC5, and were produced in bacteria and purified 
from inclusion bodies, thus lacking post translational modifications like glycosylation. In 
order to study adhesive binding properties of VE-cadherin and investigate the proposed 
hexamer model in detail, we chose to work with soluble, native human and chicken VE-
cadherin full ectodomains (residues Asp1-Asp542 for human and Asp1-Glu545 for chicken) 
expressed in mammalian cells to allow full post-translational modification. Each protein was 
expressed with a C-terminal hexa-histidine tag replacing the single transmembrane and 
cytoplasmic domains. Based on known characteristics of adhesive binding of other classical 
cadherins, we also wanted to test the importance of Trp2 and Trp4, key amino acids for type 
II cadherin homophilic binding, for VE-cadherin adhesive behavior. We therefore chose to 
introduce a double mutation, in which Trp2 and Trp4 side chains are both reduced to that of 
alanine into an additional human VE-cadherin EC1-5 construct (W2A W4A mutant). To 
address the biological relevance and biophysical behavior of the unique EC4-mediated cis 
interface suggested in the previously published studies of bacterially expressed VE-cadherin 
EC1-4 (Bibert et al., 2002; Hewat et al., 2007; Legrand et al., 2001), a further construct was 
prepared in which the N-terminal trans adhesive domains EC1-2 were omitted from human 
VE-cadherin ectodomains fragments to produce a fragment containing only membrane 
proximal domains EC3-5 (Ile204-Asp542). 
 
In addition to VE-cadherin, ectodomains of wild type mouse E-cadherin (Section 2.1.1.1), an 
extensively studied, well characterized classical type I cadherin for which structural data is 
available (Harrison et al., 2010b), was used as reference protein in glycosylation studies 
(Section 3.2) and biophysical experiments described in Sections 4.2 and 4.7. We also 
conducted studies with monomeric W2A K14E mutants of E-cadherin (Harrison et al., 
2010b), which are described in the Section 4.4 and 4.5.  
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VE- and E-cadherin proteins were expressed in and secreted from two different mammalian 
cell lines: human embryonic kidney (HEK) 293F and 293 GNTI- cells (Figure 8). The latter 
cell line lacks N-acetylglucosamine transferase I, an enzyme in the glycosylation pathway 
responsible for producing complex N-linked carbohydrate (Figure 9a). Proteins secreted from 
293 GNTI- cells have simple N-linked glycosylation in form of Man5GlcNac2, moieties that 
can be removed by endoglycosidases in vitro, producing proteins without N-linked sugars 
(Figure 9b). VE-cadherin proteins used in studies described here are therefore produced in 
either of three forms: glycosylated (from 293F cells), minimally glycosylated (from 293 
GNTI- cells) or, after treatment with Endoglycosidase H, without N-linked glycosylation. In 
vivo, cadherins are expressed with a prodomain preceding the first EC domain, which is 
removed on cell surfaces by furin proteases to produce mature cadherins (Koch et al., 2004). 
To ensure homogenous, mature N-termini and to avoid potentially inefficient removal of the 
prodomain during overexpression, we replaced the native signal sequence and prodomain of 
VE-cadherin with the signal sequence of CD33 (Section 2.1.1.1). All proteins were N-
terminally sequenced to confirm native mature N-termini; which are listed in Table 3. The 
secreted proteins were purified from conditioned media as described in Section 2.1.1.5 and 
could be concentrated in glycosylated form to final concentrations of at least 10mg/mL. 
Minimally glycosylated and deglycosylated E-cadherin proteins also reached concentrations 
of at least 10mg/mL, but solubility of VE-cadherin was reduced to approximately 0.3mg/mL 
after removal of N-linked glycosylation. Solubility could not be improved significantly by 
increase or decrease of salt in the buffers, addition of 10% glycerol or by pH-change between 
pH8.0 and pH6.0. Concentrated proteins were examined by SDS poly acryl amid gel 
electrophoresis for purity and results show VE- and E-cadherin proteins used in this work are 
greater than 99% pure (Figure 8). Interestingly, VE-cadherin proteins have apparent 
molecular weights in SDS-PAGE that are approximately 10kDa higher than predicted 
molecular weights based on primary protein sequence, suggesting the presence of high levels 
of protein glycosylation.  In contrast, E-cadherin proteins migrate at apparent molecular 
weights more similar to those predicted (Table 3).   
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The human and chicken full VE-cadherin ectodomains and EC3-5 fragments described here 
were used to study the N-linked glycosylation pattern of VE-cadherin (Section 3.2) and for 
extensive biophysical experiments to investigate VE-cadherin mediated adhesion and to test 
the VE-cadherin hexamer model with native proteins (Chapter 4). 
 
Table 3: Statistics of mammalian produced cadherins.  
 
Protein N-terminus 
Predicted 
MW [Da] 
293F 
MW [Da] 
    
Chicken VE-cad EC1-5 DWIWN 62,088 71,591 
Human VE-cad EC1-5 DWIWN 62,383 75,451 
Human VE-cad EC3-5 INDNF 39,767 47,916 
Human VE-cad EC1-5 W2AW4A DAIAN 62,153 74,589 
Mouse E-cad EC1-5 DWIVI 60,907 65,878 
Mouse E-cad EC1-5 W2A K14E DAIVI 60,084 65,069 
 
 
3.2 VE-cadherin ectodomains are highly glycosylated 
We found that mammalian expressed VE-cadherin proteins migrate with an apparent 
molecular weight in SDS PAGE approximately 10kDa higher than predictions based on 
primary sequence, indicating likely glycosylation (Figure 8 and Table 3, see above). Also, 
when comparing the migration of VE-cadherin proteins expressed in HEK 293F cells to those 
of minimally glycosylated proteins expressed in HEK 293 GNTI- cells, we find that VE-
cadherin proteins secreted by GNTI- cells have significantly lower apparent molecular 
weights, suggesting the presence of complex N-linked glycans in the fully glycosylated 
protein (Lanes 1 and 2 in Figure 10). Removal of all N-linked sugars with Endoglycosidase H 
shifted the apparent molecular weights somewhat closer to the predicted molecular weights 
(Lane 3 in Figure 10). For comparison, E-cadherin, which migrates in SDS-PAGE closer to 
its predicted weight, was also included (Lanes 4, 5 and 6 in Figure 10). Endogylcosidase H 
treatment caused a small shift for E-cadherin consistent with the presence of N-linked glycans 
(Liwosz et al., 2006), Figure 9b). However, no significant difference in electrophoretic 
mobility was observed between fully and minimally glycosylated E-cadherin (Lanes 4-6 in 
Figure 10), suggesting that the N-linked glycans of E-cadherin are less complex than those of 
VE-cadherin. 
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These findings led us to experimentally determine the precise molecular weight contributed 
by glycans for each protein by MALDI-TOF mass spectrometry analysis. First, fully 
glycosylated ectodomains of human and chicken VE-cadherin as well as mouse E-cadherin 
were analyzed, with comparison of experimentally determined masses with predicted 
molecular weights (Table 3). We determined a total glycan of 13,144Da for human VE-
cadherin, 9,503Da for chicken VE-cadherin and 4,971Da for E-cadherin. Next, we wanted to 
elucidate the relative contributions of N- and O-linked glycosylation to the total glycan. 
Therefore VE-cadherin and E-cadherin, expressed in glycosylation deficient HEK 293 GNTI- 
cells, were treated with Endoglycosidase H to specifically remove N-linked glycan, and we 
determined the molecular weight of protein without N-linked glycosylation by MALDI-TOF. 
Subtracting the molecular weight of the ‘deglycosylated’ protein from that of the fully 
glycosylated protein revealed the quantity of N-linked glycosylation (Table 4). O-
glycosylation quantities could be calculated by subtraction of predicted molecular weight 
from the ‘deglycosylated’ weight. From this analysis we found that human VE-cadherin 
ectodomains carry 2,713Da of O-linked and 10,336Da of N-linked glycosylation and chicken 
VE-cadherin ectodomains 1,836Da of O-linked and 7,667Da of N-linked glycan. We repeated 
the experiment with truncated VE-cadherin EC3-5 and found that these three domains 
contribute 8,149Da (62%) to the total glycan, of which 6,570Da is N-linked and 1,579Da O-
linked glycosylation. Using the same method as described above total glycan for E-cadherin 
was determined to be 4,971Da, composed of 1,793Da of O- and 3,178Da of N-linked sugar. 
 
Table 4: Glycosylation quantities found on mammalian produced VE- and E-cadherin ectodomains.  
 
Protein 
Total glycan 
[Da] 
N-linked glycan 
[Da] 
O-linked glycan 
[Da] 
    
Chicken VE-cad EC1-5 9,503 7,667 1,836 
Human VE-cad EC1-5 13,144 10,336 2,713 
Human VE-cad EC3-5 8,149 6,570 1,579 
Mouse E-cad EC1-5 4,971 3,178 1,793 
 
We also determined the locations of the N-linked glycosylation sites in VE-cadherin. 
Glycosylated and deglycosylated human VE-cadherin ectodomains were subjected to trypsin 
digest and the mass of the obtained peptides was determined by MALDI-TOF. Comparison of 
the two sets of peptides revealed five N-glycosylation sites: Asn14 and Asn64 in EC1, 
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Asn110 in EC2, Asn315 in EC3 and Asn395 in EC4. In EC5, the most membrane proximal 
domain, no glycosylation sites were found. O-glycosylation sites on VE-cadherin could not be 
determined, as the O-linked glycans have molecular weights too small to be detected reliably 
by our method. 
 
To examine the positions of the N-linked glycosylation sites in regard of the whole 
ectodomain, we built a homology model of the ectodomain of human VE-cadherin using the 
Swissmodel server with C-cadherin (pdb-code: 1L3W) as template. Figure 11 shows the 
experimentally identified glycosylation sites mapped on to our homology model. Comparing 
glycosylation in VE-cadherin with that of E-cadherin determined from a recently published 
structure (Figure 11, (Harrison et al., 2010b) and from biochemical analyses (Liwosz et al., 
2006) it is evident that several equivalent regions are glycosylated in both proteins (Figure 11- 
glycosylation). These are the concave face of EC3 and the concave face of EC4. However, at 
the sequence level, only one N-linked site is conserved between the two cadherins – Asn395 
(VE-cadherin numbering) in EC4. Additionally, we included mouse type II cadherins -6, -8,  
-9, -10 and -11 in our analysis and, remarkably, we found that only the Asn395 consensus 
glycosylation site is also conserved in these cadherins.  
 
Taken together, our results show that VE-cadherin ectodomains are highly glycosylated in 
comparison to type I E-cadherin and that approximately 62% of the N-linked glycosylation is 
located in domains EC3-4. Only one N-linked glycosylation site, which is located in EC4, is 
conserved within most classical cadherins. The importance of glycosylation for VE-cadherin 
function will be discussed in Section 4.8. 
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3.3 Bacterial protein production in Escherichia coli 
3.3.1 VE-cadherin protein fragments expressed in E. coli 
To assess structural and biophysical features of VE-cadherin homophilic and heterophilic 
adhesive binding, we prepared adhesive fragments of human, chicken and mouse VE-
cadherin spanning domains EC1-2. In addition, a single human domain EC1 and a fragment 
spanning only EC3-4 were prepared. These proteins were expressed at an average yield of 
260µg per liter of Rosetta2 DE3 E.coli cells and could be purified by affinity 
chromatography, ion exchange and size exclusion chromatography as described in Section 
2.1.2.3. All produced proteins by this method have native mature N-termini. To investigate 
the importance of strand swap binding for these fragments, two strand swap mutant proteins 
were also designed for mouse and chicken VE-cadherin domains EC1-2. In the first, indole 
side chains of Trp2 and Trp4 were both mutated to that of alanine (W2A W4A mutant), 
similar to the full length VE-cadherin ectodomain mutant described above. In the second, the 
N-terminus was extended by a single methionine for human and chicken VE-cadherin to 
disrupt a salt bridge involving the N-terminal amino group found to contribute to strand swap 
binding in other type I and II cadherins (Met-extension mutant). All wild-type and mutant 
fragments were successfully purified (Section 2.1.2.3) and could be concentrated to at least 
7mg/mL. Figure 12 shows the result of SDS-poly acryl amide gel electrophoresis of the 
purified proteins, indicating all proteins to be greater than 99% pure. Molecular weights 
observed on the gel correspond to predicted molecular weights based on primary protein 
sequences. 
 
Structural studies using these VE-cadherin adhesive fragments are described in Section 5.2-
5.5 and biophysical characterization of the wild-type and mutant fragments are described in 
Section 5.1.  
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3.3.2 Classical cadherin fragments expressed in E. coli 
In addition to VE-cadherin we also wanted to characterize the binding properties of other type 
I and type II cadherins and the outlier T-cadherin, as well as to perform homophilic and 
heterophilic binding experiments to elucidate specificity in cadherins.  
 
A set of six wild type untagged type II cadherins was prepared (Section 2.1.2.3): mouse type 
II cadherins-6, -8, -9, -10, and 11 encompassing domains EC1-2 and additionally chicken 
cadherin-6b EC12. The EC1-2 fragment of cadherin-8 failed to dimerize and remained 
monomeric in gel filtration and equilibrium AUC experiments, therefore we extended the 
cadherin-8 construct by domain EC3. Cadherin-8 EC1-3 was able to form dimers in solution 
(see Section 5.1 for AUC results and Table 14 for KD). All proteins were expressed in E.coli 
and purified as described above for VE-cadherin fragments. Protein expression levels of type 
II cadherins were at an average of approximately 260µg/L bacterial culture and all proteins 
yielded had mature native N-termini. Figure 13a shows that proteins were greater than 98% 
pure. All type II cadherins were soluble to concentrations of at least 7mg/mL and only 
cadherin-11 showed minimal signs of degradation by proteolysis in some preparations. SDS-
PAGE of purified proteins is shown in Figure 13a. 
 
We also prepared the type I cadherins E-cadherin and N-cadherin as well as the outlier T-
cadherin as EC1-2 adhesive fragments from mouse using the same expression system. P-
cadherin protein, produced in the same way, was kindly provided by Fabiana Bahna. Yield for 
all type I proteins was at an average of approximately 1.3mg/L bacterial culture and all had 
native mature N-termini. E- and P-cadherin were soluble to concentrations of at least 
7mg/mL, but solubility of N-cadherin was limited to 1mg/mL.  
 
The type I and type II cadherin fragments were used for analytical ultracentrifugation studies 
of homophilic binding (Sections 5.1 and 6.1) and for surface plasmon resonance studies of 
homophilic and heterophilic binding (Sections 6.2 and 6.3). 
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Table 5: Summary of bacterial produced cadherins.  
Protein Description 
  
VE-cadherin  
Human VE-cadherin EC1-2 Wild type 
Chicken VE-cadherin EC1-2 Wild type 
Mouse VE-cadherin EC1-2a Wild type 
Human VE-cadherin EC1 Wild type 
Human VE-cadherin EC3-4 Wild type 
Chicken VE-cadherin EC1-2 W2A W4A Strand swapping mutant 
Mouse VE-cadherin EC1-2 W2A W4A Strand swapping mutant 
Chicken VE-cadherin EC1-2 Met-extension Strand swapping mutant 
Human VE-cadherin EC1-2 Met-extension Strand swapping mutant 
  
Type II cadherins Wild type 
Mouse cadherin-6 EC1-2a Wild type 
Mouse cadherin-6 EC1-2 W4A Strand swapping mutant 
Chicken cadherin-6b EC1-2 Wild type 
Mouse cadherin-8 EC1-2 Wild type 
Mouse cadherin-8 EC1-3 Wild type 
Mouse cadherin-9 EC1-2 Wild type 
Mouse cadherin-10 EC1-2 Wild type 
Mouse cadherin-11 EC1-2a Wild type 
  
Type I cadherins  
Mouse E-cadherin EC1-2 Wild type 
Mouse E-cadherin EC1-2 W2A Strand swapping mutant 
Mouse E-cadherin EC1-2 E89A Strand swapping mutant 
Mouse E-cadherin EC1-2 Ala-Ala-extension Strand swapping mutant 
Mouse E-cadherin EC1-2 Met-Arg-extension Strand swapping mutant 
Mouse E-cadherin EC1-2 Asp-Trp-deletion Strand swapping mutant 
Mouse N-cadherin EC1-2a Wild type 
Mouse N-cadherin EC1-2 Ala-Ala-extension Strand swapping mutant 
Mouse P-cadherin EC1-2b Wild type 
Mouse T-cadherin EC1-2c Wild type 
Mouse T-cadherin EC1-2 I2A Strand swapping mutant 
Mouse T-cadherin EC1-2 Gly-extension Strand swapping mutant 
Mouse T-cadherin EC1-2 Met-Arg-extension Strand swapping mutant 
 a tagged versions of these proteins are listed separately in table 16;   
b P-cadherin protein: courtesy of Fabiana Bahna.   
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Type I and type II cadherin EC1-2 fragments containing mutations targeting the strand swap 
binding interface were prepared for binding experiments reported in Chapter 7. Mutations 
were introduced into E-, T- and cadherin-6 as described in Section 2.1.2.1. Strand swap 
mutant proteins W2A, E89A, Ala-Ala extension, Met-Arg-extension for E-cadherin; I2A, a 
Gly-extension and Met-Arg extension mutant for T-cadherin and W4A for cadherin-6 were 
expressed and purified in the same way as the corresponding wild type proteins. In a second 
cadherin-6 EC1-2 mutant we extended the N-terminus by residues Met and Arg, however, this 
protein was unstable in solution resulting in precipitation and was thus omitted from the final 
studies. See section 7.2 for full description of the mutations. Yield for all mutant proteins was 
similar to wild type and proteins were successfully purified and had native mature N-termini 
unless specifically altered. SDS-PAGE of all mentioned proteins shown in Figure 13b. 
 
 
3.3.3 Preparation of C-terminally tagged classical cadherins 
For SPR and co- immunoprecipitation (IP) experiments, proteins needed to be tethered to 
sensor chips or beads, respectively, by suitable engineered tags. Due to their adhesive 
mechanism cadherins require native N-termini and need to be positioned such that their 
adhesive N-termini are accessible for binding as they would be in vivo on cell membranes. 
Therefore, only C-terminal tags were tested.  These were introduced into type I N-cadherin 
and type II cadherins-6, -11 and VE-cadherin, as is summarized in Table 6. Common tags like 
the biotinylated Avi-tag (GGGLNDIFEAQKIEWHE), FLAG- (DYKDDDDK) and C9- tag 
(GGGTETSQVAPA) were used for this purpose and additionally, we designed a novel tag 
consisting of a single cysteine after three glycine residues as spacer, which will be referred to 
as “CYS-tag” (GGGC). This tag allows the use of thiol coupling in order to covalently bind 
CYS-tagged proteins to surfaces. Approximate molecular weight was assessed by SDS-PAGE 
for the C-terminally tagged proteins and they were found to be pure (Figure 14a and b).  
 
The entire set of Avi*bio-, FLAG-, C9- and CYS-tagged proteins was used in SPR 
experiments described in chapter 6 and reported in Ciatto et al. (2010) and Harrison et al. 
(2010) and the subset of C9-, FLAG- and biotinylated VE- and N-cadherin proteins were used 
in IP-experiments (Section 6.4).  
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Table 6: Summary of C-terminally tagged classical mouse cadherins and associated experiments. 
 
Cadherin Tag Experiment Section 
    
VE-cadherin Avi*bio AUC 6.2 
VE-cadherin FLAG AUC, SPR, IP 6.2, 6.4 
VE-cadherin C9 AUC, SPR, IP 6.2, 6.4 
VE-cadherin CYS AUC, SPR 6.2 
N-cadherin Avi*bio AUC, SPR, IP 6.2, 6.4 
N-cadherin C9 AUC, SPR, IP 6.2, 6.4 
N-cadherin CYS AUC, SPR 6.2 
Cadherin-6 Avi*bio AUC, SPR 6.2a 
Cadherin-11 Avi*bio AUC 6.2 
 
a This protein has been used successfully in SPR studies in Harrison et al (2010) and 
Katsamba and Carrol et al (2009) 
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Chapter 4:  
Full length VE-cadherin ectodomains  
form dimers similar to those of classical cadherins 
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4.1 Biophysical studies of the adhesive binding mechanism of native VE-
cadherin ectodomains 
Previously published binding studies conducted on bacterially produced VE-cadherin EC1-4 
domain fragments (Bibert et al., 2002; Hewat et al., 2007; Legrand et al., 2001; Taveau et al., 
2008)suggest a novel and unique binding mechanism for VE-cadherin in the context of the 
adhesive mechanism known for other classical cadherins. In this proposed model VE-cadherin 
molecules associate laterally on the same cell surface, via a strong cis interface involving 
domain EC4. Trimers then adhere to a second trimer extending from the opposing cell to 
assemble a hexamer via trans interactions in EC1 domains (Hewat et al., 2007). By contrast, 
for other classical type I and II cadherins it is known that they mediate adhesive binding by a 
3D-domain swapping mechanism between opposing monomers, resulting in strand swapped 
adhesive cadherin dimers and not higher order multimers. For type I cadherins it was recently 
found using structural analysis, cryo EM of artificial adherens junctions and assays of cell 
adherens junction formation, that an additional cis interface is necessary in order to form 
junctions, involving the EC1 domain of one protomer and EC2 of the following protomer 
(Boggon et al., 2002; Harrison et al., 2010b). However, unlike the cis interactions determined 
for bacterially expressed VE-cadherin, these type I cadherin cis interactions are very weak 
and only trans dimerization can be detected in solution equilibrium AUC experiments. 
 
We took an extensive biophysical approach to analyze the degree of multimerization and 
adhesive behavior of soluble VE-cadherin ectodomains and to test the unique binding model 
described above. Since we found that VE-cadherin ectodomains are substantially glycosylated 
(see previous section), we used only glycosylated full ectodomains of human and chicken VE-
cadherin, in addition to the W2A W4A strand swap binding mutant and a truncated VE-
cadherin EC3-5 that includes the putative trimerizing domain EC4. Their binding behavior 
was assessed by sedimentation equilibrium analytical ultracentrifugation, analytical size-
exclusion chromatography, multi angle light scattering and liposome aggregation assays.  
 
4.2 Biophysical behavior of VE-cadherin in sedimentation equilibrium 
analytical ultracentrifugation  
Sedimentation equilibrium analytical ultracentrifugation (AUC) analysis was used to 
determine the oligomerization state of VE-cadherin. We chose to investigate the association 
behavior of full VE-cadherin ectodomains, expected to produce hexamers according to the 
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hexamer model of VE-cadherin binding; a strand swap mutant, which was expected to 
trimerize via domain EC4 and truncated VE-cadherin EC3-5, also expected to associate into 
trimers. Equilibrium AUC allows determination of an exact molecular mass independently 
from molecule shape and, in addition, data can be fit to dimeric or multimeric binding models 
to yield dissociation constants (KD) in equilibrium as a measure of adhesive binding affinity.  
Interestingly, glycosylated wild type human and chicken VE-cadherin both were found to 
reach a monomer/dimer equilibrium in all conducted experiments without evidence for the 
presence of any higher order multimers (Figure 15 AUC). Human and chicken VE-cadherin 
ectodomains exhibit strong binding affinities with determined KD values of 1.14μM and 
1.03μM, respectively, which are an order of magnitude stronger than KDs determined 
previously for hexamer association. The residual values for fitting of the data to monomer-
dimer equilibrium models were uniformly close to zero, indicating a reliable fit (Figure 15). 
 
After we found that a remarkably strong affinity is associated with VE-cadherin 
homodimerization, we wished to compare it to published affinities of other cadherins. A 
binding affinity for C-cadherin EC1-5 and for two domain EC1-2 fragments of type I E- and 
N-cadherin were available. To test, if a comparison of affinities between mammalian 
expressed full length cadherins with those of bacterially produced two domain fragments is 
feasible, we performed an equilibrium AUC experiment with our mammalian expressed 
mouse E-cadherin EC1-5. A monomer/dimer equilibrium could be confirmed for this type I 
cadherin with a KD of 109μM (Table 7) matching previously published KDs for EC1-2 
fragments of the same protein (96.5μM, (Harrison et al., 2010a; Katsamba et al., 2009)). This 
suggests that it is permissible to compare the determined VE-cadherin KD to previously 
published KDs for type I cadherins. Mouse N-cadherin EC1-2 associates with a KD value of 
25.8µM (Katsamba et al., 2009) and C-cadherin full ectodomains with a KD of 64µM 
(Chappuis-Flament et al., 2001), which leads to a range of approximately 26µM -109µM for 
type I cadherin affinities. Thus, VE-cadherin adhesive binding in the range of 1µM is 
considerably stronger than type I E-, N- and C-cadherin by between 20 to 110 fold.  
 
To reduce or ablate strand swap mediated cadherin binding we mutated docking tryptophans 
Trp2 and Trp4 to alanine in VE-cadherin. The double mutant protein was subjected to 
equilibrium AUC experiments and we found that the dimerization affinity is diminished 
approximately 120 fold (Figure 15c). 
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The dimerization of this mutant, though extremely weak compared to wild-type, may suggest 
a second binding mechanism deviating from strand swap binding, similar to behavior of 
strand swap mutants of other cadherins (Ciatto et al., 2010; Harrison et al., 2010a), discussed 
in Chapter 7). Because we could not exclude, that the observed binding might arise from EC4 
triggered cis interactions, we also conducted AUC experiments with truncated glycosylated 
VE-cadherin EC3-5 to investigate the adhesive contribution of domain EC4. The results 
reveal that EC3-5 fragments fail to dimerize or trimerize and are monomers in solution 
(Figure 15d).  
 
Table 7: Dissociation constants (KD) for homodimerization of mammalian produced VE-cadherin and 
E-cadherin. 
 
Protein Description KD [µM] 
   
Human VE-cadherin EC1-5 Wild type 1.03±0.22 
Chicken VE-cadherin EC1-5 Wild type 1.14±0.04 
Mouse E-cadherin EC1-5 Wild type 109±9 
Human VE-cadherin EC1-5 W2A 
W4A Strand Swapping mutant 122.5±62.5 
Human VE-cadherin EC3-5 Wild type Monomer 
 
Overall, AUC experiments show that VE-cadherin ectodomains do not associate into 
hexamers and instead, adopt a monomer/dimer equilibrium similar to other classical 
cadherins, though with a substantially higher affinity. VE-cadherin binding was markedly 
reduced when residues Trp2 and Trp4 important for strand swap mediated adhesion were 
mutated to alanines. In addition, no association of EC3-5 fragments could be observed in our 
experiments, supporting the assumption that VE-cadherin follows a classical cadherin 3D 
domain swapping mechanism. Thus, only domains EC1-2 of VE-cadherins appear to function 
directly in adhesion, indicating that the putative hexamer model may be artifactual. 
 
 
4.3 Analytical size-exclusion chromatography 
In a different approach to further biophysically study VE-cadherin binding behavior, we 
performed analytical size-exclusion experiments, which allow different molecular species to 
be resolved according to their hydrodynamic radii. Glycosylated VE-cadherin EC1-5 was 
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passed over an analytical Superose 6 column at a concentration of 7μM, which is well above 
its KD for dimerization (see previous section). Figure 16 shows the elution profile of wild type 
VE-cadherin, which elutes in a two peak distribution: one major peak at higher molecular size 
and a minor peak at lower molecular size. The strand swap targeted mutant W2A W4A has an 
inverse peak distribution with a minimal high molecular size peak and a major lower 
molecular weight peak (Figure 16, green trace), which both overlap with those of the wild 
type protein (Figure 16, blue trace). These findings suggest in combination with our AUC 
data that the two observed peaks represent a dimer - monomer distribution and that the 
increased abundance of the lower molecular size peak in the mutant reflects its low affinity 
dimerization observed in AUC. In contrast, truncated VE-cadherin ectodomain fragments 
spanning domains EC3-5 eluted at substantially higher volume in only one peak (Figure 16, 
orange trace), suggesting it to be smaller than the five domain strand swap proteins and thus 
monomeric. 
 
The size-exclusion chromatography data are in agreement with our AUC results. VE-cadherin 
full ectodomains form homodimers and monomers; strand swap ablated cadherin elutes 
predominantly as monomer and truncated VE-cadherin lacking adhesive domains EC1-2 
resolve as only one species in size-exclusion experiments, which is most likely monomeric. 
No evidence of trimers or hexamers could be found in these experiments. Notably, VE-
cadherin EC1-5 does not elute as one species representing a dynamic mixture of monomer 
and dimer in rapid exchange as seen for E-cadherin ((Harrison et al., 2010a): Figure 5c); it 
elutes as two distinct peaks, which might indicate in comparison to other classical cadherins a 
slowed kinetic rate as we have observed in studies of E-cadherin X-dimer interface mutants 
(Harrison et al., 2010a). 
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4.4 Multi angle light scattering 
Our biophysical data derived from AUC measurements and analytical size-exclusion 
chromatography strongly favor a monomer/dimer interaction for VE-cadherin. Analytical size 
exclusion chromatography as a technique separates different protein species dependent on 
molecule shape and size, hence it confirmed that VE-cadherin adheres as homodimer, but 
cannot provide accurate molecular masses to unambiguously identify each molecular species. 
Multi angle light scattering (MALS) preceded by an analytical size exclusion column allows 
the assessment of accurate masses of each chromatographic peak and provides additional 
information about dispersity found in the peak. We passed VE-cadherin EC1-5 and EC3-5 
and additionally as a control monomeric mutant E-cadherin W2A K14E all expressed in HEK 
293 GNTI- cells over a TSKgel Super SW3000 size exclusion column at concentrations of 
1mg/mL and their molecular mass and dispersity was determined by MALS (Table 8). All 
three proteins were monodisperse, with only one species of protein present in each 
chromatographic peak. E-cadherin EC1-5 W2A K14E mutant showed a mass of 66.5kDa 
corresponding to its monomeric weight. The mass of full length VE-cadherin EC1-5 was 
found to be 137 Da corresponding to the molecular weight of two cadherin molecules and the 
EC3-5 fragment revealed a mass of 52kDa showing it to be monomeric. 
 
Table 8: Molecular weight for human VE-cadherin EC1-5 and EC3-5 and mouse E-cadherin W2A 
K14E determined by MALS. 
 
Protein MALS MW [Da] Oligomerization state 
   
Human VE-cad EC1-5 137,400 Dimer 
Human VE-cad EC3-5 51,970 Monomer 
Mouse E-cad EC1-5 W2A K14E 66,500 Monomer 
 
The results of this experiment confirm data of AUC and analytical size-exclusion experiments 
supporting the conclusion that VE-cadherin forms adhesive dimers via adhesive domains 
EC1-2 and not higher order multimers. 
 
 
  
80 
 
4.5 Liposome aggregation assays with cadherin ectodomains 
VE-cadherin is crucial for the angiogenesis and maintenance of the integrity of the vascular 
endothelium, enabling formation of cell-cell adhesion junctions between endothelial cells 
(Uehara, 2006) Introduction 1.8). To mimic VE-cadherin adhesion at endothelial junctions 
and to study VE-cadherin interactions in an assay system more closely approximating cellular 
conditions, we used cadherin coated liposomes serving as ‘artificial cells’. Liposomes 100nm 
diameter lipid bilayer micelles composed of a 9:1 ratio of DOPC and Nickel chelating DGS-
NTA (Ni), were coated with cadherin ectodomains for aggregation experiments. C-terminally 
His-tagged VE- and E-cadherin ectodomains can be affinity bound to the liposome via their 
His-tag to Nickel (II) ions presented on the liposome surface (Figure 17, left panel). Thus, 
cadherins are oriented on liposomes with their N-terminal EC1 domains exposed. A lipid 
bilayer also has the beneficial property that it is not a static surface, but is instead fluid and 
allows proteins to diffuse similar to a cell membrane environment. Therefore, it is possible 
after initial cadherin-mediated contact between two liposomes has occurred for artificial 
junctions to assemble by recruitment of mobile cadherin on the surface. In the experiment, 
liposomes are incubated with the purified cadherin ectodomains to allow aggregation (Figure 
17, right panel). Multi liposome aggregates scatter more light than a suspension of single 
liposomes, thus scattering of light can be used to monitor cadherin-mediated liposome 
aggregation. Optical density (OD) at a wavelength of 650nm was measured over a time period 
of 2,500 seconds in 20 second intervals after addition of cadherin proteins to liposomes to 
initiate aggregation.  
 
First, we performed liposome aggregation assays with wild type E-cadherin ectodomains. E-
cadherin has been shown in many independent assay systems to mediate adhesion, including 
in cryo EM studies of adherens junctions (Farquhar and Palade, 1963; Harrison et al., 2010b; 
McNutt and Weinstein, 1973) and cell-cell aggregation assays (Katsamba et al., 2009; Patel et 
al., 2006; Shimoyama et al., 2000). Therefore, we used E-cadherin to test that liposome 
aggregation assays are applicable to cadherin adhesion. Figure 17b (right panel) shows the 
result of E-cadherin mediated liposome aggregation, as a plot of monitored OD against 
aggregation time. It can be observed that optical density increased steadily suggesting 
occurrence of liposome aggregation, which reached a ‘steady state’ at approximately 750sec, 
indicating an equilibrium in which rates of liposome association and dissociation are 
balanced. To test if aggregation is a general property of liposomes in solution or if it is a 
property inherent only to cadherin coated liposomes, we monitored uncoated liposomes for  
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the same period of time. No notable change in optical density could be detected during the 
course of the experiment, which clearly shows that no spontaneous liposome aggregation 
occurs in the absence of cadherin (Figure 17b).  
 
In addition, we tested the aggregation ability of E-cadherin mutants W2A K14E, in which 
mutations disrupt the strand swap and X-dimer interfaces leaving it with no adhesive 
properties (Harrison et al., 2010a). Liposomes were not aggregated by the double interface E-
cadherin mutants (Figure 17b, right panel). Thus, aggregation observed in the liposome assays 
is induced by specific E-cadherin strand swap interactions mimicking the extracellular 
process of cell adhesion and making liposome aggregation suitable to measure trans 
homophilic binding of cadherins. 
 
We tested wild type full ectodomains of human VE-cadherin EC1-5 in this assay system at 
concentrations of 8µM. VE-cadherin aggregated liposomes efficiently and the aggregation 
profile had a closely similar shape to that of type I E-cadherin-mediated aggregation with the 
difference that equilibrium was reached slightly later at around 1,500s (Figure 17b, left 
panel). We also conducted liposome aggregation experiments with the VE-cadherin strand 
swap mutant W2A W4A and the EC3-5 fragment. Introduction of the W2A W4A mutation 
into VE-cadherin reduced the ability to aggregate liposome significantly to only minimal 
levels in comparison to wild type VE-cadherin (Figure 17b, left panel, red trace). These data 
suggest that ablation strand swap mediated trans adhesion is sufficient to impair liposome 
aggregation, but at the same time, it was not able to abolish homophilic binding entirely. 
These findings closely agree with our AUC experiments showing residual binding for the VE-
cadherin strand swap mutant (see above). In contrast, the double interface mutant of E-
cadherin (W2A K14E) ablated E-cadherin adhesive binding almost entirely. Given that this 
mutant is designed to disrupt the strand swap binding and X-dimer interface in E-cadherin, 
one could assume, that the residual observed binding between strand swap VE-cadherin 
mutants might be due to X-dimer formation. To examine if VE-cadherins trans adhesive 
properties are localized solely in EC1-2 like in other type I and type II cadherins or if domains 
EC3-5 also participate in aggregation of liposomes, we tested truncated EC3-5 fragments. No 
change in absorbance could be detected during the course of the experiment above negative 
controls with liposomes alone (Figure 17b, left panel). Lack of any liposome aggregation 
indicates that VE-cadherin domains EC3-5 are not able to exhibit trans adhesive binding, 
which suggests in turn that residual binding observed for the VE-cadherin strand swap mutant 
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is likely to be mediated by EC1-2 domains, which could be speculated to arise from X-dimer 
formation (Harrison et al., 2010b). 
 
The liposome experiments show that wild type VE-cadherin can efficiently aggregate 
liposomes by protein inherent trans adhesive properties similar to those of E-cadherin. 
Further, these data suggest, that for initial VE- and E-cadherin mediated adhesive contact 
between lipid membranes the cadherin transmembrane and cytoplasmic domains and 
intracellular interactions appear to be dispensable.  
 
 
4.6 Electron microscopy studies of in vitro VE-cadherin junctions 
Electron micrographs of VE-cadherin junctions in the endothelium show that apposed plasma 
membranes are almost parallel to each other with an enrichment of protein density in the 
intercellular space and that extracellular adhesion is stabilized by linking of the cytoplasmic 
cadherin domain via intracellular proteins to actin filaments that concentrate at junctional sites 
(Uehara, 2006). In addition, Taveau et al. (2008) published cryo EM micrographs of artificial 
junctions formed by bacterially produced VE-cadherin EC1-4. These liposomes showed a 
double layered midline in between liposomes, which could be fitted with the VE-cadherin 
hexamer proposed by Hewat et. Al. (2007). Our laboratory also performed cryo EM studies 
on E-cadherin coated liposomes revealing artificial junctions different from those published 
for VE-cadherin EC1-4, but similar to cryo EM data of adhesive junctions (Harrison et al., 
2010b). Our studies of glycosylated, native full VE-cadherin ectodomains all suggest 
uniformly that VE-cadherin behaves as a classical cadherin dimer and does not associate into 
higher order multimers such as those reported for the bacterially produced EC1-4 fragments. 
Therefore, we wanted to visualize artificial adherens junctions assembled by our glycosylated 
VE-cadherin in order to compare these to junctions assembled by type I E-cadherin and to 
previously published data for bacterial VE-cadherin junction assembly. 
 
Liposomes, which were also used in liposome aggregation assays described in Section 4.5, 
were coated with C-terminally tagged wild type human VE –cadherin and incubated until 
liposome aggregation reached equilibrium. Aggregates were then transferred to holey copper 
carbon EM grids and flash frozen for imaging by cryo-EM. Figure 18a shows an electron 
micrograph of two single liposomes in the hole of the carbon grid in which buffer and  
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liposomes become trapped keeping the sample hydrated during freezing. Liposomes are easily 
determined in micrographs by two crisp dark bands around their edge, which represent the 
two leaflets of the lipid bilayer. Most of the liposomes visualized in these experiments have a 
mantle of dense, grainy, unorganized matter evenly distributed over the surface, representing 
a coating of cadherin ectodomains (Figure 18a, black arrow). These are easily distinguishable 
from liposomes that are uncoated or minimally coated on which there is no diffuse density 
attached to the surface and only the lipid bilayer is seen (Figure 18a, white arrow).  
 
Liposome aggregation occurs in three dimensions in suspension and the large clusters are then 
transferred to flat grids for freezing, so that mostly multilayered aggregates appear on the 
grids as Figure 18b shows.  
 
This sample thickness complicates intensive study as there is too much electron density for 
clear visualization of individual contacts. Nonetheless, single layers of ‘two dimensional’ 
contact forming liposomes were observed, as are shown in Figure 18c and d. These liposomes 
show examples of artificial adherens junctions, which have the following features:  
a) straightening of the lipid bilayer at the contact site in comparison to usual rather rounded 
shape of liposomes, b) membranes of apposing liposomes involved in junction formation are 
approximately in parallel and c) enrichment of electron density between the apposing 
liposomes (Figure 18c, black arrow). Another phenomenon we frequently observed is shown 
in Figure 18 (white arrow) in which soluble, ‘free’ cadherin, which is not affinity bound to a 
liposome surface, binds to cadherin ectodomains coated on liposomes. 
 
Figure 18d shows an electron micrograph of an aggregate of three liposomes including two 
large contact sites which show the characteristic features of artificial adherens junctions and 
an intermembrane spacing of approximately 40nm. It appears that almost all cadherin bound 
to the middle liposome was recruited into the junctions, as there is almost no apparent 
cadherin density on the liposome surface outside the junction. VE-cadherin ectodomains 
located in the junction appear to be densely concentrated and well ordered and show a thin, 
more electron-dense “midline”, which is parallel to and evenly spaced from both liposome 
lipid bilayers. The midline could be caused by overlapping cadherin EC1 domains in strand 
swap dimer conformation. The occurrence of a midline is reminiscent of junctions observed in 
desomosomes, which are assembled by desmocollins and desmogleins, also members of the 
cadherin superfamily (Al-Amoudi and Frangakis, 2008; He et al., 2003). Additionally, in EM 
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micrographs of E-cadherin coated liposomes which also formed artificial adherens junctions, 
a similar phenomenon was observed (Harrison et al., 2010b). Previously published cryo EM 
of liposome junctions assembled by bacterially produced VE-cadherin EC1-4 lacked this 
feature and had a more even distribution of density between apposed lipid layers, indicating a 
very different arrangement of cadherin from that observed here (Bibert et al., 2002; Taveau et 
al., 2008).  
 
In conclusion, artificial adherens junctions assembled by mammalian produced VE-cadherin 
have a dense “midline”, which suggests an arrangement of ectodomains different from that in 
previously reported artificial junctions formed by bacterially produced proteins. Our native 
VE-cadherin artificial junctions are more similar to those of type I E-cadherin (Figure 6, 
(Harrison et al., 2010b)), supporting in conjunction with our biophysical studies described in 
Section 4.1-4.3 and 4.4, a classical cadherin binding mechanism for VE-cadherin involving 
trans adhesion between monomers, possibly accompanied by weak cis interactions. Notably, 
VE-cadherin ectodomains are capable to form adherens junction like structures in liposomes 
without transmembrane and intracellular domains. This suggests that initial intermembrane 
contact and junction assembly are triggered by VE-cadherin ectodomains alone, although for 
strengthening of initial junctions into mature adherens junctions in vivo, the transmembrane 
and cytoplasmic domains as well as intracellular binding partners may be necessary.  
 
 
4.7 Atomic force microscopy imaging studies of VE-cadherin ectodomains 
Experiments conducted with glycosylated VE-cadherin involving equilibrium AUC (Section 
4.2), analytical size exclusion (Section 4.3), MALS (Section 4.4), liposome aggregation 
assays (Section 4.5) and cryo EM studies of artificial adherens junctions described in the 
previous section, strongly suggest, that natively glycosylated VE-cadherin adopts adhesive 
behavior closely similar to that of other classical cadherins. We wanted to obtain data on an 
atomic level about the binding mechanism of VE-cadherin, but attempts to obtain diffracting 
crystals of glycosylated full-length human and chicken VE-cadherin ectodomains were in 
vain. Therefore, we chose atomic force microscopy (AFM) imaging as an alternative to shed 
light on the overall arrangement of VE-cadherin dimers and those of E-cadherin for 
comparison. Full cadherin ectodomains were tethered to poly-L-lysine coated mica surfaces at 
a concentration of 2nM (8µM for E-cadherin) and subsequent imaging of the samples was 
performed in tapping mode (see Section 2.2.5).  
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Three dimensional AFM imaging data could be successfully derived from VE-cadherin and 
E-cadherin samples. Two distinct shapes reappeared in the resulting images for each protein 
(Figure 19a and b, c left and right panel). One of these can be described as a crescent shaped 
form and has a length of 28±2nm for VE-cadherin and 21.1±0.2nm for E-cadherin (19a, c left 
panel). They are markedly reminiscent in curvature and shape of individual protomers in the 
ublished C-cadherin crystal structure (Figure 19, (Boggon et al., 2002), pdb:1L3W). The other 
recurring form identified in the AFM images is approximately 48±9nm long for VE-  
(Figure 19b) and 33.2±1.3nm for E-cadherin (Figure 19c, right panel) and appears to be 
composed of two of the aforementioned crescent shaped forms, overlapped at their N-termini 
with a resulting increase in measured sample thickness in this region (Figure 19b and c, right 
panel). The overall arrangement of E- and VE-cadherin complexes is strikingly similar to the 
crystallographically determined C-cadherin strand swapped trans dimer and to dimers of E- 
and N-cadherin reported recently (Boggon et al., 2002; Harrison et al., 2010b). These data 
suggest that VE-cadherin ectodomains form complexes shaped like classical cadherin dimers, 
including a clear increase in sample thickness due to the overlap of EC1 domains, and a 
corresponding dimer length that is slightly less than twice the monomer length. Overall, it 
appears that the strand swap mechanism common to other classical cadherins also underlies 
VE-cadherin homophilic binding. Cigar shaped objects like the previously reported hexamers 
which were abundant and readily identifiable in cryo EM studies of bacterially produced VE-
cadherin EC1-4 (Hewat et al., 2007) could not be identified in any of the AFM images.  
 
Notably, in comparison to VE-cadherin images, in those for E-cadherin fewer dimeric forms 
and a larger number of single protomers were found. The different distinct distribution of 
monomers and dimers might arise due to a difference in affinities for homodimerization, 
because E-cadherin affinity is approximately two orders of magnitude lower than that of VE-
cadherin. At the low protein concentrations required for the imaging experiments, VE-
cadherin therefore has more dimers present than the lower affinity E-cadherin. 
 
This data supports our previous findings that native full VE-cadherin ectodomains form strand 
swapped dimers like other classical cadherins, which appear similar in arrangement to those 
of type I cadherins. 
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4.8 VE-cadherin EC4 domain enables multimerization only when 
glycosylation is absent 
Despite previously published evidence for a hexamer as the minimal adhesive unit, which was 
found for bacterially produced VE-cadherin EC1-4 fragments (Bibert et al., 2002; Hewat et 
al., 2007; Legrand et al., 2001), native, glycosylated VE-cadherin behaved as a classical 
cadherin dimer in all of our biophysical experiments (see Sections 4.2-4.7). Additionally, VE-
cadherin exhibited behavior similar to that of type I E-cadherin in liposome aggregation 
assays (Section 4.5), cryo EM studies of artificial adherens junctions (Section 4.6) and shares 
the overall dimer configuration with those of type I cadherins, as AFM imaging experiments 
revealed (see previous section). These findings question the biological relevance of the 
putative hexamer model for VE-cadherin mediated homophilic adhesion involving a strong 
cis trimer interface located in EC4.  
 
Between the published work in which hexamers are observed (Bibert et al., 2002; Hewat et 
al., 2007; Legrand et al., 2001) and our own studies, two striking differences in the protein 
used are evident. The differences are the presence glycosylation, which is present in our 
proteins but absent from the bacterially expressed proteins and the inclusion of domain EC5, 
which is again present only in our constructs. To investigate what effect glycosylation and 
domain EC5 have on VE-cadherin adhesive behavior, we initially produced a truncated VE-
cadherin EC3-4 fragment in bacteria lacking both glycosylation and domain EC5, in addition 
to lacking the N-terminal adhesive domains EC1-2 such that association of the EC3-4 
domains could be specifically studied. 
 
First, we tested the bacterially produced human VE-cadherin EC3-4 fragments in equilibrium 
AUC experiments. Surprisingly, we found it to behave as a strong dimer with a KD of 
1.93±0.26µM, which is approximately in the same range as the described KDs for full length 
VE-cadherin ectodomains (Table 7). Additionally, in some of these experiments, EC3-4 
domains associated via an isodemic mechanism, in which the dissociation constants for every 
addition of monomer are considered the same, which leads to multimerization. Although 
curves could not be fitted to an explicit trimer model, the data suggest that higher order 
complexes were formed, which is possibly triggered by non-specific hydrophobic protein 
interactions (Weis et al., 1991). These data are in direct contrast to the biophysical evaluation 
of mammalian produced glycosylated VE-cadherin EC3-5 proteins, which did not associate 
and consistently remained monomeric in all experiments (Section 4.2-4.5).  
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The results suggested that high affinity multimeric association of the bacterial protein might 
be directly due to absence of glycosylation in EC4, or to absence of the EC5 domain. To test 
this hypothesis, we studied association behavior of a human VE-cadherin EC3-5 fragment 
produced in glycosylation deficient HEK 293 GNTI- cells (Section 3.1) in equilibrium AUC 
experiments. Results showed that, unlike equivalent fully glycosylated fragments, minimally 
glycosylated EC3-5 proteins formed isodesmic aggregates or weak dimers with KD values in 
the range of 221µM, which is closely similar to the behavior of the bacterial EC3-4 fragment 
(Table 9). When N-glycosylation was fully removed from the protein by treatment with 
Endoglycosidase H, we obtained similar results as for the minimally glycosylated protein. 
Also, we found that this association happens independently from the presence of calcium (II) 
ions (not shown). The lower affinity in comparison to that found for bacterially expressed 
EC3-4 fragments might be due to the presence of O-glycosylation or to the presence of the 
EC5 domain, which had to be included in the mammalian constructs due to lack of expression 
in EC3-4 trials. Nonetheless, the experiments establish a clear role for N-linked glycosylation 
in preventing non-specific aggregation of EC3-4 domains. We wanted to identify if the non-
specific interaction in minimally glycosylated proteins is specific to cis interactions or if these 
proteins can also mediate trans adhesion in liposome aggregation assays. Natively 
glycosylated EC3-5 fragments failed to aggregate liposomes as described in Section 4.5. 
When glycosylation was only minimal, EC3-5 fragments gained the ability to aggregate 
liposomes (Figure 20a, left panel). This suggested that lack of complex glycosylation leads to 
non-specific protein associations in cis or trans. 
 
In liposome aggregation assays using full length ectodomains, minimally glycosylated VE-
cadherin EC1-5 behaves similar to the glycosylated protein, with the exception that 
equilibrium is reached in shorter time and the degree of aggregation appears to be higher 
(Figure 20a, right panel). In addition, we conducted equilibrium AUC experiments, which 
showed that minimally glycosylated or deglycosylated VE-cadherin EC1-5 formed isodesmic 
aggregates in presence or absence of calcium (II) ions with reproducible isodesmic KD(i) of 
approximately 7.8µM and 3.4µM, respectively. Despite the fact that cadherin homophilic 
interactions are calcium dependent (Harrison et al., 2010b; Takeichi, 1991), isodesmic 
aggregation was found to be independent from calcium, which strongly suggests the observed 
interactions to be artifactual. Interestingly, the ideal number of protomers in isodesmic 
polymerizing systems is n=6 (Frieden and Goddette, 1983), coinciding with the number of 
protomers in bacterially produced VE-cadherin multimers detected previously (Hewat et al., 
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2007). When N-linked glycosylation was fully removed from VE-cadherin EC1-5 by 
Endoglycosidase H the protein became unstable and prone to aggregate, resulting in heavy 
precipitation and precluding testing in functional assays. 
 
Table 10: Different glycosylation pattern of human VE-cadherin protein fragments results in different 
behavior in equilibrium AUC experiments.  
 
Protein Glycosylation 
Isodesmic 
behavior 
observed? Dimerization KD [µM] 
    
VE-cadherin EC3-4 None (produced in bacteria) Yes 1.93±0.26 
VE-cadherin EC3-5 Native No NAa 
VE-cadherin EC3-5 Minimal Yes 178±43 
VE-cadherin EC3-5 Deglycosylated Yes 299 
VE-cadherin EC1-5 Native No 1.03±0.22 
VE-cadherin EC1-5 Minimal Yes 65±19b 
VE-cadherin EC1-5 Deglycosylated Yes NAc 
 
a Protein is found to be monomeric; see Section 4.2 for detail. 
b Affinity value has a high error due to protein aggregation and precipitation during the experiment. 
c Deglycosylated VE-cadherin EC1-5 could only be fitted to an isodesmic model, not to an equilibrium 
dimer model. Heavy precipitation due to aggregation occurred during experiments. 
 
How does glycosylation affect association of EC3-4 domains? Our findings in concert with 
the fact that the cis interface found in putative hexameric structures is located in domain EC4, 
prompted us to look more closely at the N-linked glycosylation site Asn395 located in this 
domain, (Figure 20b). This site is conserved within most of the type I and II cadherins as 
described in Section 3.2. A close up view of the region of domain EC4 in which the glycan is 
positioned was generated based on the human VE-cadherin homology model (Figure 20b). 
The N-linked site appears to be nested in an environment of predominantly non-charged and 
hydrophobic surface residues, which an attached sugar moiety would shield from non specific 
contact (Figure 20b). Thus, this area might be responsible for the unspecific interactions 
prompting the observed multimers in VE-cadherin fragments without glycosylation.  
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Overall, data derived from different biophysical studies involving full length and truncated 
VE-cadherin fragments in various glycosylation states, suggest strongly that the trimeric cis 
association triggered by EC4 that forms the basis for hexamer formation previously reported 
in bacterially produced VE-cadherin EC1-4 fragments represent an artifact due to lack of 
glycosylation. Removal of N-linked glycosylation appears to expose protein regions which 
are normally shielded by sugar moieties in the native protein, allowing non-specific and non-
biologically relevant interactions which may result in artifactual multimers. These data 
support the hypothesis that domain EC4 is only able to form higher order multimers when 
glycosylation is absent. 
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Chapter 5:  
Structure of the homophilic binding interface  
of a VE-cadherin EC1-2 adhesive fragment 
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5.1 EC1-2 domains are responsible for strand swap mediated 
homodimerization 
We showed in biophysical experiments described in sections 4.1-4.8 that full length VE-
cadherin EC1-5 homodimerizes, whereas truncated EC3-5 domain fragments lack this ability 
and do not associate. These data suggest that domains EC1 and 2 are crucial for VE-cadherin 
to mediate trans adhesive binding. This is in agreement with published data from crystal 
structures (Boggon et al., 2002; Patel et al., 2006), biophysical experiments such as 
equilibrium AUC (Harrison et al., 2010a; Katsamba et al., 2009), cell-cell adhesion and 
domain shuffling experiments (Patel et al., 2006) showing that the trans-adhesive properties 
of all typical classical cadherins, map to N-terminal domains EC1-2 (Harrison et al., 2010a; 
Shan et al., 2004). The strand swapped mature adhesive interface itself involves residues in 
EC1 and in particular residue Trp2 for type I cadherins or Trp2 and Trp4 for type II cadherins 
(Patel et al., 2006; Shapiro et al., 1995). Further studies identified the X-dimer interface as a 
binding intermediate in E-cadherin and cadherin-6 adhesion and revealed, that EC1 and 2 are 
both required for this interface and for proper adhesive function, especially EC1 and EC2 
residues in and around the Ca2+ binding interdomain linker region (Ciatto et al., 2010; 
Harrison et al., 2010a) and Chapter 7). The detailed binding mechanism for VE-cadherin 
mediated adhesion has not been determined at the atomic level, but previous antibody binding 
studies targeting the A strand containing residues Trp2 and Trp4 (May et al., 2005) and our 
experiments  with full length ectodomains and truncated VE-cadherin fragments (Section 4.1-
4.5, 4.8) strongly suggest that VE-cadherin employs a similar binding mode to other classical 
cadherins and domains EC1-2 are crucial for adhesion.  
 
To test if VE-cadherin EC1-2 domains are also sufficient for full trans binding activity, 
human, chicken and mouse VE-cadherin fragments spanning putative adhesive domains EC1-
2 were produced in bacteria as described in Section 2.1.2.3. The multimerization behavior 
was analyzed by equilibrium analytical ultracentrifugation and we found, that all three VE-
cadherin formed dimers in solution which is in agreement with results we obtained for full 
length human and chicken ectodomains (Table 7). The KDs for dimerization were determined 
to be 1.63µM for chicken, 2.22µM for mouse and 4.38µM for human VE-cadherin (Table 
10), values in the same range to the corresponding full length proteins (Table 7), suggesting 
EC1-2 domains are sufficient for full activity and that absence of any glycosylation in EC1-2 
does not have any influence on adhesive binding and affinities of two domain fragments. This 
is in contrast to full length proteins, which are strongly dependent on native glycosylation in 
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domains EC3-5 (See Section 4.8). These data suggest that EC1-2 domain proteins are 
appropriate for studies focused on the VE-cadherin binding mechanism. 
 
Table 10: Dissociation constants (KD) for homodimerization of VE-cadherin EC1 and EC1-2 
fragments.   
 
Protein Description KD [µM] 
   
h VE-cadherin EC1-2 Wild type 4.38±1.2 
m VE-cadherin EC1-2 Wild type 2.22±0.11 
ck VE-cadherin EC1-2 Wild type 1.63±0.19 
h VE-cadherin EC1 Wild type NA a 
m VE-cadherin EC1-2 W2A W4A Strand swapping mutant NA a 
ck VE-cadherin EC1-2 W2A W4A Strand swapping mutant NA a 
h VE-cadherin EC1-2 Met-extension Strand swapping mutant 231±78 b 
m VE-cadherin EC1-2 Met-extension Strand swapping mutant 70±100 b 
 
a Protein is found to be monomeric in equilibrium AUC experiments. 
b Due to instability of mutant proteins heavy precipitation occured during the experiments resulting in 
errors. 
 
Classical cadherins bind by exchanging, or “swapping”, N-terminal A*-strands with each 
other to form strand swapped dimers, in which either Trp2 for type I cadherins or Trp2 and 
additionally Trp4 for type II cadherins are docked into a hydrophobic pocket in the partner 
EC1 domain. The adhesive properties of type I and type II cadherins are impaired and 
homodimerization involving the strand swap mechanism is prevented when indole side chains 
of tryptophan residues are mutated those of alanine (Harrison et al., 2010b; Kitagawa et al., 
2000; May et al., 2005; Tamura et al., 1998). We wanted to test if Trp2 and Trp4 in VE-
cadherin are needed for adhesive binding of our EC1-2 fragments, so Trp2 and Trp4 in 
human, mouse and chicken VE-cadherin were mutated to alanines and proteins used in 
equilibrium AUC experiments. Human mutant proteins had very low expression levels and 
could not be purified in sufficient amounts for AUC experiments. Data for mouse and chicken 
mutant VE-cadherin revealed that the mutant proteins fail to dimerize and remain monomeric 
after introduction of the strand swap mutation W2A W4A (Table 10). Human and mouse VE-
cadherin mutants, in which the N-terminus is extended by a single methionine, showed 
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reduced adhesive behavior (Table 10) These data strongly support the idea that VE-cadherin 
utilizes the strand swap mechanism common to classical cadherins. 
 
For E-cadherin and cadherin-6 it can been demonstrated, that after ablation of strand swap 
binding, some weak residual binding remains, which can be attributed to a different interface 
referred to as the X dimer, involving regions of both EC1 and EC2 (Chapter 7, Harrison 
2010). VE-cadherin EC1-2 W2A W4A mutants did not show residual binding within AUC 
detection limits (~1mM KD). Thus, we removed the entire domain EC2 and expressed domain 
EC1 alone for equilibrium AUC experiments. Results showed that VE-cadherin EC1 domain 
cannot homodimerize and remained monomeric in solution, suggesting that VE-cadherin also 
requires EC2 and therefore possibly an X dimer intermediate.  
 
Taken together, our data show that VE-cadherin EC1-2 forms homodimers in solution and 
appears to utilize a strand swap mechanism common to classical cadherins. Both domains are 
necessary to mediate adhesive binding. Notably, dimerization of two domain VE-cadherin 
fragments was independent of glycosylation state.  Therefore, VE-cadherin EC1-2 fragments 
expressed in bacteria are suitable for structural studies of the adhesive binding interface. 
 
 
5.2 Screening and optimization of crystals of VE-cadherin EC1-2 
While our experiments with full length native VE-cadherin ectodomains and with smaller 
adhesive fragments show that VE-cadherin is likely to bind via a strand swapped dimer 
mechanism with a similar overall configuration to other classical cadherins, details of the 
adhesive interface on a molecular level remain elusive. In order to determine details of the 
adhesive interface on atomic level we wanted to study the minimal EC1-2 binding unit  of 
VE-cadherin using protein crystallography. 
 
Chicken two domain fragments of VE-cadherin crystallized at 8.6mg/mL in sitting drop 
experiments of initial sparse matrix screens in three different conditions, all with high 
molecular weight PEG as precipitant (Figure 21a). Crystals found in the condition containing 
0.2M calcium acetate, o.1M sodium cacodylate, pH6.5 and 16% (w/v) PEG 8,000 were small, 
non bifringent, single crystals with sharp edges (Figure 21a, left panel). The other drop 
contained two sharp edged very bifringent hexagonal crystal plates found in precipitate  
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(crystallization condition listed in Figure 21a, middle panel) and the last drop (composition 
shown in Figure 21a, right panel) contained soft edged, very bifringent rectangular boxes 
surrounded by precipitate (Figure 21a right panel). 
 
Crystals shown in the left panel of Figure 21a, were chosen for optimization as they had sharp 
edges and no protein precipitate was found in the drop. A large number of small crystals is 
usually caused by high nucleation rates, which indicate a precipitant concentration and/or 
protein concentration that are too high. We changed for optimization to hanging drop assays 
and reduced the precipitant concentration in the crystallization solution. At the same time we 
shifted the protein:crystallant ratio from initial 1:1 to a 2:1 ratio with 2fold protein in 
comparison to mother liquor, lowering the initial precipitant concentration while increasing 
total protein concentration in the drop (Figure 21b, optimization). We found significantly 
improved crystals in the altered condition which were larger in all three dimensions, cuboidal 
and bifringent (Figure 21b). Crystals grew up to approximately 300-400µm size (Figure 21b), 
which were sufficiently sized to test for X-ray scattering behavior. We mounted crystals in 
Hampton nylon loops of 200µm size, immersed crystal prior to freezing in cryo-protectant 
composed of the crystallization solution with an additional 30% glycerol and flash froze the 
crystals in liquid nitrogen. Diffraction data was collected at the National Synchrotron Light 
Source, Brookhaven National Laboratories using beam line X4C. Crystals diffracted to 2.1Å 
resolution and a full data set 180 frames could be collected from a single VE-cadherin crystal 
with one degree rotation per image. One of the recorded diffraction images is shown in Figure 
22 depicting a representative diffraction pattern with sharp diffraction spots, indicating low 
mosaicity (0.57°). Data was processed to a resolution of 2.1Å with Denzo and Scalepack and 
unit cell dimensions were a=b= 99.973Å and c=105.987Å. With α=β=γ=90°. Examination of 
systematic absences in the data, identified the space group as either P43212 or P41212; of these 
two possibilities, P43212 was determined to be correct during molecular replacement.  
 
Matthews coefficient analysis indicated that two molecules were present in the 
crystallographic asymmetric unit, with a solvent content of approximately 56% (Vm=2.8 
Å3/Da). The structure could be solved with molecular replacement using the crystal structure 
of cadherin-11 EC1-2 (pdb code 2A4E) as search model. We built the structure in alternating 
cycles of molecular building in Coot and refinement in Refmac (ccp4i suite) to a final R-
factor of 18.29% and Rfree – factor of 24.18. Detailed data collection and refinement statistics  
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are summarized in Table 11. The Ramachandran plot of the refined structure revealed 97.1% 
of the residues were in favorable regions and no structural outliers are present. The structure 
of chicken VE-cadherin EC1-2 is described in Section 5.3. 
 
In addition to chicken VE-cadherin, we also screened human and mouse VE-cadherin EC1-2 
fragments at 4°C and 20°C for crystallization in over 800 different conditions each in sparse 
matrix crystal screening suites. Human VE-cadherin formed clear, non bifringent spherulites 
in one condition, (composition listed in Figure 23a), and mouse VE-cadherin yielded non 
bifringent needle clusters in a condition composed of 0.1M Imidazole pH8.0 and 10% (w/v) 
PEG 8,000 (Figure 23a, right panel). However, despite extensive optimization efforts 
including changes of precipitant concentrations, precipitant type, pH-variation and 96 
different additives, we could not improve the initially obtained spherulites during 
optimization trials. Mouse VE-cadherin crystals could be improved as the size of the blades in 
needle clusters could be enlarged and the number of clusters in comparison to the initial hit 
reduced (Figure 23b). However, despite extensive efforts, crystal blades remained too thin in 
the third dimension and were consequently highly fragile (Figure 23b, right panel, note the 
crystal cracking).  
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5.3 Crystal structure of chicken VE-cadherin EC1-2 reveals a strand 
swapped dimer 
We crystallized chicken VE-cadherin EC1-2 and obtained high resolution diffraction data up 
to 2.1Å from which a structure could be solved as described in the previous section. Data 
collection and refinement statistics are summarized in Table 11. 
 
Table 11: Crystallographic data and refinement statistics. 
Data collection  
Space group P43212  
Cell dimensions a, b, c (Å); α, β,  (°) 99.97, 99.97, 105.99; 90, 90, 90 
Resolution (Å) 80-2.1 
Rmerge 13.7 (41.8) 
I/I 1,395.2/64.4 (339.1/48.2) 
Completeness 100(100) 
Redundancy 14.1 
Observed reflections 450,866 
Unique reflections 31,991 
Refinement   
Resolution (Å) 72.7-2.1 
Number of reflections 31,937  
Rwork 18.29 
Rfree 24.18 
Number of atoms 3,841 
Protein 3,247 
Ion 6 
water 588 
R. m. s. deviations  
Bond length (Å) 0.016 
Bond angles (°) 1.592 
Mean B factors (Å2)  
Protein 19.38 
Ion 13.58 
water 32.06 
Ramachandran plot  
Outliers (%) 0  
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Favored (%) 97.1 
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In the crystallographic asymmetric unit two molecules are present, which are both closely 
similar to each other (Figure 24). The protomers have an elongated, slightly curved overall 
shape reminiscent of that of previously published classical cadherin structures. Each molecule 
consists of two extracellular cadherin (EC) domains, which are each composed of a seven 
stranded β-barrel fold and are characteristic for cadherins. EC domains are connected with 
each other through a short interdomain linker (Figure 25a) in which three divalent calcium 
ions are coordinated (Figure 25a, inset) as observed in all previously reported type I and II 
cadherin structures. Predominantly, acidic residue side chains and backbone carbonyl groups 
of EC1, the interdomain linker and EC2, in addition to a single solvent water molecule, 
contribute to the calcium coordination (Figure 25a). Specifically, domain EC1 provides the 
calcium coordinating residues Glu11, Glu12, Asp 62 and Glu64, which are conserved within 
all type II cadherins. In type I subfamily members Glu12 is replaced with asparagine that does 
not directly coordinate calcium (II) and remains solvent exposed, but they otherwise share the 
same calcium (II) coordination pattern. Side chains of residues Asp96, Asn98 and Asp99 in 
the linker region and Asp132 and Asp184 of domain EC2 and in addition, back bone carbonyl 
groups of residues Ile97, Asn100 and His139 also coordinate calcium (II). This calcium 
binding linker region thus forms a continuous network of bonds between the successive 
domains and is likely to limit flexibility of the two EC domains relative to each other, and to 
rigidify VE-cadherins overall shape, precisely as suggested by other classical cadherins 
structures consistent with other experimental data (Ahrens et al., 2003; Sotomayor and 
Schulten, 2008). 
 
The two VE-cadherin protomers observed in the crystallographic asymmetric unit form a 
strand swapped dimer, which shares the essential features with those of other classical 
cadherins (Figure 24). Both N-terminal EC1 domains are arranged approximately 
perpendicular to each other forming a symmetrical adhesive dimer interface, in which the N-
terminal segments of the respective A-strand, the A*-strand, are exchanged between 
protomers (Figure 24, 25b). Protomers are arranged in a trans orientation in the dimer as if 
extending from opposing cell surfaces. On the molecular level, tryptophan side chains at 
positions two and four are central to this ‘strand swap’ dimer. Trp2 and Trp4 are located on 
the A*-strand and are reciprocally docked into a hydrophobic cavity, the ‘acceptor pocket’, of 
the partnering molecule. This intermolecular docking is stabilized by three types of 
interactions (Figure 25b, inset). Both ε1 nitrogen atoms of Trp2 and Trp4 indole rings engage  
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in intermolecular hydrogen bonds with the backbone carbonyl group of Pro86 and the side 
chain oxygen of Ser88, respectively. The interaction between Trp2 and Pro86 is also found in 
other structures of classical cadherins. whereas the latter hydrogen bond is unique to the VE-
cadherin dimer. In other type II cadherins, the Trp4 side chain forms instead an indirect 
hydrogen bond via a water molecule with the residue equivalent to Ser88. 
 
Additionally, Trp2 and Trp4 side chains partake in hydrophobic van der Waals interactions 
with residues lining the hydrophobic acceptor pocket. Residues Leu24, Ala73 and Phe90 are 
positioned at the “base” and Tyr35 and Ile75 towards the “top” of the hydrophobic pocket. 
The last of the observed pocket interactions is a salt bridge formed by the carboxyl group of 
Glu85, which holds the N-terminal amino group of Asp1 in place through an ionic interaction 
as if locking the exchanged strands. This salt bridge is conserved within classical cadherins 
and along with Trp related interactions is crucial for proper cadherin mediated binding 
(Harrison et al., 2005) explaining the necessity of native N-termini for strand swapping 
cadherins, since an extended N-terminus, would lead to a shift of the salt bridge position. In 
addition to the pocket related interactions, two more intermolecular hydrogen bonds can be 
observed near the periphery of the pocket region. The back bone carbonyl group of Asp1 and 
amide group of Ile3, both located on the donor A-strand of one protomer, engage in hydrogen 
bonds with the back bone amide and carbonyl group of B-strand residues Ser27 and Thr25, 
respectively, from the other protomer. 
 
 
5.4 The VE-cadherin strand swapped interface is unique 
The specific molecular interactions between the donor strand and acceptor pocket in the 
strand swapped dimer of VE-cadherin described above are closely similar to those observed 
in structures of type II cadherins -8, -11 and MN- (Patel et al., 2006). However, sequence 
identity analysis suggests an outlier position for VE-cadherin within the type II cadherins and 
indeed the crystal structure revealed features that are unique to the adhesive interface of VE-
cadherin, which will be elucidated below.  
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5.4.1 VE-cadherin uses a different set of residues for trans dimerization than other 
classical cadherins 
We examined the adhesive interface of VE-cadherin in comparison to those of type I and II 
subfamily members in detail and first determined how much solvent accessible surface area is 
buried in the respective interfaces using the program PISA. Resulting buried surface area 
(BSA) values are summarized in Table 12. We found that EC1 domains contribute almost all 
of the interface residues in the adhesive strand swapped dimer and thus focused our detailed 
comparison on EC1 domains. In type I subfamily members E-, N- and C-cadherin BSA values 
average approximately to 850Å per protomer (Table 12) and in type II cadherin-8, -11, and 
MN the adhesive interface buries a markedly larger region of 1,225-1,265Å per protomer 
(Table 12, (Patel et al., 2006)). In comparison, VE-cadherin buries an interface of 1067Å per 
protomer (Table 12), which is almost exactly intermediate between the areas buried in type I 
and II cadherins.  
 
Table 12: Buried accessible surface area (BSA) for type I and type II cadherin interfaces, BSA value 
for one protomer given.  
 
Protein BSA [Å²] a pdb ID 
   
EC1-domain   
ck VE-cadherin 913.0 3PPE 
m cadherin-8 1264.2 1ZXK 
m cadherin-11 1225.8 2A4C 
ck MN-cadherin 1254.9 1ZVN 
m E-cadherin 817.3 2QVF 
m N-cadherin 875.8 2QVI 
x C-cadherin 847.6 1L3W 
   
EC12-domains   
ck VE-cadherin 1066.2 3PPE 
m cadherin-8 1271.9 2A62 
m cadherin-11 1529.2 2S4E 
m E-cadherin 817.3 2QVF 
m N-cadherin 875.8 2QVI 
x C-cadherin 847.6 1L3W 
a In case of two molecules per asymmetric unit, values given for chain A.  
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To visualize the molecular surface area that is buried in the strand swap interface, EC1-
domains of VE-cadherin and representatives of the type I (E-cadherin) and type II (cadherin-
11) subfamilies are shown in Figure 26a as molecular surface representation with the surface 
region buried in the dimer interface shown in blue as the ‘footprint’ of the partner protomer. 
The ‘footprint’ for E-cadherin is relatively small (Figure 26a, left panel) and located around 
the ‘upper’ half of the EC1 domain, corresponding to the region in which the swapped A*-
strand is docked into the acceptor pocket of the partnering molecule (Figure 26b, left panel). 
In type II cadherins residues Trp2, as in type I cadherins, and in addition Trp4 are anchored in 
a proportionally larger hydrophobic acceptor pocket (Figure 26, middle panel).  
 
However, the dimer interface in type II cadherins is extended along the ‘face’ of the entire 
domain EC1 towards the base (Figure 26, middle panel), This is in contrast to the buried 
surface area found in type I cadherins, where the interface is restricted to the ‘upper half’ of 
the domain (Figure 26a and b, left and middle panel) and, together with the larger swapped 
element, explains the higher BSA values for type II cadherin dimers. In VE-cadherin is the 
adhesive region limited to the “upper” half of domain EC1 (Figure 26a, right panel) 
corresponding to the A*-strand and hydrophobic acceptor pocket (Figure 26b, middle panel), 
like in type I cadherins. Strikingly, despite VE-cadherin having close similarity in the strand 
swap region, the extended non-swapped region present in type II cadherins is absent from the 
adhesive interface of VE-cadherin leaving this particular region solvent exposed. 
 
The non-swapped hydrophobic region contributing to the adhesive dimer that is characteristic 
to type II cadherins is formed by hydrophobic residues 8, 10, 13 and 20 contributed from both 
protomers (Figure 27a and b). These residues interact via van der Waals interactions and stack 
closely against each other in the swapped dimer (Figure 26b, middle panel, (Patel et al., 
2006)). These residues are conserved in character at the sequence level in typical type II 
cadherins, but not in VE-cadherin, which has mostly hydrophilic residues at these positions 
similar to type I cadherins (Figure 27a). These residues in VE-cadherin are not found to 
engage in intermolecular protein-protein interactions of any kind in this region (Figure 27b, 
Figure 26, right panel), leading to an overall dimer arrangement more reminiscent of that of 
type I cadherins than type II cadherins (Figure 26). Although VE-cadherin lacks the extended 
non-swapped hydrophobic region of type II cadherins, it shares most residues required for 
interactions between the swapped strand and the acceptor pocket closely with those of type II 
cadherins (Figure 27b).  
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The structure of the adhesive VE-cadherin dimer reveals a unique adhesive interface, in that 
the VE-cadherin interface resembles that of type I cadherins, whereas the strand-swap 
interactions between A*-strand and acceptor pocket are almost completely conserved between 
VE-cadherin and type II subfamily members. This strongly suggests that VE-cadherin 
represents an outlier among the type II classical cadherins. 
 
 
5.4.2 Analysis of structural superpositions of VE-cadherin with type I and II cadherins 
To identify the impact of divergence at the sequence and binding interface level on general 
arrangement of the VE-cadherin protomer and dimer, we superposed VE-cadherin protomers 
with those available from type I and type II cadherin structures.  
 
The overall structures of EC1-2 single protomers appear quite similar to each other in respect 
of relative orientation of EC domains and the overall EC domain fold (Figure 28a, left panel, 
superpositions). Root mean square (r. m. s.) deviations were also determined for superposed 
cadherin pairs (Table 13). 
 
VE- and type II cadherin-11 have an r.m.s value of 1.85Å over 194 aligned Cα-atoms, 
whereas VE-cadherin and type I E-cadherin compare to 1.51Å over 187 Cα-atoms. In 
comparison, E-cadherin and cadherin-11 have a higher r. m. s deviation of 2.3Å over 183 Cα-
atoms. Evaluated over EC1-2 structures, VE-cadherin superpositions suggest that the structure 
is similarly different from type I and II cadherins. In comparison type I subfamily members  
E-, C- and N-cadherin superposed with each other yield in r. m. s. d. values in the range of 
0.99-1.13Å, indicating closely similar structural arrangement.  
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Table 13: Root mean square deviations between superposed EC1 (yellow), EC2 (red) and EC12 (blue) 
domains of type I and type II cadherins. 
 
 
EC1 
VE 11 8 MN E N C EC2 
EC12  
VE - 
1.16a 1.15 1.31 1.52 1.66 1.84 
1.02 1.16 NA b 1.09 1.17 1.27 
11 1.86 - 
0.78 0.55 1.42 1.67 1.67 
0.96 NA 1.01 1.04 1.18 
8 1.46 1.65 - 
0.80 1.34 1.63 1.62 
NA 1.35 1.35 1.30 
MN NA NA NA - 
1.49 1.75 1.75 
NA NA NA 
E 1.52 2.31 1.87 NA - 
0.94 0.86 
0.73 0.69 
N 1.70 2.13 1.83 NA 0.94 - 
1.01 
0.80 
C 2.01 2.36 2.40 NA 1.14 1.21 - 
 
a In case of two molecules present in the crystallographic asymmetric unit, values retrieved by 
superpositions of chain A only.   
b Structural data only available for domain EC1. 
 
Although, domains EC1-2 are required for trans adhesion, specificity appears to arise from 
differences in domain EC1 to which the mature swapped interface maps (Patel et al., 2006). 
Therefore, we also superposed single EC1 domains of selected strand-swapped cadherin 
structures separately with VE-cadherin and each other (Table 13, lavender for EC1, purple for 
EC2 domain r. m. d. values, respectively). When calculations are restricted to EC1 domains 
alone, VE-cadherin is more similar to type II cadherins with r. m. s. deviations in the range of 
1.11-1.16Å in comparison to values in the range of 1.53-1.84Å for comparisons with type I 
cadherins. This difference can be explained by the fact, that type II cadherins lack a structural 
feature of a quasi β-helix between A- and B-strands which is specific to type I cadherins 
(Figure 28b). Also, presence of two tryptophan residues in all type II cadherins, which require 
a larger acceptor pocket than type I cadherins, might contribute to the lower r. m. s. deviations 
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between VE-cadherins and type II subfamily members. Additionally, swapping A* strands of 
type II cadherins and VE-cadherin align closely in an orientation different from that in type I 
cadherins, which likely arises from the differences in the adhesive dimer interface between 
the two subfamilies (See Section 5.4, Figure 28a and c). Notably, however, type II cadherins 
MN, 8 and 11 are almost identical to each other as suggested by r. m. s. deviations in the 
range of 0.53-0.68Å (Table 13). These analyses suggest that VE-cadherin is to some extent a 
structural outlier within type II cadherins.  
 
Next, dimer superpositions were investigated. The overall arrangement of type I and II 
cadherin dimers was compared by superposing based on one of the protomers of the dimer 
with that of the other dimer (Figure 28a, right panel). Results reveal that VE-cadherin has a 
markedly divergent dimer arrangement in comparison to type I and II cadherin dimers as the 
relative orientation of the long axes of EC2 domains appears to be almost linear. We 
determined the angles between protomers in swapped dimers of VE-cadherin, E-cadherin as 
representative of type I cadherins and type II cadherin-11 using PyMol to determine angles 
between partner EC2 longitudinal axes. The angle of the VE-cadherin dimer was found to be 
168°. Type I E-cadherin and type II cadherin-11 have much smaller angles of 129° and 143°, 
respectively, which suggests that VE-cadherin adopts a different arrangement in the adhesive 
interface in comparison to those of other classical cadherins that is likely to arise from the 
unique features of the swapped interface described above. 
 
 
5.5 Investigation of other interfaces in the VE-cadherin crystal structure 
Recent crystal structures of E-, N- and C-cadherin revealed a potential cis interface between 
cadherins oriented as if originating from the same cell surface (Boggon et al., 2002; Harrison 
et al., 2010b). The interface occurs between the face of EC1 opposite the strand swap 
interface and the base of EC2 of a partner molecule. The interface was observed in EC1-2 as 
well as EC1-5 domain fragments of E- and N-cadherin (pdb-code 2QVF and 2QVI and E- and 
N-cadherin EC1) and the full ectodomain of C-cadherin (pdb-code 1L3W). Mutations that 
disrupt this interface were found to prevent the ordered assembly of these cadherins in 
artificial junctions between liposomes and to destabilize cellular junctions between cadherin 
transfected cells. These results suggest that the combination of cis and trans interactions in 
cadherin ectodomains are responsible for initial junction formation. VE-cadherin also forms 
adherens junctions (see Introduction 1.8.2 and Section 4.6) suggesting the possibility that a 
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similar set of cis and trans interactions is involved. We therefore set out to examine other 
crystal contacts of the chicken VE-cadherin structure that might function in assembly of the 
cadherin at junctions in addition to the swapped trans interface. In order to determine contacts 
of interest we evaluated the crystal packing by buried surface area in contact regions with 
PISA. There are four crystal contacts that bury a surface area over 300Å per protomer. The 
largest buried surface area, 1068.9Å2 per protomer, corresponds to the trans dimer described 
in the previous section (Figure 25 (overall dimer) in Section 5.4). The second largest buried 
area (716.8Å2) is found for a contact between EC1 domains of VE-cadherin protomers on the 
face opposite the strand swap interface (Figure 29a). The remaining two interfaces are found 
to bury 440.9-458.5Å2 of the solvent accessible surface area of a protomer. The same 
interfaces are found independently for both protomers present in the crystallographic 
asymmetric unit and have a highly similar arrangement, in which the molecules are oriented 
approximately perpendicular to each other with the contact region below the strand swap 
interface at the top of EC2 of one protomer and the side of EC1 for the other (Figure 29b). In 
principle, either of the interfaces observed in addition to the swapped trans interface could 
contribute to assembly of VE-cadherin in junctions. However, we have no evidence for 
biological relevance of these additional crystal contacts at this point. Notably, there is no 
indication of crystal contacts similar to the reported type I cadherin cis interface in the VE-
cadherin structure. The interface is also absent from previously reported type II cadherin -6, -
8 and 11 structures (pdb-codes 3LND, 2A62 and 2A4E, respectively). Nonetheless, there is 
evidence from cryo EM studies and other experiments (Kiener et al., 2006; Uehara, 2006) that 
VE-cadherin and other type II cadherins form adherens junctions. This assembly is likely to 
require an additional cis interaction enabling lateral junction formation that is different to that 
of E-, N- and C-cadherins, especially as it was shown that a passive ‘diffusion trap’ is not 
sufficient for junction formation in the absence of such interactions (Wu et al., 2010). Clearly, 
further studies of type II cadherins are needed to understand how their ectodomains assemble 
into adherens junctions.  
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Chapter 6: 
 Binding affinities and adhesive specificity in  
the type II cadherin subfamily 
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6.1 Comparison of VE-cadherin and type II cadherin homophilic binding 
affinities in analytical ultracentrifugation experiments 
Given the differences in the strand swapped adhesive interfaces of VE- and type I and II 
cadherins identified in our structure of VE-cadherin EC1-2 (see Section 5.3), we wanted to 
compare VE-cadherin binding affinities with those of other classical cadherins.  
 
VE-cadherin binding affinities for the full length ectodomain as well as the two domain 
fragments were reported in Sections 4.2 (mammalian) and 5.1 (bacteria) and bind tightly with 
affinities in the low micromolar range (Table 7 (mammalian VE-cadherin) and 10 (bacterial 
VE-cadherin), Section 4.2 and 5.1, respectively). Despite a similar overall binding interface 
between VE-cadherin and type I cadherins, reported type I cadherin binding affinities of 
human E-, N- and frog C-cadherin, 156µM, 24.6µM and 64µM, respectively, are overall at 
least one order of magnitude weaker than those of VE-cadherin (Table 7 and 10 , (Chappuis-
Flament et al., 2001; Katsamba et al., 2009). The only affinity measurement reported for type 
II cadherins at the time this work was conducted was for a two domain fragment of mouse 
cadherin-6 (Harrison et al., 2010a; Katsamba et al., 2009), which shows tight adhesive 
binding (KD 3.13µM) within the same range of that of VE-cadherin. Based on KD values 
found for these two type II cadherins, it appears that binding affinity in the low micromolar 
range may be a general property of this subfamily. To test this hypothesis a set of adhesive 
EC1-2 fragments of mouse type II cadherins -9, -10 and -11 and chicken cadherin-6b and in 
addition cadherin-8 EC1-3 were designed and produced in E. coli (Section 2.1.2.3). We 
performed sedimentation equilibrium AUC experiments for each of these proteins to 
determine their KD values for homodimerization. Surprisingly, type II cadherin affinities were 
found to stretch over a wide range from 9.2µM for cadherin-6b to 42.2µM for cadherin-10 
(Table 14). These data unambiguously show that not all type II cadherins share a dimerization 
affinity as strong as that of VE-cadherin and cadherin-6 and that significant variation in 
homodimerization affinity exists in the type II cadherin subfamily. Despite the large range of 
adhesive binding affinities, overall the tested type II cadherins showed stronger binding than 
type I subfamily members.  
 
In total, we determined affinities for five type II cadherins in addition to VE-cadherin and 
cadherin-6 and found a high degree of variation in homodimerization strength. Within this 
range, these data suggest that one of the strongest binding affinities yet determined belongs to 
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VE-cadherin. This is surprising based on our finding that the VE-cadherin strand swapped 
dimer buries a lesser surface area than in other type II cadherins (Section 5.4). 
 
Table 14: Dissociation constants (KD) for homodimerization of wild type classical type II cadherins.   
 
Protein Description KD [µM] 
   
ck cadherin-6b EC1-2 Wild type 9.2±0.6 
m cadherin-6 EC1-2 Wild type 3.13±0.1 a 
m cadherin-8 EC1-3 Wild type 15±0.4 
m cadherin-9 EC1-2 Wild type 17±1.1 
m cadherin-10 EC1-2 Wild type 42±2.7 
m cadherin-11 EC1-2 Wild type 33.8±0.2 
m VE-cadherin EC1-2 Wild type 2.22±0.11b 
 
a KD also reported by Katsamba and Carrol et al. (2009) and Harrison et al. (2010a). 
b KD also reported in Section 5.1. 
 
 
6.2 Adhesive specificity of type II cadherins in surface plasmon resonance 
assays 
Type II cadherins were reported previously to heterophilically interact promiscuously but in a 
specific pattern in cell-cell aggregation experiments involving a set of eight different proteins 
(Shimoyama et al., 2000). The results revealed that certain cadherin pairs: cadherin-6 and -9; 
cadherin-7 and -14; cadherin -8 and -11 and cadherin-9 and -10 form fully intermixed cell 
aggregates similar to those formed between cell lines expressing the same cadherins, 
suggesting that each pair has matched binding specificities. However, for cells expressing 
other combinations: cadherin-6 and -7, cadherin-6 and -10, cadherin-7 and -9, cadherin-7 and 
-12, cadherin -9 and -14 and cadherin-12 and -14 partial intermixing is observed in that cells 
expressing each cadherin form separate aggregates, which interact with each other to some 
extent. This type of aggregate was also found in cell aggregation assays of N- and E-cadherin 
transfected cells and was explained to arise from a heterophilic interaction with intermediate 
strength between both homophilic protein-protein binding strengths (Katsamba et al., 2009). 
Other combinations of type II cadherins, such as cadherin-6 and -8 and cadherin-9 and -11, 
showed no tendency to coaggregate in the study conducted by Shimoyama et al. (2000). 
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Interestingly, we found that specificities reported in Shimoyama et al. (2000) mirror the 
pattern of sequence identity in the type II cadherin subfamily and heterophilically adhering 
cadherins can be grouped by position in the phylogenetic tree (Figure 30). For example, 
cadherins -6, -9 and -10 form a group that are related at the sequence level and exhibit full or 
partial intermixing in all combinations(Shimoyama et al., 2000).  This suggested a potential 
rational basis for patterns of specificity in the subfamily that remained to be fully tested. 
 
Table 15: Sequence identities given in per cent between EC1 (lavender) and EC1-2 (light blue) 
domains of all strand swapping classical cadherins used in our studies. 
 
 EC1 
VE 11 8 10 9 6 N E 
EC12  
VE 100 45 45 38 41 39 / 26 
11 47 100 72 64 62 62 35 28 
8 45 76 100 59 59 60 35 29 
10 43 71 66 100 78 84 32 28 
9 45 68 65 82 100 79 32 27 
6 43 69 67 84 82 100 34 29 
N 34 40 40 38 38 39 100 58 
E 31 33 33 33 32 34 / 100 
 
The published cell aggregation study is not comprehensive as not all of the thirteen presently 
known type II cadherins, including VE-cadherin, were studied. Based on substantial 
differences on sequence level between VE-cadherin and other type II cadherins (Table 15) 
which were found to translate into a unique strand swapped adhesive interface (Section 5.4), 
the question arises if VE-cadherin can exhibit heterophilic binding to other type II or even to 
type I cadherins. Furthermore, although cell aggregation assays are a powerful tool to 
elucidate binding specificities of cell-cell adhesion proteins (Shimoyama et al., 2000), they 
are only semi-quantitative being strongly dependent on equal expression levels and are time 
consuming to conduct, limiting the suitability of the assay for large sets of proteins. We 
therefore set out to establish an assay system omitting these problems, where heterophilic 
binding within the type II cadherin subfamily can be quantitated. In studies our group 
conducted previously, surface plasmon resonance (SPR) was used as method for homophilic 
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binding studies including E-, N-, T- cadherin and cadherin-6 (Ciatto et al., 2010; Harrison et 
al., 2010a; Katsamba et al., 2009) and also to assess relative heterophilic binding specificity 
of type I E- and N-cadherins with each other and type II cadherin-6 (Katsamba et al., 2009). 
We wanted to test if this method can be used to thoroughly and quantitatively study homo- 
and heterophilic binding characteristics of purified cadherin proteins on molecular level and 
additionally, if our findings on molecular level correlate to cadherin behavior demonstrated 
on cellular level. 
 
 
6.2.1 Identification of a suitable tag for immobilization of VE-cadherin for SPR 
Surface Plasmon Resonance (SPR) as technique can assess relative binding between 
cadherins. One cadherin is immobilized on the sensor chip surface and the other, the 
‘analyte’, is passed over in solution, (Figure 31). In case of protein-protein interactions total 
mass on the surface changes which is detected by change of reflection angles of a laser 
focused on the opposite side of the sensor surface chip (Figure 31). In order to conduct 
homophilic and heterophilic binding studies with VE-cadherin and other classical cadherins, a 
suitable tag for immobilization on the sensor chip surface needed to be determined. Previous 
studies of binding behavior of type I E-, N- and outlier T-cadherin as well as type II cadherin-
6 were conducted with soluble native EC1-2 domain cadherins as the analytes and C-
terminally Avi-tagged biotinylated equivalents (cadherin-Avi*bio), which were captured on 
the sensor chip surface by immobilized NeutrAvidin, a high affinity biotin binding protein 
approximately with a binding affinity in the femtomolar range (Ciatto et al., 2010; Harrison et 
al., 2010a; Katsamba et al., 2009). The captured ‘cadherin-Avi*bio’ proteins are positioned 
upright resulting in proteins with free adhesive domains pointing away from the sensor chip 
surface, which can be used for homo- and heterophilic binding studies (Figure 31). This 
technique and experimental set up was suitable for binding experiments with type I N-, E- and 
atypical T- cadherin and type II cadherin-6 (Ciatto et al., 2010; Harrison et al., 2010a; 
Katsamba et al., 2009). However, limitations were discovered for detecting ‘slow’ kinetic 
binding behavior because molecules have a small limited time to engage in protein-protein 
interactions in the course of the experiment (Harrison et al., 2010a).  
 
Based on these data we prepared VE-cadherin and type II cadherin-11 both with C-terminal 
biotinylated Avi-tags (Section 3.3.3 and 2.1.2.3). However, we found that in equilibrium  
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AUC experiments homodimerization is ablated and the cadherins remained monomeric 
despite free unaltered N-termini (Table 16 (KD of C-terminally tagged cadherins). Abrogation 
of binding might arise from the hydrophobic nature of the Avi-tag 
(GGGLNDIFEAQKIEWHE; biotinylation on Lys), which may interfere with protein folding 
or association. Thus, this tag was found to be unsuitable for these particular cadherins and a 
new approach was taken, in which proteins are tethered to the chip-surface by an antibody-
antigen interaction. An eight amino acid FLAG- tag (DYKDDDDK) was chosen to replace 
the Avi*bio-tag on the VE-cadherin C-terminus. Purified VE-cadherin-FLAG (Section 2.1.2.3 
and 3.3.3), was subjected to equilibrium AUC experiments to test for proper 
homodimerization and was found to dimerize with a KD of 25.6±2µM, which a little weaker 
than that of the wild type protein but nonetheless indicative of binding (Table 16 and Table 
10). 
 
FLAG-antibodies were linked to the surface of the sensor chip by amine coupling and VE-
cadherin-FLAG was captured on the surface by antigen - antibody recognition. However, VE-
cadherin-FLAG proteins dissociated continuously from the surface after capture resulting in 
unreliable measurements (Figure 32a). Subsequently, three more FLAG-antibodies (Figure 
32a, Table 2) with different specifications were tested which all resulted in a highly unstable 
surface. This problem might be due to a weak affinity of antibody-FLAG binding. Therefore, 
an alternative antigen-antibody pair, the C9-tag and the Rho 1d4 antibody, were tried for VE-
cadherin and additionally for N-cadherin, a protein for which SPR studies can be conducted 
as a positive control. This tag has, like the FLAG tag, mostly hydrophilic residues and is 
composed of nine residues with the sequence TETSQVAPA (Table 16). AUC experiments of 
N-cadherin-C9 and VE-cadherin-C9 confirmed that homodimerization is not impaired and 
KDs are in the same range as those of wild type proteins (Table 16). In the same experimental 
set-up as for the FLAG-experiment, 1d4 antibodies were amine coupled to the CM4 sensor 
chip and either N-cadherin-C9 or VE-cadherin-C9 captured on the surfaces by the C9-1d4 
interaction. The diffusion of C9-tagged protein off the chip was monitored and found to be 
highly similar to that of the FLAG-tagged protein (Figure 32b, the C9 diffusion), so the C9-
tag is also unsuitable for the desired experiments.  
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Table 16: Dissociation constants (KD) for homodimerization of C-terminally tagged classical type I 
and II cadherins EC1-2 from mouse. Standard Error is reported.  
 
Protein Description KD [µM] 
   
VE-cadherin-Avi*bio GGGLNDIFEAQKIEWHE a Monomer 
Cadherin-11-Avi*bio GGGLNDIFEAQKIEWHE a Monomer 
Cadherin-6-Avi*bio GGGLNDIFEAQKIEWHE a 2.9±0.3 
N-cadherin-Avi*bio GGGLNDIFEAQKIEWHE 9.2±1.3 
VE-cadherin-FLAG DYKDDDDK 25.6±2.0 
VE-cadherin-C9 TETSQVAPA 42.4±3.8 
N-cadherin-C9 TETSQVAPA 24.2±0.73 
VE-cadherin-CYS GGGC 5.17±0.25 
N-cadherin-CYS GGGC 9.50±0.76b 
 
a Biotin is added to lysine. b KD also reported in Section 5.1. 
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For studies centered on the comparison of relative binding, a stable surface is a necessity, so a 
different approach was needed. Covalent amine coupling of cadherin proteins to the surface is 
not suitable as these proteins need to have free, unaltered N-termini and need to be positioned 
‘upright’ on the chip. A milder covalent coupling method targets free thiol groups from 
cysteine side chains instead of free amine groups on lysine side chains or N-terminal amino 
groups. This method was considered suitable for VE-cadherin as there is no cysteine group in 
the native EC1-2 protein. A single amino acid-tag, the CYS-tag (GGGC) was designed and 
added to the C-terminus of N- and VE-cadherin (Section 3.3.3). AUC experiments of VE- and 
N-cadherin-CYS confirmed functionality of the proteins as they homodimerize with affinities 
in the same range of those of wild type proteins (Table 16). To see if the CYS-tag is adequate 
for the desired experiments, we first conducted cadherin binding studies with N-cadherin-
CYS and native wild type N-cadherin at different concentrations, because binding profiles for 
comparative reasons using N-cadherin-Avi*bio were available (Katsamba et al., 2009).  
 
In order to couple the proteins chemically to the sensor chip surface, they first needed to be 
bound via ionic interactions to the negatively charged CM-dextran surface. In solution pH 
lower than the pI of the protein surface, proteins are positively charged and can be pre-
concentrated in the CM-dextran moiety of the chip. To find the optimal pH in which most 
protein accumulates on the surface, N-cadherin-CYS is diluted into different solution pHs in 
the range of 3.5-5.0 and flown over the sensor chip. Figure 33a shows that proteins at pH4.0 
yielded the highest binding response in comparison to other solution pH, which was then used 
to preconcentrate N-cadherin-CYS on the chip prior immobilization. As described in more 
detail in methods Section 2.2.7.2, the carboxyl groups on CM-dextran were activated with 
NHS/EDC (Figure 33b (1)) and prepared with PDEA to introduce reactive disulfide groups 
(Figure 33b (2)). After chip surface activation, N-cadherin-CYS is coupled to the chip (Figure 
33b (3)) and the remaining free thiol groups were blocked by L-cysteine (Figure 33b (4)). A 
total of 1,542 RU of N-cadherin-CYS was covalently bound to the surface (Figure 33b) and 
the surface was found to be stable with no dissociation like in antibody-antigen experiments 
observed (Figure 32a (FLAG-tagged cadherin), 32b (C9-tagged cadherin)). 
 
We conducted a homophilic binding N-cadherin experiment with a 3-fold dilution series of 
concentrations in the range of 40-0.49μM of wild type N-cadherin as analyte. The binding 
profile is depicted in Figure 33c  and shows concentration dependent binding behavior highly  
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similar to the published results of N-cadherin-Avi*bio (Katsamba et al., 2009). Due to 
chemical covalent binding, surfaces were stable during the experiments.  
 
These findings prompt the conclusion that the designed CYS-tag is a new, suitable tag for 
cadherin binding experiments performed with SPR. We proceeded to use this tag to conduct 
studies of VE-cadherin binding behavior.  
 
 
6.2.2 Identification of running buffer for VE-cadherin in SPR experiments 
In order to identify cadherin-specific binding, any unspecific binding of VE-cadherin analyte 
to the chip needs to be disrupted. We passed wild type mouse VE-cadherin in a buffer 
composed of 150mM NaCl, 10mM Tris-Cl pH8.0, 3mM CaCl2 over an unmodified chip-
surface and observed strong unspecific binding between VE-cadherin and the unmodified 
CM4 surface (Figure 34a, left panel, unspecific binding). To decrease unspecific interactions, 
0.25mg/mL Bovine serum albumin was added to the running buffer and the experiment was 
repeated. No binding to the unmodified surface could be detected (Figure 34a, right panel, no 
unspecific binding). Therefore, running buffer for all subsequent experiments was 150mM 
NaCl, 10mM Tris-Cl pH8.0, 3mM CaCl2 and 0.25mg/mL Bovine serum albumin.  
 
 
6.2.3 Assessing homophilic VE-cadherin binding in SPR-experiments 
In order to analyze VE-cadherin homophilic and heterophilic binding, VE-cadherin-CYS was 
immobilized on the CM4 sensor chip as described for N-cadherin-CYS (Section 6.2.1 and 
2.2.7.2). As shown in Figure 34b (immobiliziation) two different flow cells were prepared 
with distinct concentrations, 1,575RU (low surface, red trace) and 4643RU (high surface, 
green trace). As observed in the N-cadherin experiment, the surface is stable as VE-cadherin-
CYS does not diffuse off the surface due to covalent immobilization (Figure 34b). 
 
Native VE-cadherin was injected over these surfaces in a concentration range of 40µM to 
78.1nM in a two-fold dilution series.  
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A binding response was observed (Figure 35a) in shape reminiscent to that of type II 
cadherin-6 (Figure 36, (Harrison et al., 2010a)). The binding response produced is 
approximately 5RU for the low and ~10RU for the high concentration surface and was 
observed in two independent runs and two independent experiments. The binding response is 
above the background level, but because it is only ~10RU, it cannot be confidently attributed 
to homophilic cadherin binding. The low binding response is surprising because both the 
tagged and analyte VE-cadherin fragments used in the experiments are known to form 
homodimers in AUC experiments (Table 16). However, VE-cadherin mediates adhesion with 
very high affinity in comparison to other classical cadherins (Sections 4.2, 5.1 and 6.1), so it 
is possible, that most of the analyte VE-cadherin molecules and the ones immobilized on the 
chip are homodimerized leaving only very few proteins present as monomers that are 
available for interactions (Section 6.2). This would strongly inhibit the binding response only 
in the case that association and dissociation kinetics of the dimers were insufficiently rapid 
that little or no exchange between dimers occurs in the time frame of the experiment  
(~1 minute). This led us to suspect that VE-cadherin binding might be kinetically different 
from that of other type II cadherins. Type II cadherin-6 appears to have a slower on- and off-
rate than type I N-cadherin as suggested by the shallower association and dissociation SPR 
curves (Figure 33c, Figure 36), but it appears that the rates for VE-cadherin are even lower. 
Therefore, we tried to shift homodimerization kinetics into a more favorable area by raising 
the temperature in which experiments are conducted from 25°C to 37°C based on the idea, 
that higher temperature should accelerate on/off rates and therefore increase availability of 
free monomer in solution and on the surface. Indeed, it could be observed that binding 
responses are increased at 37°C and when comparing VE-cadherin high-surface and low-
surface result, it appears that the binding response is still concentration dependent (Figure 
35b). However, this set-up could not be used in further studies because after temperature 
increase, reproducibility of the binding responses suffered. This experimental outcome, 
together with the findings that VE-cadherin and VE-cadherin-CYS are capable of 
homodimerization in AUC (Table 16) and in addition to size exclusion experiments showing 
an elution profile of two separate peaks for monomer and dimer (Section 4.3, Figure 16), 
clearly suggests that low binding responses are produced by unfavorable kinetics for this type 
of experiment. This phenomenon has also been observed before for cadherins with impaired 
X-dimer interfaces, which like VE-cadherin failed to produce a strong binding response in 
SPR experiments despite the fact that they were found to dimerize in AUC and size exclusion 
studies(Harrison et al., 2010a).   
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6.2.4 Homophilic and heterophilic adhesive binding of type II cadherins 
Cell aggregation studies by Shimoyama et al. (2000) revealed a heterophilic binding 
specificity pattern for type II cadherins (see Introduction 1.6 and Section 6.2, see also: (Patel 
et al., 2006; Price et al., 2002)) and SPR was used successfully as method to analyze 
heterophilic binding of type I N- and E- cadherin (Katsamba et al., 2009). Now we wanted to 
test if it is also applicable to type II mediated heterophilic binding. It was interesting to 
examine heterophilic binding between VE-cadherin and other type II cadherins, as VE-
cadherin docks Trp2 and Trp4 into an acceptor pocket nearly identical to type II cadherins, 
but has outside this region a substantially different interface. We decided to assess relative 
heterophilic adhesive cadherin binding between a set of seven mouse type II cadherins as 
analytes: cadherin-6, -8, -9, -10, -11 and VE-cadherin to captured cadherin-6-Avi*bio or 
immobilized VE-cadherin. Notably, cadherin-6, -9, -10 and cadherin-8, -11 share high 
sequence identity within these subgroups and are closely related by phylogenetic analysis 
(Table 15 and Figure 30). 
  
Cadherin-6-Avi*bio dimerizes in AUC experiments with a KD of 2.9±0.3µM similar to that of 
the wild type protein and was used previously to study cadherin adhesive interactions 
(Harrison et al., 2010a; Katsamba et al., 2009). Type II cadherin-6-Avi*bio is captured by 
NeutrAvidin immobilized on the CM4 sensor chip, which leaves the two domain cadherin 
fragments oriented in an upright position with their adhesive EC1 domain easily accessible. In 
order to compare relative binding of different type II cadherins to each other, the 
concentrations for each analyte were chosen according to their KD, in order to have equal 
amounts of calculated free monomer present in SPR experiments. Concentrations for all 
analyte proteins used in this experiment are summarized in Table 17.  
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Table 17: Summary of analyte proteins and their concentrations and distribution of monomer and 
dimer for SPR experiments. 
 
Protein 
Protein 
concentration 
[µM] 
KD[µM] 
Concentration 
dimer [µM] 
Concentration 
monomer [µM] 
     
VE-cadherin EC1-2 141.8 2.2 64.9 12 
Cadherin-6 EC1-2 104 3.13 45.0 12 
Cadherin-8 EC1-3 31.2 15 9.6 12 
Cadherin-9 EC1-2 30.1 17 8.9 12 
Cadherin-10 EC1-2 18.8 42.2 3.4 12 
Cadherin-11 EC1-2 20.5 33.8 4.3 12 
 
Binding of each of the cadherin-analytes to immobilized cadherin-6-bio was tested over a 
time course of 1 minute at 25°C in two repeats with three buffer injections in between sample 
injections. Wild type, untagged cadherin-6 gives a specific homophilic binding response of 
84RU (Figure 36a) which is almost identical to that seen in previously conducted studies 
(Harrison et al., 2010a; Katsamba et al., 2009). Remarkably, cadherin-9 and cadherin-10 
could also be observed to bind to captured cadherin-6 with heterophilic binding responses of 
54RU and 28RU, respectively (Figure 36a). In contrast, cadherin-8, -11 and VE-cadherin 
failed to bind and no response above background could be detected.  
 
In a second experiment, we wanted to investigate if heterophilic binding between VE-
cadherin and other type II subfamily members could be detected when VE-cadherin is 
immobilized on the surface. VE-cadherin-CYS was immobilized as described in the previous 
section (Figure 34b) and the same set of analytes (Table 17) was consecutively injected. Wild 
type VE-cadherin produced the typical low homophilic binding response as described in 
Section 6.2.3 (Figure 35a). However, no binding was detected for cadherin-6, -8, -9, -10 and -
11 (Figure 36b) confirming the previous VE-cadherin-cadherin-6-Avi*bio result.  
 
The observation that VE-cadherin does not bind to captured cadherin-6 or to cadherin-6, -8, -
9, -10 and -11 when immobilized on the surface may suggest that VE-cadherin does not 
engage in heterophilic interactions with other members of the type II cadherin subfamily, with 
the caveat that even homophilic VE-cadherin binding can only be weakly detected by SPR 
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probably due to kinetic reasons. Ergo, heterophilic interaction between VE-cadherin and other 
type II subfamily members might occur, but in relation to an already weak wild type binding 
response, this result is inconclusive. This issue could be addressed by alternative functional 
assays such as immunoprecipitation and cell-cell aggregation, which allow longer contact of 
proteins with each other and are less dependent on binding kinetics. 
  
More broadly, the results of the SPR experiments regarding type II cadherin heterophilic 
binding on a molecular level correlate perfectly with binding specificities obtained from cell-
cell aggregation studies and reveal more subtle differences in binding between related 
cadherins (Shimoyama et al., 2000). Type II cadherins exhibit a high degree of specificity in 
heterophilic binding mirroring the phylogenetic tree despite the fact that they all share high 
levels of sequence identity in their adhesive domains (Table 15). In particular, our results 
indicate that the separate subgroups of cadherin-6,-9,-10 and cadherin-8,-11 may show 
binding within but not between groups. Within the cadherin-6,-9,-10 group it appears that 
even minor sequence differences translate into distinct binding specificity. In general, SPR 
experiments could be shown to be suitable to assess type II cadherin heterophilic binding 
properties in a quantitative fashion, which can in future be extended to the entire set of 13 
type II cadherins. 
 
 
6.3 Heterophilic adhesive binding between type I subfamily members and 
VE-cadherin 
Published cell-cell aggregation, SPR and domain shuffling experiments have shown that, 
while adhesive heterophilic binding is detectable in certain combinations within type I and 
type II cadherin subfamilies, heterophilic interactions between type I and type II subfamilies 
are not detected ((Katsamba et al., 2009; Patel et al., 2006; Shimoyama et al., 1999; 
Shimoyama et al., 2000) and Introduction 1.6). Molecular binding between VE-cadherin and 
type I cadherins has not been investigated, however, experiments focused on interactions 
between VE-cadherin and type I subfamily members in the vascular endothelium revealed 
that VE-cadherin expels from adherens junctions type I N- and P-cadherin, which are in vivo 
co-expressed with VE-cadherin on vascular endothelial cells (Jaggi et al., 2002) and 
Introduction 1.8.2). To test if there are interactions on a molecular level between adhesive 
EC1-2 fragments of VE-cadherin and those of type I cadherins, we tested E-, N- and P- 
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cadherin for potential heterophilic interactions with immobilized VE-cadherin-CYS in SPR 
assays. Immobilized N-cadherin-CYS was used as a control. 
 
One N-cadherin and two VE-cadherin surfaces (low and high concentration) were prepared as 
described in Section 6.2 (Figure 33b for N-cadherin-CYS immobilization, 34b for VE-
cadherin-CYS immobilization). When wild type, untagged N-cadherin was consecutively 
injected over the three described surfaces, a strong, concentration dependent homophilic 
binding response could be detected for the N-cadherin surface, as expected (see Section 6.2). 
Interestingly, strong binding was also detected between the N-cadherin analyte and both VE-
cadherin surfaces. Binding was well above 10RU, thus is likely to represent specific 
heterophilic binding. We also found that the binding was concentration dependent for both N-
cadherin in solution and immobilized VE-cadherin (Figure 37). When soluble, untagged E-
cadherin was injected as analyte no binding occurred on VE-cadherin surfaces (Figure 37), 
but a heterophilic binding response was observed on the N-cadherin surface, which is in 
agreement with results of previous N- and E-cadherin heterophilic binding studies (Figure 37, 
(Katsamba et al., 2009)). When P-cadherin was used as the analyte, heterophilic binding to 
VE- and N-cadherin was detected as minimal binding below 10RU on all three surfaces, with 
strongest binding, approximately 4RU, to N-cadherin (Figure 37). Lastly, we tested wild type 
T-cadherin binding to type I N-cadherin and II VE-cadherin, with the result, that no binding 
could be observed (Figure 37), suggesting that background non-specific binding levels are 
low such that even minimal binding responses found in these experiments should correspond 
to specific heterophilic interactions.  
 
N-cadherin bound heterophilically to VE-cadherin surfaces, so we tested if VE-cadherin as 
analyte would also bind to immobilized N-cadherin. Results showed that only a very minimal 
binding response could be detected in this combination, which nevertheless was dependent on 
analyte concentrations (Figure 38). VE-cadherin was suggested to have unfavorable kinetics 
for SPR experiments (Section 6.2.3), which might explain, why no heterophilic interactions 
could be observed with VE-cadherin as analyte based on the assumption that molecules can 
be ‘trapped’ by slowed kinetics in a dimer state in the analyte more readily than in the 
immobilized layer.  
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VE-cadherin has a divergent strand swapped adhesive interface in comparison to type I 
cadherins, so we tested if the N-/VE-cadherin interaction is dependent on the strand swap 
mechanism. We used strand swap impaired mutant N-cadherin W2A (Katsamba et al., 2009; 
Tamura et al., 1998) as the analyte, which was injected over the high and low concentration 
VE-cadherin surfaces and the N-cadherin surface. We recorded no binding response between 
N-cadherin mutant W2A and immobilized N-cadherin consistent with prevention of strand 
swapping. In contrast, strand swapping impaired N-cadherin W2A mutant bound to a high 
level to VE-cadherin surfaces, which was approximately 35-40fold stronger than the 
heterophilic binding observed for similar analyte concentrations of wild type N-cadherin, 
(Figure 37). This heterophilic interaction was also concentration dependent with regard to 
both VE-cadherin concentration on the surface and analyte mutant N-cadherin concentration, 
suggesting that this interaction is not artifactual.  
 
Overall, we found that VE-, E- and T-cadherin do not heterophilically interact, but minimal 
heterophilic interaction between P- and VE-cadherin occurred. Interestingly, N-cadherin and 
VE-cadherin show strong heterophilic interactions, which can be dramatically enhanced by 
impairing strand swapping in N-cadherin. Notably, the type I cadherins to which VE-cadherin 
binds, N-cadherin and P-cadherin, are in vivo both present in vascular endothelial cells along 
with VE-cadherin. In these cells, VE-cadherin is found to expel N-cadherin from junctions, 
leaving it dispersed over the cell surface (Gentil-Dit-Maurin et al., 2010; Jaggi et al., 2002). 
Therefore, it is possible that the observed heterophilic interactions may be important cis 
interactions and not adhesive trans interactions, supported by the data that N-cadherin wild 
type and mutant both bind well to immobilized VE-cadherin. 
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6.4 Co-immunoprecipitation assays to detect cadherin high affinity binding 
Mouse VE-cadherin EC1-2 produced only minimal binding responses in the SPR experiments 
described above, but these proteins adhere homophilically with strong affinities in low 
micromolar range in equilibrium AUC experiments (Section 4.2 and 5.1) and therefore the 
low SPR response may be due to kinetic effects as discussed in Section 6.2. We sought a 
complementary method which like AUC can detect cadherin interactions over long time 
periods and is relatively insensitive to kinetic effects, but that is, like SPR, suitable for 
detection of both, homophilic and heterophilic interactions. Thus, we conducted co-
immunoprecipitation (co-IP) experiments with soluble purified cadherin EC1-2 fragments at 
high concentrations. 
 
C-terminally tagged two domain cadherins were used in the assays to provide accessible, not 
sterically impaired antigens for immunoprecipitation and antibody detection. For E- and N-
cadherin we used Avi*bio-tags (E-, N-cadherin-Avi*bio), FLAG-tags were used for VE-
cadherin (VE-cadherin-FLAG) and C9-tags for VE- and N-cadherin (VE-, N-cadherin-C9). 
All proteins were previously confirmed by AUC to be able to dimerize in solution with KDs 
similar to that of wild type untagged proteins (Table 16 in Section 6.2.1).  
 
First, we conducted co-IP assays of homophilic adhesive cadherin binding. Equimolar 
quantities of N-cadherin-Avi*bio and N-cadherin–C9 were incubated together over a time of 
three hours to allow dimer formation. The complexes were precipitated by the immune 
reaction of 1d4 antibody recognizing C9-antigen tagged N-cadherin and pulled down with 
protein G coated magnetic beads. The pulled down proteins were separated by SDS-PAGE, 
transferred by western blot and presence of biotinylated N-cadherin in immunoprecipitates 
and supernatants was detected using NeutrAvidin-HRP (Figure 39). We found biotinylated N-
cadherin-Avi*bio in immunoprecipitates of N-cadherin-C9 (Figure 39a Lane 3 and Figure 
39b Lane 1), showing that differently tagged N-cadherin proteins dimerized and that these 
associations were sufficiently stable to be detected in this assay. A negative control, 
containing only biotinylated N-cadherin, protein G and 1d4 antibody, did not show presence 
of biotinylated N-cadherin in immunoprecipitates, thus, no unspecific binding between 
magnetic beads and N-cadherin-Avi*bio and NeutrAvidin-HRP occurred (Figure 39b, Lane 
2). These data show that co-immunoprecipitation assays are a suitable method to detect 
cadherin adhesive binding.  
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We performed the same experiment for VE-cadherin, using VE-cadherin-FLAG and VE-
cadherin-C9. Magnetic beads coated with antibodies against the C9 tag were used for 
immunoprecipitation (clone 1d4). VE-cadherin-FLAG was detected in the 
immunoprecipitates of VE-cadherin-C9 (Figure 39a Lane 1), and could not be detected in the 
negative control omitting the C9-tagged protein from the reaction (Figure 39a, Lane 5). 
Therefore, we can conclude that C-terminally tagged VE-cadherins have the ability to 
homophilically interact with each other. Co-IP experiments allow a long time for protein-
protein interaction to occur, so that dimerization of VE-cadherin-C9 and –FLAG can reach 
equilibrium, potentially overcoming the ‘slow’ binding kinetics which we suggest to be the 
cause for only minimal binding responses in SPR experiments.  
 
The homophilic binding results correlate with other biophysical data derived for adhesive 
cadherin binding, so in the same experiments we tested if heterophilic interactions can also be 
detected by this method. Therefore, the previously characterized heterophilic binding pair N- 
and E-cadherin were allowed to interact in form of E-cadherin-Avi*bio and N-cadherin-C9 
(Figure 39b). In addition, we investigated heterophilic binding between VE-cadherin and N-
cadherin observed in SPR using two combinations: N-cadherin-Avi*bio with VE-cadherin-C9 
and N-cadherin-C9 with VE-cadherin-FLAG (Figure 39a). The complexes were pulled down 
with respective C9-tagged proteins and 1d4 antibody as described before, separated by SDS-
PAGE and transferred by western blot. Biotinylated proteins were detected by NeutrAvidin-
HRP and VE-cadherin-FLAG by anti-FLAG antibodies in immunoprecipitates and 
supernatants. E-cadherin-Avi*bio and VE-cadherin-FLAG, were only detectable in the 
respective supernatants, but not in any of the heterophilic immunoprecipitates (Figure 39a). 
This suggests that heterophilic cadherin binding, between N- and VE-cadherin or between N- 
and E-cadherin is too unstable to be detected in this assay system in comparison to 
homophilic interactions. Our findings suggest in concert with previous data (Shan et al., 
2000), that only very stable, high affinity cadherin-cadherin interactions can be detected by 
co-immunoprecipitation experiments. 
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Chapter 7: 
 Homophilic adhesion  
without the cadherin strand swap motif 
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Recently our group published results describing the role of a novel, non-swapped binding 
interface, named the ‘X-dimer’ interface, in  T-cadherin adhesive binding in addition to a role 
for X-dimer formation in classical cadherin binding (Introduction 1.5, (Ciatto et al., 2010; 
Harrison et al., 2010a). Although I was not the first author, part of my thesis work contributed 
to both manuscripts and the impact will be addressed in this section. 
 
7.1 Background and significance 
In past extensive studies of the adhesive interface located on EC1 domains of classical type I 
and type II cadherins revealed that a three dimensional domain swapping mechanism 
underlies the homophilic binding, in which the N-terminal portion of the A*-strand, Trp2 
(type I) or Trp2 and Trp4 (type II), is docked into an hydrophobic acceptor pocket of the 
partnering molecule. However, the two domain crystal structure of wild type chicken T-
cadherin, an outlier of the classical cadherin family, revealed an adhesive dimer involving a 
similar face of domain EC1, but the region corresponding to the A*-strand of other classical 
cadherins was not strand swapped. This was named the ‘X-dimer’ interface due to the 
approximately cross shaped orientation of the protomers. Mutations targeting the novel 
interface based on the derived structural data were sufficient to abrogate T-cadherin 
dimerization in equilibrium AUC, SPR, cell aggregation and neuron outgrowth experiments 
(Ciatto et al., 2010), suggesting a biological role for this interface and supporting a model in 
which mature adhesive dimers of T-cadherin adopt an X shaped dimer configuration with no 
contribution of strand swapping. 
 
To test this model different mutations targeted to the strand swap region analogous to 
mutations known to prevent strand swapping were introduced into T-cadherin and for 
comparison into E-cadherin (type I) and cadherin-6 (type II), both known to form adhesive 
interfaces involving A*-strand exchange between partnering molecules. These mutations 
should diminish adhesive binding in the cadherins which bind via strand swapping, but should 
have no effect on T-cadherin adhesive properties if the proposed model is correct. 
 
 
7.2 Strand swap site directed T-cadherin mutations do not affect adhesive 
binding 
We altered in T-, E- and cadherin-6 residues required for strand swap dimer formation in 
typical classical cadherins to observe the effects on homodimerization in equilibrium AUC 
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experiments. Several different point mutations were tested. Residues Trp2 (type I) and Trp2 
and Trp4 (type II) are crucial for strand swapped dimerization and binding can be prevented 
by reduction of these side chains to those of alanine (Harrison et al., 2005). Thus, a W2A 
mutation was introduced into E-cadherin and a W4A mutation in cadherin-6 (single Trp 
mutation shown for type II VE-cadherin to abolish binding, (May et al., 2005)). In T-cadherin 
we changed Ile2, found at an equivalent position to that of Trp2 in strand swapping type I 
cadherins, and mutated it also to alanine. Another crucial interaction, which can be disrupted 
in order to prevent proper strand swapping, is the salt bridge between glutamic acid (at 
position 89 in E-cadherin) and the N-terminal amino group of the first residue, which 
stabilizes the A*-strand in the strand swap dimer conformation. Thus, the mutation E89A was 
introduced into E-cadherin, reducing the carboxyl side chain of Glu89 to that of alanine. In a 
different approach, we moved the N-terminal amino group further away from the stabilizing 
carboxyl group in order to disrupt salt bridge formation by extending the N-terminus of E-
cadherin by two alanines (Ala-Ala extension) or methionine and arginine (Met-Arg-
extension). Similarly, we extended the N-terminus of T-cadherin by a single glycine residue 
(Gly-extension) or by Met-Arg. In addition to these mutants targeting a single interaction in 
the strand swapped dimer, we created an E-cadherin mutant in which both two N-terminal 
residues Asp1 and Trp2 are deleted, which should prevent salt bridge formation (Asp1) and 
anchoring of the A*-strand (Trp2) at the same time. 
 
The strand swap dimer targeted mutations were introduced into adhesive EC1-2 fragments of 
T-cadherin, E-cadherin and cadherin-6 proteins that were produced in bacteria (Section 
2.1.2.3). Their homophilic binding was tested in sedimentation equilibrium AUC experiments 
in order to explore the effect of the introduced mutations. Determined affinities are 
summarized in Table 18  and profiles of sedimentation AUC experiments are presented in 
Figure 40. Wild type T-cadherin homodimerizes with a moderate affinity corresponding to a 
KD of 41.4±1.7µM, which is in the same range of those of C- and E-cadherin ectodomains 
described previously, 64µM and 109µM, respectively (Chappuis-Flament et al., 2001; 
Harrison et al., 2010b). Mutant proteins targeting potential strand swapping residues, T-
cadherin I2A, Gly- and Met-Arg-extension, were found to form dimers in solution with KDs 
similar to that of the wild type protein: 37.1±4.1µM (I2A), 16.5±0.8µM (Gly-extension) and 
34.1±6.3µM (Met-Arg-extension). Thus, strand swap interface targeted mutations did not 
inhibit T-cadherin homodimerization significantly. In contrast, equivalent mutations 
introduced into E-cadherin and cadherin-6 showed strong effects on their homodimerization 
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behavior and diminished adhesive binding affinities markedly (Figure 40b,c). In strand swap 
E-cadherin mutant W2A a ten fold decrease of affinity in comparison to that of wild type 
protein occurred (Figure 40, Table 18) and for cadherin-6 the wild type affinity was decreased 
by the strand swap W4A mutation even more significantly, resulting in a 100fold weakened 
affinity of 321±0.5µM (Figure 40c, Table 18). The Ala-Ala-extension mutant interfering with 
the stabilization of the swapped A*-strand and the Asp-Trp deletion E-cadherin mutant, 
removing part of the swapping strand, diminished the homodimerization properties similarly, 
resulting in KDs of 811±97µM and 662±28.5µM, respectively. A less severe effect is seen for 
the E-cadherin E89A mutation, which weakened the affinity approximately by 2.5fold (Figure 
40b, Table 18).  
 
Table 18: Dissociation constants KDs from equilibrium AUC analyisis for cadherin-6, E- and T-
cadherin wild type and strand swapping mutants. Standard error is given. 
  
Protein Description KD [µM] 
   
Cadherin-6 EC1-2   
Mouse cadherin-6 EC1-2a Wild type 3.1±0.1 
Mouse cadherin-6 EC1-2 W4A Strand swapping mutant 321±0.5 
   
E-cadherin EC1-2   
Mouse E-cadherin EC1-2 Wild type 98.6±15.5 
Mouse E-cadherin EC1-2 W2A Strand swapping mutant 916±47 
Mouse E-cadherin EC1-2 E89A Strand swapping mutant 293±11 
Mouse E-cadherin EC1-2 Ala-Ala-extension Strand swapping mutant 811±97 
Mouse E-cadherin EC1-2 Met-Arg-extension Strand swapping mutant 257.5±17.5 
Mouse E-cadherin EC1-2 Asp-Trp-deletion Strand swapping mutant 662±28.5 
   
T-cadherin EC1-2   
Mouse T-cadherin EC1-2 Wild type 41.4±1.7 
Mouse T-cadherin EC1-2 I2A Strand swapping mutant 37.1±4.1 
Mouse T-cadherin EC1-2 Gly-extension Strand swapping mutant 16.5±0.8 
Mouse T-cadherin EC1-2 Met-Arg-extension Strand swapping mutant 34.1±6.3 
 
a tagged versions of these proteins are listed separately in Table 16. 
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7.3 Context of the mutational data in the published work 
Strand swap mutations had no effect on T-cadherin adhesive binding in equilibrium AUC 
experiments, which shows that the swapped interface seen in other type I and II cadherins is 
not involved in T-cadherin mediated adhesion. Together with cell aggregation assays, AUC 
and SPR experiments showing that mutations targeting the observed novel X-dimer interface 
result in complete loss of T-cadherin adhesive binding (Ciatto et al., 2010), these data suggest 
that the X-shaped configuration is the primary adhesive interface of T-cadherin.  
 
Interestingly, although strand swap mutants of type I E-cadherin and type II cadherin-6 were 
found in AUC experiments to have markedly reduced affinities, they were not monomeric but 
formed weak homodimers. Structures of E-cadherin W2A, E89A, the Ala-Ala extension 
mutant and cadherin-6 W4A, determined by other authors and reported in Harrison et al. 
(2010a) revealed formation of X-shaped dimers closely similar to those of T-cadherin. These 
structures suggested potential biological relevance of this interface in type I and II cadherins 
in addition to the well studied strand swap adhesive interface. Mutations targeting the X-
dimer interface in these proteins slowed the exchange between monomers and strand swapped 
dimers considerably such that proteins no longer mediated adhesion in aggregation assays or 
SPR experiments despite having intact swapping interface regions, suggesting that in classical 
cadherins the X-dimer interfaces function as a kinetic intermediate indispensible for proper 
strand swap mediated cadherin adhesion.  
 
Therefore, cadherins appear to employ two different interfaces for homodimerization. One of 
these, the X-dimer interface, is shared by typical classical cadherins and atypical T-cadherin 
while the other interface, the strand swap dimer, is specific to typical classical cadherins, 
mediating mature adhesive cadherin binding. 
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Chapter 8: 
 Discussion 
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8.1 VE-cadherin adhesion is mediated by a classical cadherin dimer 
We embarked on an extensive biophysical study of VE-cadherin adhesive behavior to test a 
novel model for homophilic VE-cadherin adhesive interactions that has been suggested in the 
literature and is remarkably different from that known for other classical cadherins. The 
published model is based on solution biophysical data and cryo-EM studies of bacterially 
produced VE-cadherin EC1-4 fragments and suggests that the adhesive binding unit of VE-
cadherin is composed of six molecules which assemble into a hexameric structure based on 
two sets of interactions (Al-Kurdi et al., 2004; Bibert et al., 2002; Hewat et al., 2007; Lambert 
et al., 2005; Legrand et al., 2001). One of these, an extensive interaction involving domain 
EC4, organizes three VE-cadherin molecules laterally into a trimer and the second interaction, 
mediated by EC1 domains connects two trimers from juxtaposed cell surfaces in a trans 
fashion, which results in the proposed hexamer (Hewat et al., 2007). In contrast, for other type 
I and type II classical cadherins there is extensive evidence from a wide array of studies for 
formation of trans adhesive dimers between single protomers by 3D domain swapping 
mediated by EC1 domains (Boggon et al., 2002; Harrison et al., 2010b; Haussinger et al., 
2004; Patel et al., 2006; Shapiro et al., 1995). For type I cadherins, there is evidence for 
subsequent assembly into adherens junctions by weak cis interactions (Boggon et al., 2002; 
Harrison et al., 2010b), but strong trimeric interactions similar to those suggested for VE-
cadherin have not been observed for other cadherins. Both, the proposed hexamer model and 
the known classical cadherin interaction, have in common that EC1 domains mediate trans 
binding, but they differ in the respective cis interactions; a suggested strong trimeric 
interaction mediated by EC4 for VE-cadherin that is sufficiently stable to be detected in 
solution and a weak cis interaction for type I cadherins involving domains EC1 and EC2 that 
becomes detectable only in the context of adhesion between membranes. 
 
VE-cadherin fragments EC1-4 exhibiting hexameric behavior in cryo-EM and solution 
biophysics studies were all bacterially produced from inclusion bodies and lacked post-
translational modification as well as the membrane proximal domain EC5 (Legrand et al., 
2001). Bacterially produced fragments spanning domains EC1-5 also formed hexamers in 
analytical size exclusion chromatography experiments (Legrand et al., 2001). We embarked 
on extensive biophysical and imaging studies of VE-cadherin ectodomains produced in 
mammalian HEK 293 cells to examine hexameric VE-cadherin binding behavior in detail 
using proteins more closely similar to those in vivo in terms of post-translational modification. 
However, we found that these natively glycosylated VE-cadherin ectodomains uniformly 
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formed a monomer/dimer equilibrium in solution with no evidence of higher order multimers 
in analytical ultracentrifugation, gel filtration, multi-angle light scattering and imaging 
experiments.  We also found that isolated, natively glycosylated EC3-5 VE-cadherin 
fragments are monomeric, consistent with the idea that strong binding interactions of VE-
cadherin are mediated only by domains EC1-2. Confirming this, we observed VE-cadherin 
EC1-2 fragments to dimerize with similar affinities to full-length ectodomains. These data 
imply that EC4-mediated cis-trimer interactions do not form in solution for VE-cadherin 
ectodomains in their native state. Our findings for VE-cadherin are therefore more similar to 
behavior observed for other classical cadherins (Boggon et al., 2002; Harrison et al., 2010a; 
Harrison et al., 2010b; Haussinger et al., 2004; Nagar et al., 1996; Patel et al., 2006; Shapiro 
et al., 1995). 
 
Furthermore, we identified the likely reason for the discrepancies in VE-cadherin behavior 
between our findings and previous work in which the hexamer model was proposed. We find 
that VE-cadherin carries substantial quantities of N-linked glycosylation in comparison with 
glycosylation found in type I cadherins (Boggon et al., 2002; Harrison et al., 2010b; Liwosz et 
al., 2006). We identified one glycosylation site at Asn395 (numbering for mature human VE-
cadherin) conserved throughout type I and II cadherins, which is located in domain EC4 - the 
domain responsible for trimerization in the bacterial hexamer model (Bibert et al., 2002; 
Hewat et al., 2007). As mentioned above, domains EC3-5 of VE-cadherin, when glycosylated, 
failed to homodimerize and remained monomeric in all biophysical experiments, which is in 
direct contrast to the prediction of the hexamer model (Bibert et al., 2002). However, removal 
of N-linked glycosylation from VE-cadherin fragments encompassing the putative trimer site 
(domains EC3-4 and EC3-5) led to strong dimeric protein interactions or aggregation in 
analytical ultracentrifugation and appearance of the ability to aggregate liposomes. Similarly, 
dimerization was also found by Bibert et al (2002) for bacterially produced EC3-4. Although 
the fragments EC3-4 did not associate into trimers, it has been shown previously, that proteins 
with non-specific hydrophobic associations can sometimes form complexes composed of 
unexpected numbers of protomers (Weis et al., 1991). Interestingly, full-length VE-cadherin 
ectodomains also became prone to non-specific aggregation in AUC experiments and able to 
more efficiently aggregate liposomes after N-linked glycosylation was reduced enzymatically 
or by expression in HEK 293 GNTI- cells. Our data strongly suggest that EC4-mediated cis 
binding interactions, which are central to the hexamer binding model, are an artifact caused 
by lack of N-linked glycosylation in VE-cadherin and that expression of VE-cadherin 
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fragments in bacteria in previous studies (Al-Kurdi et al., 2004; Bibert et al., 2002; Hewat et 
al., 2007; Legrand et al., 2001) resulted in non-biological, artifactual hexamer assemblies. 
Interestingly, we find that lack of N-linked glycosylation does not equally affect all cadherins 
because, in contrast to the findings for VE-cadherin, binding interactions of purified E-
cadherin EC1-5 fragments were independent of their N-linked glycosylation. Proteins were 
stable and adopted the same adhesive binding behavior with highly similar affinity values. 
Nonetheless, even in type I cadherins, N-linked glycosylation may play a role, albeit a more 
subtle one, in regulating adhesion at the cell surface (Liwosz et al., 2006).  
 
Our finding of a classical cadherin monomer/dimer behavior for VE-cadherin is in agreement 
with electron microscopic studies performed by Ahrens et al. (2003), which also used 
mammalian expressed VE-cadherin ectodomains and suggested VE-cadherin to adopt a 
homodimerization mechanism similar to classical type I E-, N- and P-cadherins with no 
occurrence of hexamers (Ahrens et al., 2003). Hexamer interactions have therefore only been 
described for bacterially expressed constructs (Al-Kurdi et al., 2004; Bibert et al., 2002; 
Hewat et al., 2007; Lambert et al., 2005; Legrand et al., 2001). 
 
Our AFM imaging studies revealed that VE-cadherin not only homodimerizes in common 
with other studied classical cadherins, but that protomer and overall dimer arrangement are 
closely similar to those of type I cadherins based on previous structural data (Boggon et al., 
2002; Harrison et al., 2010b). Protomers adopted crescent shaped curved forms, and dimers 
appear to be composed of two protomers overlapping at their termini in a similar fashion and 
with similar overall length to those observed in structures and EM studies of E-, N-, P- and C-
cadherin(Ahrens et al., 2003; Farquhar and Palade, 1963; McNutt and Weinstein, 1973). Two 
previous AFM imaging studies of VE- (Baumgartner et al., 2000) and N-cadherin (Harrison et 
al., 2005) C-terminally attached to Fc domains, could also identify cadherin monomers 
similar in overall shape and curvature to those we observe, but dimers were not described. As 
mentioned above, VE-cadherin binding activity was found to reside in domains EC1-2 in 
solution studies, which lead us to conclude that the overlapping regions seen in our AFM 
studies are amino terminal.  
 
In addition to similarity in overall dimer configuration between VE-cadherin and previously 
characterized classical cadherins observed in the above expeiments, our structure of the 
adhesive dimer of chicken VE-cadherin EC1-2 shows that VE-cadherin homodimerization is 
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mediated by the 3D domain swapping mechanism typical for classical cadherins (Boggon et 
al., 2002; Haussinger et al., 2004; Patel et al., 2006). However, the adhesive interface reveals 
features specific to VE-cadherin, as discussed below. 
 
 
8.2 Variations on a common binding mechanism in classical cadherins 
The VE-cadherin structure reported in this work has characteristics of adhesive interfaces 
found in both type I and II cadherins. The strand swap region and domain orientation of EC1 
domains is closely similar to that of other type II cadherins in that the key residues Trp2 and 
Trp4 located on the A*-strand are docked into the large hydrophobic acceptor pocket of the 
interacting molecule. However, the interface outside the immediate pocket differs 
substantially from that of type II cadherins as intermolecular interactions are restricted to the 
hydrophobic pocket and do not extend along the entire face of the EC1 domain. Absence of 
these ‘outer’ interactions results in an overall dimer organization of EC1 domains more 
reminiscent of that of type I cadherins as only the upper half of domain EC1 partakes in 
homodimerization. VE-cadherin is the only cadherin found so far to combine these 
characteristics. A unique, almost linear overall arrangement of protomers in the dimer is also 
found, and accessible surface area per protomer buried in the adhesive interface is 
approximately intermediate between small type I interfaces and large type II cadherin 
interfaces. Overall, VE-cadherin is a structurally divergent type II cadherin based on the 
homodimer structure. 
 
Our structure of VE-cadherin shows clearly how differences on the sequence level, in this 
case in the region of the extended interface in EC1, translate into substantially divergent 
adhesive interfaces despite the same underlying strand swap mechanism. Numerous structures 
of classical cadherins have been reported to date, including. full length structures of type I 
cadherins E-, N- and C-cadherin (Boggon et al., 2002; Harrison et al., 2010b), and a wide 
array of adhesive EC1, EC1-2 or EC1-3 fragment structures of type II cadherins MN, 8 and 
11, (Patel 2006). In addition, in the final stages of preparation of this thesis, I determined a 
structure of a strand swapped dimer of another type II cadherin, cadherin-10 EC1-2, revealing 
an adhesive interface sharing the swapped A-strand using Trp2 and Trp4 and the extended 
non-swapped hydrophobic interface with other typical type II cadherins. Taken together with 
the newly determined chicken VE-cadherin EC1-2 structure of a divergent type II cadherin 
interface, we can infer from these numerous structures the diversity in strand swapped 
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adhesive interfaces within classical cadherins. Broadly, all classical cadherins except T-
cadherin (see below) commonly exchange the amino terminal part of the A-strand between 
EC1 domains, but differ with respect to the exact element that is swapped (Trp2 in type I, 
Trp2 and Trp4 in type II) and to the involvement of an extended non-swapped interface, 
which is absent in type I cadherin and atypical type II VE-cadherin dimers. 
 
Indirect evidence from all structures available provide insight to the adhesive mechanism of 
other cadherin subfamilies with similarity to the classical cadherins, like desmosomal 
cadherins, for which at present time no binding interface structures are available. Sequence 
analysis show presence of a tryptophan residue and pocket residues in similar positions to 
these structural elements in type I cadherins. Cryo electron tomography studies of 
desomosomes (Al-Amoudi and Frangakis, 2008) together with functional evidence suggest 
that these proteins are most likely to exchange A-strands for homodimerization, but further 
investigations are needed to reveal details of adhesion.  
 
But not all classical cadherins facilitate 3D domain swapping for adhesive binding. T-
cadherin, a divergent GPI-linked type I cadherin lacking strand swap residue Trp2 and 
residues lining the type I hydrophobic pocket forms adhesive dimers via a different interface, 
involving the ‘base’ of the EC1 domain and the ‘top’ of the EC2 domain resulting in an X-
shaped dimer configuration (Ciatto et al., 2010). Strand swap targeted mutations in T-
cadherin reported here did not impair dimerization and thus the strand swapping mechanism 
plays no role in T-cadherin adhesion (Ciatto et al., 2010). However, mutations targeting the 
X-dimer interface abrogated T-cadherin homodimerization completely suggesting this 
interface to be the only biological important site. Interestingly, when strand swapping was 
impaired by mutagenesis in type I E-cadherin (Harrison et al., 2010a), N-cadherin (J.V., 
personal communication) and type II cadherin-6 (Harrison et al., 2010a), structures of these 
proteins revealed that they use the same interface as observed for T-cadherin. Biophysical 
evidence suggests the interface to function as a binding intermediate in these cadherins. VE-
cadherin also might use the X-dimer as intermediate, based on the remaining ability of strand 
swap mutant VE-cadherin EC1-5 W2A W4A to form weak dimers in AUC experiments and 
to aggregate liposomes, however, this remains to be tested by direct mutational studies 
targeting the X interface.  
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Outside the classical sub branch of the cadherin superfamily, protocadherins, which have one 
additional EC domain in comparison to classical and desmosomal cadherins and other even 
more distantly related members show no conservation of strand swap residues. These will 
almost certainly employ even more divergent mechanisms to fulfill the task of adhesive 
binding, which need to be studied in detail in the future.  
 
 
8.3 Adherens junction assembly – differences within the classical cadherin 
subfamilies 
Although our studies revealed many details about trans dimerization of VE-cadherin, certain 
points remain elusive. How do VE-cadherin and other type II cadherins laterally organize into 
adherens junctions? We observed cadherin like junction formation in our cryo-EM studies of 
artificial junctions formed by VE-cadherin between liposomes. In addition, VE-cadherin was 
also found in vivo at adherens junctions in juxtaposed endothelial cells by EM (Uehara, 2006). 
Adherens junction formation has also been reported for type II cadherin-11 in 
immunoflourescence studies (Kiener et al., 2006) which show overall similar topology and 
organization as adherens junctions formed by type I cadherins (Boggon et al., 2002; Harrison 
et al., 2010b; McNutt and Weinstein, 1973). Abundant evidence from crystal structures, cryo 
EM of artificial junctions, EM of in vivo junctions and functional assays has led to some 
understanding of adherens junctions assembled by type I cadherins (Boggon et al., 2002; 
Haussinger et al., 2004; McNutt and Weinstein, 1973). Strand swapped cadherin dimers 
appear to use a second interface for lateral assembly, the so called cis interface, which forms 
involving β-strands C, F and G of the face of EC1 with contribution of the quasi β-helix on 
one molecule and B, D and E strands of the face towards the ‘top’ of EC2 on the second 
molecule (Boggon et al., 2002; Harrison et al., 2010a). Mutational studies targeting this 
interface reveal that both trans and cis interactions are essential for E-cadherin to assemble 
into stable junctions between cells, or into ordered artificial junctions between liposomes 
(Harrison et al., 2010b). It appears at least for type I cadherins that passive diffusion trap and 
cytoplasmic interactions are not sufficient to trigger initial clustering of cadherins into 
junctions (Wu et al., 2010). Therefore it is likely that type I cadherins rely on the described 
ectodomain mediated mechanism for stable junction formation. For type II cadherins, the 
requirements for junction assembly are not known. Although the cis interface was present in 
all EC1-2 and EC1-5 structures of mouse type I E-, N- and C-cadherins (Boggon et al., 2002; 
Harrison et al., 2010a; Harrison et al., 2010b; Haussinger et al., 2004; Parisini et al., 2007), no 
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similar cis interaction was present in type II cadherin EC1-3 and EC1-2 structures of 
cadherin-8, -11 (Patel et al., 2006) or in the VE-cadherin structure reported here. These 
findings strongly suggest that the cis interface observed for type I cadherins does not have a 
role in the type II subfamily. 
 
A critical look at EM images of artificial adherens junctions between liposomes reveals that 
junctions formed by VE-cadherins show a strong midline in the intermembrane density that is 
not observed in similar preparations of artificial junctions of type I cadherins. This might be 
therefore indicative of a different cis arrangement. Interestingly, desmosomes, which are 
formed by the classical cadherin-related cadherins desmocollin and desmoglein, also appear 
different from type I cadherin junctions in cryo-EM and show a broadly similar electron-
dense midline to that seen for VE (Al-Amoudi and Frangakis, 2008). Both desmosomal 
cadherins and type II cadherins also lack a structural element in EC1 referred to as a quasi β-
helix, which contributes to the cis interface in type I cadherins. 
 
Thus, at the current time we have no evidence for a cis interface responsible for lateral 
junction assembly with physiological relevance for type II cadherins. A full length VE-
cadherin structure would elucidate the ectodomain-mediated aspects of junction assembly of 
this important cadherin crucial to angiogenesis and maintenance of the vascular endothelium 
and may be relevant to other classical type II cadherins. Physiological relevance of any 
potential cis interface observed could then be assessed by mutagenesis studies, which could 
also be used to test the relevance of the additional lattice contacts observed in the EC1-2 
structure reported here. Trials to obtain diffracting crystals of chicken and human full 
ectodomains were unsuccessful, so in future experiments a multi species approach will be 
taken using bovine, mouse, frog and zebrafish (Larson et al., 2004) VE-cadherin, which show 
78%, 75%, 55% and 37% sequence identity differences to human VE-cadherin. The 
substantial sequence differences increase the chance of different behavior in crystallization 
trials. Another future aim is to elucidate the overall assembly of VE-cadherin junctions and 
other type II cadherin mediated junctions by cryo electron tomography of artificial adherens 
junctions between liposomes.   
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8.4 Type II cadherin specificity – a code to crack 
SPR experiments with purified type II cadherins to elucidate the binding specificity pattern 
within this group showed promiscuous binding between cadherin-6, -9 and -10, but no 
interactions were observed between cadherin-6 and cadherin-8 and -11. Type II cadherins-6, -
9, -10 are more related to each other on sequence level (78-84% sequence identity, EC1-
domains) than they are to cadherin-8 and -11 (59-64% sequence identity, EC1 domains). 
Similarly, cadherin-8 and -11 share with each other a higher similarity on sequence level 
(72% identity) than to cadherin-6, -9, -10 (59-64%). These data together suggest that there are 
subgroups within the type II family that engage in restricted heterophilic interactions. Our 
data agree with promiscuity and selectivity patterns derived from cell aggregation data (Patel 
et al., 2006; Price et al., 2002; Shimoyama et al., 1999; Shimoyama et al., 2000). From these 
data we can extract evidence for other subgroups that may interact preferentially, for example 
cadherin-8 and -11 and cadherin-7 and -14 (Shimoyama et al., 2000).  
 
Because data derived from our SPR studies directly correlates with data from cell aggregation 
assays we will expand the studies to include all combinations of type II cadherins. 
Preliminary data from SPR experiments further to those reported in Section 6.2.4 of this thesis 
show that cadherin-11 coupled to the sensor surface binds heterophilically to cadherin-8, in 
preference to binding to less related cadherins-6, -9, and -10. This supports our theory that 
type II cadherin promiscuity and selectivity directly relates to sequence identity and therefore 
to sub-subfamily organization within the type II family. Future experiments will aim to 
measure a type II cadherin-wide SPR matrix to test this more fully. 
 
In contrast to cell aggregation assays conducted by Shimoyama et al (2000), in which 
expression levels of cadherin-9 and -10 were substantially lower, SPR studies conducted on 
purified proteins had exact same protein concentrations for analyte cadherins, which enables 
quantitative comparisons of heterophilic binding facilitated by a certain cadherin. SPR 
experiments provided a more finely grained quantitation, as we can see that cadherin-6 prefers 
homophilic binding at least 1.5fold over heterophilic binding to cadherin-9 and 3fold over 
cadherin-10, which is difficult to discern from aggregation assays as for example homophilic 
cadherin-6 aggregates looked identical to cadherin-6/ cadherin-9 cell aggregates. Nonetheless, 
the general trend in our data correlates with the findings on cellular level. We see a hierarchy 
for binding to cadherin-6: homophilic > heterophilic with cadherin-9 > heterophilic with 
cadherin-10. Notably, cadherin-6 and -10 formed in cell-cell aggregation assays heterophilic 
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aggregates, with cadherin-6 expressing cells surrounded by cadherin-10 expressing cells 
(Shimoyama et al., 2000). This kind of heterogeneous aggregate has also been observed in N- 
and E-cadherin transfected cell aggregates (Katsamba et al., 2009; Patel et al., 2006), in which 
N-cadherin expressing cells (high affinity homophilic binding) were surrounded by E-
cadherin expressing cells (low affinity homophilic binding), which indicated that the 
organization of cell aggregates was driven by thermodynamical rules/ homophilic binding 
affinity. In agreement, with cadherin-6 has a homodimerization affinity of 3.1µM and 
cadherin-10 a substantially lower KD of 42.2µM. However, affinities of cadherin-6 and -9 are 
not equal, 3.13µM and 17µM, respectively, but nonetheless homogeneous aggregates are 
formed, indicating that affinities alone do not govern aggregate morphology.  
 
The observed fine differences in specificity are especially interesting because type II 
cadherins are all closely similar to each other on sequence and structural levels (Patel et al., 
2006) even more so than type I cadherins. For example mouse E- and N-cadherin share in 
their EC1 domain a sequence identity of 58%, whereas within the type II subfamily, sequence 
identity reaches up to 84%. The minimal differences in sequence between cadherin-8, -11 and 
cadherin-6, -9 , -10 nonetheless cause homophilic preference over heterophilic interactions as 
seen in our SPR experiments. For example, cadherin-6 shows preference for homophilic 
binding over binding with cadherin-9 and -10 (Shimoyama et al., 2000), although on sequence 
level it shares >82% of identity with specificity governing EC1 domains of the latter 
cadherins. It will be interesting to relate patterns of binding preference from SPR experiments 
conducted with all type II cadherins to specific residue differences in the binding interface. 
Results of these studies could then be applied to mutagenesis studies to determine the minimal 
set of residues that need to be mutated in order to convert type II cadherins specificity. Such 
an approach should be facilitated by the small number of non-conserved residues in EC1 for 
type II cadherins. 
 
It is not uncommon for cell-cell adhesion molecules that very small differences are sufficient 
to determine binding specificity. For example, in Dscam molecules, which function as 
important neural cell adhesion and recognition molecules in the fly, as few as one non-
conserved residue positioned in an important homophilic binding region localized within 
parallel β-strands in the dimer is enough to govern specificity (Wojtowicz et al., 2007). This is 
reminiscent of the fine tuned specificity found in type II cadherins and suggests the possibility 
that sensitivity of binding affinity to very small binding site differences might be a general 
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feature of homophilic systems. Considering the knowledge from domain shuffling 
experiments showing that cadherin domain EC1 governs specificity (Nose et al., 1990; Patel 
et al., 2006; Price et al., 2002) and structural data for type II cadherins MN, 8, 10 and 11 
(Patel et al., 2006), (Brasch, unpublished data), regions in which residue exchanges might 
have a dramatic effect on specificity must lie outside the core strand swap region, which 
shows essentially no variation. Thus, the region lining the rim of the acceptor pocket or the 
extended non swapped hydrophobic interface along domain EC1 are a likely possibility for 
minor residue changes to translate into specificity.  
 
But does type II cadherin binding specificity play a role in vivo? A wide array of type II 
cadherins are found to be co-expressed in the CNS (Price et al., 2002; Suzuki, 1997) in 
distinct but overlapping patterns. Also, there is a correlation between expression of certain 
type II cadherins and segregation of different regions in the CNS (Patel et al., 2006; Suzuki, 
1997). Studies of Price et al (2002) elucidated an important role for multiple type II cadherins 
in motor pools in the spinal cord which are linked to motor organization. Motor pools are 
small groups of clustered functional subsets of motor neurons in the lateral motor column of 
the spinal cord (Price et al., 2002). No type I cadherins, except divergent T-cadherin, are 
found to be expressed in motor pools (Fredette and Ranscht, 1994; Price et al., 2002) which 
appear to segregate from each other by switching on expression of different sets of type II 
cadherins, sometimes with different expression levels of each (Price et al., 2002). MN-
cadherin for example is abundant in all neurons of this region before distinct motor pools 
form. Then MN-cadherin expression is lost for most motor pools, but maintained in the 
Adductor pool, which leads to its segregation from the eF pool, which expresses an identical 
complement of cadherins except for MN (Price et al., 2002). When MN-cadherin expression 
is also induced in the eF pool by in ovo electroporation to equalize the cadherins,, loss of 
segregation leading to intermixing is observed (Price et al., 2002). Interestingly, 
electroporation of a mutant MN-cadherin containing the EC1 domain of cadherin-6b, a 
cadherin already expressed in both pools, does not cause intermixing suggesting that 
differences in the adhesive interface of MN and 6b (74% identical in EC1) are sufficient to 
drive biologically relevant cell sorting (Patel et al., 2006).  
 
One clear exception in the type II cadherin family regarding combinatorial type II cadherin 
expression is VE-cadherin which is expressed exclusively in the vascular endothelium and is 
unlikely to be involved in cell sorting processes with other type II cadherins. The divergent 
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interface we observe is likely to reflect that no selection pressure has acted on VE-cadherin to 
maintain selective, promiscuous interactions with other type II cadherin subfamily members. 
Our SPR experiments suggest that VE does not cross interact with any of type II cadherins-6, 
-8, -9, -10 and -11, which is most likely due to hydrophilic residues in VE-cadherin, where 
type II cadherins show a non-polar extended interface region. However, SPR experiments 
involving VE-cadherin binding were hampered by weak homophilic binding responses that 
were probably due to ‘slow’ kinetics, since VE-cadherin binding in longer time-frame AUC 
experiments was strong. VE-cadherin kinetic behavior studied in single molecule force 
microscopy experiments between endothelial cells by Wirtz et al (2006) revealed in 
comparison to type I cadherins E and N a substantially longer bond lifetime, which is in 
agreement with the binding responses we observe in SPR experiments. Notably, type II 
cadherins in general were found to have ‘slower’ kinetics than type I cadherins, which is 
reflected by the shape of the binding curves in our SPR experiments and in published results 
of dual pipette assays (Chu et al., 2006). Co-ip experiments could be successfully used to 
identify homophilic binding between the same VE-cadherin proteins used for SPR 
experiments, but appear not to be sensitive enough for detection of heterophilic binding such 
as that between VE- and N-cadherin or between N- and E-cadherin, which appears to be less 
stable. Nonetheless, if type II cadherin heterophilic binding is more stable, we might be able 
to assess heterophilic binding with co-ip experiments. Otherwise, cell aggregation assays of 
VE-cadherin transfected cells with those expressing other type II cadherins will be needed in 
order to confirm our results that show no binding between VE-cadherin and other members of 
the type II subfamily. Surprisingly, VE-cadherin has never been tested before in cell 
aggregation assays with other type II cadherins, published cell studies are limited to type I E-, 
N- and P-cadherin expressing cells. 
 
8.5 Interactions between cadherins in vascular endothelial cells  
VE-cadherin, a divergent type II cadherin crucial for angiogenesis and vascular maintenance, 
is expressed exclusively in the vascular endothelium and forms adherens junctions between 
endothelial cells (Breier et al., 1996; Dejana, 1996; Dejana et al., 1996; Gentil-Dit-Maurin et 
al., 2010; Lampugnani et al., 1992; Vittet et al., 1997). Co-expressed in the endothelium 
alongside VE-cadherin are type I N-cadherin and in low levels P-cadherin which do not co-
localize in adherens junctions in endothelial cells in which VE-cadherin is present (Gentil-
Dit-Maurin et al., 2010; Jaggi et al., 2002; Liaw et al., 1990; Navarro et al., 1998; Salomon et 
al., 1992). This is in contrast to other tissues, in which N-cadherin and P-cadherin are 
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junctional (Gentil-Dit-Maurin et al., 2010; Jaggi et al., 2002; Navarro et al., 1998). VE-
cadherin displaces N-cadherin actively from endothelial adherens junctions, leaving it evenly 
dispersed over the cell surface (Jaggi et al., 2002; Navarro et al., 1998; Salomon et al., 1992). 
This is not a general activity of VE-cadherin but is specific for N-cadherin because E-
cadherin and P-cadherin junction formation in transfected cells was not disturbed by co-
expressed VE-cadherin (Jaggi et al., 2002). In our SPR experiments we found very 
surprisingly a strong heterophilic binding of N-cadherin wild type or strand swap mutant 
protein to VE-cadherin. This is the first time that a strong interaction has been observed 
between a type I and type II cadherin; in most experiments conducted to investigate 
heterophilic binding no interactions were observed between type I and II cadherins, for 
example between cadherin-6 and N- or E-cadherin (Katsamba et al., 2009; Nakagawa and 
Takeichi, 1995; Patel et al., 2006; Shimoyama et al., 1999; Shimoyama et al., 2000). The 
interaction between VE- and N-cadherin was independent from strand swap exchange, as 
W2A strand swap mutant protein of N-cadherin was also observed to bind to VE-cadherin 
surfaces. This is in agreement with the fact that both proteins have remarkably different 
adhesive strand swap interfaces and also with previous results from plate-cell adhesion 
assays, in which cells transfected with either N- or VE-cadherin failed to heterophilically bind 
to each other (Breviario et al., 1995; Navarro et al., 1998). Therefore, it can be excluded that 
this interaction is mediating trans-adhesion, indicating it to be lateral. It is interesting to 
speculate that this interaction could trigger the displacement of N-cadherin by VE-cadherin 
from vascular endothelial adherens junctions. Interestingly, in transfection experiments the N-
cadherin extracellular domain was shown to be involved in the displacement, supporting this 
possibility. 
 
Despite strong evidence of binding between VE- and N-cadherin in SPR experiments, this 
interaction could not be observed in co-ip experiments, which might be due to instability and 
short bond life time, which appears likely considering the traces suggesting fast on/off 
binding rates in SPR experiments. In the future, we need to expand our studies and test if VE-
cadherin strand swap mutants also bind heterophilically to N-cadherin in SPR experiments to 
determine if the interaction is fully independent of the strand swap interface. In addition, we 
plan to investigate if the putative complex can be purified by size exclusion chromatography 
of N-cadherin VE-cadherin mixtures to confirm our SPR binding data and potentially to allow 
us to determine a crystal structure of the complex to shed light on this novel interaction on a 
molecular level.   
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9. Future Directions 
 
The described work provides detailed and extensive insight into the structure and binding 
mechanism of VE-cadherin, which is the major cell-cell adhesion receptor found in adherens 
junctions in the vascular endothelium, where it plays a critical role in vascular angiogenesis 
and maintenance. The adhesive dimer of VE-cadherin was found to utilize the 3D domain 
swapping mechanism in common with other classical cadherins, however, the adhesive 
interface was shown to be unique to this particular cadherin as it shares features of adhesive 
interfaces observed for type I and type II cadherins and exhibiting remarkably strong binding 
affinities. However, the molecular mechanism underlying VE-cadherin assembly in adherens 
junctions remains elusive. Electron micrographs of artificial junctions between liposomes are 
different from those of type I cadherins, suggesting that the junction assembly of VE-cadherin 
and maybe other type II cadherins, too, is different from that reported for type I cadherins. 
Therefore, crystallization of full length ectodomains of VE-cadherin of different species will 
be attempted so that potential ectodomain-mediated interfaces involved in clustering at 
junctions can be determined. In parallel we will examine the organization of VE-cadherin in 
junctions formed between liposomes by electron microscopy tomography. Additionally, 
relevance of crystal contacts other than the adhesive dimer observed in the VE-cadherin EC1-
2 crystal structure will be tested by targeted mutagenesis studies.  
 
An experimental set up was designed for systematic binding studies with the aim to 
understand promiscuous adhesive binding inherent to classical type II cadherins. Based on 
results reported here, which confirm and extend previous cell aggregation data, it was 
possible to propose for the first time a binding code underlying the regulation type II 
cadherin-mediated cell-cell adhesion in the CNS. This binding code will be tested in future by 
extending these experiments to an overall binding matrix including the 13 known classical 
type II cadherins. Binding preferences for the cadherins tested can then be used to relate 
specificity to the small set of non-conserved residues in the adhesive domain EC1. It will be 
of great interest to identify the minimal set of residues responsible for adhesive specificity in 
these cadherins. 
 
For the first time we observed binding between a type I and type II classical cadherin, N- and 
VE-cadherin, which are co-expressed in the vasculature. Based on our findings, this 
interaction appears to be independent from the strand swap mechanism and likely to be a 
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lateral interaction. This novel interaction needs to be validated in future experiments. The 
complexes formed between VE- and N-cadherin can be tested for stability by size exclusion 
chromatography and then could be co-crystallized, which would provide detail on this novel 
interface on atomic level.  
 
Overall, this work provides an extensive study of structural and biophysical adhesive binding 
features of VE-cadherin and insight into the binding code of classical type II cadherins, which 
contributes to the understanding of the binding interface diversity and specificity in cadherin 
cell-cell adhesion. 
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